<SEC-DOCUMENT>0001513162-21-000128.txt : 20211014
<SEC-HEADER>0001513162-21-000128.hdr.sgml : 20211014
<ACCEPTANCE-DATETIME>20211014165906
ACCESSION NUMBER:		0001513162-21-000128
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		47
CONFORMED PERIOD OF REPORT:	20210831
FILED AS OF DATE:		20211014
DATE AS OF CHANGE:		20211014

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37863
		FILM NUMBER:		211323829

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bmra-20210831.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 14 19:29:04 UTC 2021 -->
<html xmlns:bmra="http://www.biomerica.com/20210831" xmlns:compsci="http://compsciresources.com" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace"><head><title>Form 10Q</title>
<meta content="text/html" http-equiv="Content-Type" />
</head> <body><div> </div><div style="page:WordSection1"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">UNITED STATES</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">SECURITIES AND EXCHANGE COMMISSION</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">WASHINGTON, D.C. 20549</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">10-Q</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Mark One)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">[<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentQuarterlyReport">X</ix:nonNumeric>] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">FOR THE QUARTERLY PERIOD ENDED <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate">AUGUST 31, 2021</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">OR</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">[ ]</ix:nonNumeric> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Commission File Number:&#160; <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-37863</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">BIOMERICA, INC.</span></b></ix:nonNumeric></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">--------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Exact name of registrant as specified in its charter)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber">95-2645573</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">--------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(State or other jurisdiction of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;(I.R.S. Employer</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">incorporation or organization)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;Identification No.)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">17571 Von Karman Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Irvine</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">92614</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">-------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Address of principal executive offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Zip Code)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Registrant's telephone number including area code:&#160; (<ix:nonNumeric contextRef="c0" name="dei:CityAreaCode">949</ix:nonNumeric>) <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber">645-2111</ix:nonNumeric></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">--------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">--------------------------------------------------------------------------------------------------------------------------------------------------------------------</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Former name, former address and former fiscal year, if changed since last report.)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt; TEXT-INDENT:0.5in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Securities registered pursuant to Section 12(b) of the Act:</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="WIDTH:550.1pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="733"> <tr style="HEIGHT:16.8pt"> <td style="HEIGHT:16.8pt; WIDTH:177.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">(TITLE OF EACH CLASS)</span></p></td> <td style="HEIGHT:16.8pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 24%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;(TICKER SYMBOL) </span></p></td> <td style="HEIGHT:16.8pt; WIDTH:48.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">(NAME OF EACH EXCHANGE ON WHICH REGISTERED)</span></p></td></tr> <tr style="HEIGHT:8.1pt"> <td style="HEIGHT:8.1pt; WIDTH:177.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;----------------------------------- </span></p></td> <td style="HEIGHT:8.1pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 24%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;-----------------------------------&#160; </span></p></td> <td style="HEIGHT:8.1pt; WIDTH:48.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">&#160;------------------------------------------------------------------------------- </span></p></td></tr> <tr style="HEIGHT:16.8pt"> <td style="HEIGHT:16.8pt; WIDTH:177.85pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:Security12gTitle"><span style="FONT-SIZE:10pt; COLOR:black">Common, par value $.08</span></ix:nonNumeric></p></td> <td style="HEIGHT:16.8pt; WIDTH:24%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 24%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="FONT-SIZE:10pt; COLOR:black">BMRA</span></ix:nonNumeric></p></td> <td style="HEIGHT:16.8pt; WIDTH:48.02%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric> Capital Market</span></p></td></tr></table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 69.65pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Indicate by check whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 69.65pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; color: black;"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric> [X]&#160; No [<span style="font-size: 10pt;"><span style="text-decoration:underline">&#160; </span></span>]</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 69.65pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 69.65pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (paragraph 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).</span></p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 69.65pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; color: black;"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric> [X]&#160; No [<span style="font-size: 10pt;"><span style="text-decoration:underline">&#160; </span></span>]</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 69.65pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 69.65pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Indicate by check mark whether the registrant is a large accelerated, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer,", "accelerated filer,", "smaller reporting company", and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 69.65pt 0pt 0in">&#160;</p> <p>&#160;</p>
<table cellpadding="0" cellspacing="0" style="width: 6.25in; border-collapse: collapse;" width="600">
<tr style="height: 15pt;">
<td style="height: 15pt; width: 122.9pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Large Accelerated Filer <span style="text-decoration: underline;">[ &#160;]</span></span></p>
</td>
<td style="height: 15pt; width: 189.6pt; padding: 0in;">&#160;</td>
<td style="height: 15pt; width: 137.5pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Accelerated Filer&#160;&#160;&#160;[<span style="text-decoration: underline;">&#160; </span>]</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-Accelerated Filer</ix:nonNumeric> &#160;&#160;<span style="color: black;">[X]</span></span></p>
</td>
<td style="height: 15pt; padding: 0in;">&#160;</td>
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Smaller Reporting Company <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness">[X]</ix:nonNumeric></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; padding: 0in;">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Emerging Growth Company <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany">[<span style="text-decoration: underline;">&#160; </span>]</ix:nonNumeric></span></p>
</td>
</tr>
</table> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 69.65pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 69.65pt 0pt 0in">&#160;</p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 69.65pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family: 'Times New Roman','serif'; color: black;">[<span style="font-size: 10pt;"><span style="text-decoration:underline">&#160; </span></span>]&#160;</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 69.65pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 69.65pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).</span></p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 69.65pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">&#160;<span style="color: black;">Yes [<span style="font-size: 10pt;"><span style="text-decoration:underline">&#160; </span></span>]&#160; No <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany">[X]</ix:nonNumeric></span></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 69.65pt 0pt 0in">&#160;</p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 69.65pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">The number of shares of the registrant's common stock outstanding as of October 14, 2021 was <ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">12,511,210</ix:nonFraction>. <span style="page-break-before: always; clear: both;"><br/></span></span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <div style="text-align: left;"> <a id="TOC"></a><table cellpadding="0" cellspacing="0" style="width: 635.05pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="847">

<tr style="height: 15pt;">
<td colspan="3" style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">BIOMERICA, INC.</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td colspan="3" style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">INDEX</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#Part1">PART I </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#Part1">Financial Information </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#ITEM1">Item 1. </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#ITEM1">Financial Statements: </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 80%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#IS">Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) &#8211; Three Months Ended August 31, 2021 and 2020 (restated) </a></span></p>
</td>
<td style="height: 26.25pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#BS">Condensed Consolidated Balance Sheets (unaudited) August 31, 2021 and May 31, 2021 (restated) </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 26.25pt;">
<td style="height: 26.25pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 26.25pt; width: 80%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#SHEQ">Condensed Consolidated Statements of Shareholders&#8217; Equity &#8211; (unaudited) Three Months Ended August 31, 2021 and 2020 (restated) </a></span></p>
</td>
<td style="height: 26.25pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 14.85pt;">
<td style="height: 14.85pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.85pt; width: 80%; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#CF">Condensed Consolidated Statements of Cash Flows (unaudited) - Three Months Ended August 31, 2021 and 2020 (restated) </a></span></p>
</td>
<td style="height: 14.85pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">4</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#NOTES">Notes to Condensed Consolidated Financial Statements (unaudited) </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">5 - 14 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#MD&amp;A">Item 2. </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#MD&amp;A">Management's Discussion and Analysis of Financial Condition and Results of Operations </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">14 - 16</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#ITEM3">Item 3. </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#ITEM3">Quantitative and Qualitative Disclosures about Market Risk </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">16</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#ITEM4">Item 4.&#160; </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#ITEM4">Controls and Procedures </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">16 - 17</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#PART2">PART II </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#PART2">Other Information&#160; </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#LEGAL">Item 1. </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#LEGAL">Legal Proceedings </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">17</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#RISKS">Item 1A. </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#RISKS">Risk and Uncertainties </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">17 - 18</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#OTHERINFO">Item 5. </a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#OTHERINFO">Other Information </a>&#160;</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">18</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#EXHIBIT">Item 6.</a></span></p>
</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#EXHIBIT">Exhibits </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">18</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 80%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><a href="#SIGNATURE">Signatures </a></span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">19</span></p>
</td>
</tr>

</table></div></div><div><span style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><span style="PAGE-BREAK-BEFORE:always; clear: both;"><br/></span></span></div><div> </div><div style="page:WordSection2"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC">Table of Contents&#160; </a></span></p> <a id="Part1"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">PART I - FINANCIAL INFORMATION</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">SUMMARIZED FINANCIAL INFORMATION</span></p> <a id="ITEM1"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 1. FINANCIAL STATEMENTS</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">BIOMERICA, INC. AND SUBSIDIARIES</span></p> <a id="IS"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></p> <p style="font-size: 10pt; font-family: 'Courier New'; text-align: center; margin: 0in 0in 0pt;"><span style="font-family: 'Times New Roman','serif';">AND COMPREHENSIVE LOSS (UNAUDITED)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="width: 750pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="1000">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="5" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Three Months Ended</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2020</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman', 'serif'; margin: 0in 0in 0pt; text-align: center;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">( As Restated)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net sales </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">1,261,787</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">1,143,806</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cost of sales </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="0" unitRef="usd">1,350,757</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="0" unitRef="usd">1,025,717</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Gross (Loss) Profit</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" sign="-" unitRef="usd">88,970</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">118,089</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Operating Expenses: </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Selling, general and administrative </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">1,011,535</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">1,305,944</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Research and development </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">439,864</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">711,505</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in 0in 0in 0.25in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total operating expense </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">1,451,399</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">2,017,449</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Loss from operations </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">1,540,369</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">1,899,360</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Other Income: </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Dividend and interest income </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="0" unitRef="usd">6,805</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="0" unitRef="usd">8,091</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Loss before income taxes </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">1,533,564</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">1,891,269</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Provision for income taxes </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">9,017</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="usd">1,125</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,542,581</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,892,394</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Basic net loss per common share </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.12</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.16</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Diluted net loss per common share </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.12</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.16</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.65pt;">
<td style="height: 16.65pt; width: 2.9in; background: #b8cce4; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Weighted average number of common and <br/>common equivalent shares: </span></p>
</td>
<td style="height: 16.65pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 16.65pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 16.65pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 16.65pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 16.65pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Basic </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">12,426,784</ix:nonFraction> </span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">11,748,377</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Diluted </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares">12,426,784</ix:nonFraction> </span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares">11,748,377</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15.75pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,542,581</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,892,394</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Other comprehensive loss, net of tax: </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Foreign currency translation </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">5,613</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">1,721</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.9in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.9in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Comprehensive loss </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">1,548,194</ix:nonFraction>)</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">1,894,115</ix:nonFraction>)</span></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 0in 0pt; text-align: left;"><span style="font-family: 'Times New Roman','serif';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The accompanying notes are an integral part of these statements.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">1</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">BIOMERICA, INC. AND SUBSIDIARIES</span></p> <p style="font-size: 10pt; font-family: 'Courier New'; text-align: center; margin: 0in 0in 0pt;"><span style="font-family: 'Times New Roman','serif';">CONDENSED CONSOLIDATED BALANCE SHEETS<br/></span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <div style="text-align: left;"> <p>&#160;</p>
<table cellpadding="0" cellspacing="0" style="width: 750pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="1000">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">May 31, 2021</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-family: 'Times New Roman','serif';"> <span style="font-size: 10pt; color: black;">(Unaudited)</span></span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(As Restated)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Assets</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Current Assets:</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">4,996,623</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">4,199,311</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accounts receivable, less allowance for doubtful accounts<br/>&#160; &#160; &#160; &#160;of $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" unitRef="usd">742,524</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" unitRef="usd">837,415</ix:nonFraction> as of August 31, 2021 and&#160; May 31, 2021, respectively<br/></span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" unitRef="usd">772,190</ix:nonFraction></span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" unitRef="usd">1,455,051</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Inventories, net</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd">2,861,779</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd">3,206,255</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Prepaid expenses and other</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd">315,221</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd">370,290</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total current assets</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">8,945,813</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd">9,230,907</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Property and equipment, net of accumulated depreciation and amortization&#160;<br/>&#160; &#160; &#160; &#160;of $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="usd">2,000,167</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="usd">1,972,357</ix:nonFraction> as of August 31, 2021 and May 31, 2021, respectively<br/></span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><span style="font-size: 10pt; color: black; font-family: 'times new roman', times, serif;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">287,852</ix:nonFraction></span></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><span style="font-size: 10pt; color: black; font-family: 'times new roman', times, serif;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">310,520</ix:nonFraction></span></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Right of use assets, net of accumulated amortization of $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization" scale="0" unitRef="usd">531,974</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization" scale="0" unitRef="usd">469,077</ix:nonFraction><br/>&#160; &#160; &#160; &#160;as of August 31, 2021 and May 31, 2021, respectively<br/></span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><span style="font-size: 10pt; color: black; font-family: 'times new roman', times, serif;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" unitRef="usd">1,490,184</ix:nonFraction></span></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><span style="font-size: 10pt; color: black; font-family: 'times new roman', times, serif;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" unitRef="usd">1,553,081</ix:nonFraction></span></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Investments</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="0" unitRef="usd">165,324</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="0" unitRef="usd">165,324</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Intangible assets, net of accumulated amortization of $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd">83,683</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd">126,769</ix:nonFraction> as<br/>&#160; &#160; &#160; &#160;of August 31, 2021 and May 31, 2021, respectively<br/></span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" unitRef="usd">360,292</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="0" unitRef="usd">294,830</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Other assets</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" unitRef="usd">266,582</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="0" unitRef="usd">264,151</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total Assets</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">11,516,047</ix:nonFraction> </span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd">11,818,813</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Liabilities and Shareholders' Equity</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Current Liabilities:</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accounts payable and accrued expenses</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">641,404</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="0" unitRef="usd">583,380</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accrued compensation</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="0" unitRef="usd">507,722</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="0" unitRef="usd">388,896</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Lease liability, current portion</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" unitRef="usd">332,967</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" unitRef="usd">327,944</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total current liabilities</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">1,482,093</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd">1,300,220</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Lease liability, net of current portion</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" unitRef="usd">1,230,898</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" unitRef="usd">1,291,570</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total Liabilities</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">2,712,991</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd">2,591,790</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Commitments and contingencies (Notes 1 and 6)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-0">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</div></td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-1">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Shareholders' Equity:</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Preferred stock, Series A 5% convertible, $<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></ix:nonFraction> par value,<br/>&#160; &#160; &#160; &#160;<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">571,429</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction contextRef="c5" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding as of August 31, 2021 and May 31, 2021<br/></span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-2"><span style="font-size: 10pt; color: black;">-</span></div></td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-3"><span style="font-size: 10pt; color: black;">-</span></div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Preferred stock, undesignated, <ix:nonFraction contextRef="c3" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockNoParValue" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockNoParValue" scale="0" unitRef="usdPershares">no</ix:nonFraction></ix:nonFraction> par value,<br/>&#160; &#160; &#160; &#160;<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="bmra:PreferredStockUndesignatedShares" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="bmra:PreferredStockUndesignatedShares" scale="0" unitRef="shares">4,428,571</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction contextRef="c3" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding as of August 31, 2021 and May 31, 2021<br/></span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-4"><span style="font-size: 10pt; color: black;">-</span></div></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-5"><span style="font-size: 10pt; color: black;">-</span></div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Common stock, $<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares">0.08</ix:nonFraction></ix:nonFraction> par value,<br/>&#160; &#160; &#160; &#160; <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">25,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">12,510,210</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">12,307,157</ix:nonFraction></ix:nonFraction> issued and outstanding at<br/>&#160; &#160; &#160; &#160;&#160;August 31, 2021 and May 31, 2021, respectively</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">1,000,815</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in; text-align: right;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd">984,571</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Additional paid-in-capital</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">39,944,726</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">38,836,743</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated other comprehensive loss</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="0" sign="-" unitRef="usd">53,569</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="0" sign="-" unitRef="usd">47,956</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated deficit</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">32,088,916</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">30,546,335</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 6.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total Shareholders' Equity</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">8,803,056</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">9,227,023</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 6.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total Liabilities and Shareholders' Equity</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">11,516,047</ix:nonFraction> </span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd">11,818,813</ix:nonFraction> </span></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 0in 0pt; text-align: left;"><span style="font-family: 'Times New Roman','serif';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The accompanying notes are an integral part of these statements.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">2</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">B<span style="COLOR:black">IOMERICA, INC. AND SUBSIDIARIES</span></span></p> <a id="SHEQ"></a><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">For the Three Months Ended August 31, 2020 (As Restated)</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="width: 763.8pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="1018">

<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="4" style="height: 14.7pt; width: 112.4pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Series A 5% Convertible</span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 57pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 14.7pt; width: 80.95pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated Other</span></p>
</td>
<td style="height: 14.7pt; width: 5.25pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 3.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.35pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="4" style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 112.4pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Common Stock</span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="4" style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 112.4pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Preferred Stock</span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 14.7pt; width: 64.65pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Additional </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 14.7pt; width: 80.95pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Comprehensive</span></p>
</td>
<td style="height: 14.7pt; width: 5.25pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 14.7pt; width: 57.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated</span></p>
</td>
<td style="height: 14.7pt; width: 3.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.35pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 50.3pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Shares</span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: windowtext 1pt solid; height: 14.7pt; border-right: 0px; width: 57.9pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Amount</span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 50.3pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Shares</span></p>
</td>
<td style="height: 14.7pt; width: 5.55pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: windowtext 1pt solid; height: 14.7pt; border-right: 0px; width: 56.55pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Amount </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 64.65pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;Paid-in Capital</span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 80.95pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Loss</span></p>
</td>
<td style="height: 14.7pt; width: 5.25pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 57.9pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Deficit</span></p>
</td>
<td style="height: 14.7pt; width: 3.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 58pt; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Balances, May 31, 2020. restated</span></p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">11,740,089</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">939,205</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">321,429</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 5.55pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 14.7pt; width: 48.9pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">25,714</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 14.7pt; width: 57pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">36,388,056</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 14.7pt; width: 71.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">39,841</ix:nonFraction>)</span></p>
</td>
<td style="height: 14.7pt; width: 5.25pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">23,100,081</ix:nonFraction>) </span></p>
</td>
<td style="height: 14.7pt; width: 3.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 14.7pt; width: 50.35pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">14,213,053</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.55pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 48.9pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 57pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 71.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.25pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 3.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.35pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercise of stock options</span></p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">12,500</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">1,000</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 5.55pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 48.9pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 57pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">13,900</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 71.9pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 14.7pt; width: 5.25pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 14.7pt; width: 3.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.35pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">14,900</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.55pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 48.9pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 57pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 71.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.25pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 3.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.35pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Foreign currency translation</span></p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 5.55pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 48.9pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 57pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 71.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">1,721</ix:nonFraction>)</span></p>
</td>
<td style="height: 14.7pt; width: 5.25pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 14.7pt; width: 3.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.35pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">1,721</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.55pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 48.9pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 57pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 71.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.25pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 3.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.35pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Compensation expense in connection with options granted</span></p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 5.55pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 48.9pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 57pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c14" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd">246,787</ix:nonFraction> </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 71.9pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 14.7pt; width: 5.25pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 14.7pt; width: 3.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 7.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 14.7pt; width: 50.35pt; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd">246,787</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.55pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 48.9pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 57pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 71.9pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.25pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 3.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.35pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 50.3pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 4.15pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 50.3pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 50.3pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 5.55pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 48.9pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 57pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 14.7pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 9pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 71.9pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 14.7pt; width: 5.25pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 50.3pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,892,394</ix:nonFraction>)</span></p>
</td>
<td style="height: 14.7pt; width: 3.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 14.7pt; border-right: 0px; width: 50.35pt; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,892,394</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 14.7pt;">
<td style="height: 14.7pt; width: 256.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.55pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 48.9pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 57pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 4.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 71.9pt; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 5.25pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 3.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 7.65pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 14.7pt; width: 50.35pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.4pt;">
<td style="height: 15.4pt; width: 256.65pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Balances, August 31, 2020, restated</span></strong></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 50.3pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">11,752,589</ix:nonFraction> </span></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 4.15pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$&#160;</span></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 50.3pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c17" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">940,205</ix:nonFraction>&#160;</span></p>
</td>
<td style="height: 15.4pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 50.3pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c18" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">321,429</ix:nonFraction> </span></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 5.55pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$&#160;</span></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 48.9pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c18" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">25,714</ix:nonFraction> </span></p>
</td>
<td style="height: 15.4pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$&#160;</span></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 57pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">36,648,743</ix:nonFraction> </span></p>
</td>
<td style="height: 15.4pt; width: 4.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 9pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$&#160;</span></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 71.9pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">41,562</ix:nonFraction>) </span></p>
</td>
<td style="height: 15.4pt; width: 5.25pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$&#160;</span></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 50.3pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c21" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">24,992,475</ix:nonFraction>) </span></p>
</td>
<td style="height: 15.4pt; width: 3.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 7.65pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$&#160;</span></p>
</td>
<td style="border-top: 0px; height: 15.4pt; border-right: 0px; width: 50.35pt; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">12,580,625</ix:nonFraction> </span></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">For the Three Months Ended August 31, 2021</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="width: 757.85pt; border-collapse: collapse; margin-left: auto; margin-right: auto; height: 241px;" width="1010">

<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 64.7833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.6667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 58.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="4" style="height: 15px; width: 140.25px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Series A 5% Convertible</span></p>
</td>
<td style="height: 15px; width: 5.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 12.3px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 73.75px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15px; width: 107.317px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated Other</span></p>
</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 70.85px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 64.0333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="4" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 141.917px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Common Stock</span></p>
</td>
<td style="height: 15px; width: 5.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="4" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 140.25px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Preferred Stock</span></p>
</td>
<td style="height: 15px; width: 5.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15px; width: 87.1667px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Additional </span></p>
</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15px; width: 107.317px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Comprehensive</span></p>
</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15px; width: 80.1333px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated</span></p>
</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 64.0333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 64.7833px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Shares</span></p>
</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: windowtext currentcolor; border-style: solid none; border-width: 1pt 0px; height: 15px; width: 69.9833px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Amount</span></p>
</td>
<td style="height: 15px; width: 5.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 57.8px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Shares</span></p>
</td>
<td style="height: 15px; width: 9.41667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: windowtext currentcolor; border-style: solid none; border-width: 1pt 0px; height: 15px; width: 70.8px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Amount </span></p>
</td>
<td style="height: 15px; width: 5.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 87.1667px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;Paid-in Capital</span></p>
</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 107.317px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Loss</span></p>
</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 80.1333px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Deficit</span></p>
</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 75.1px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Balances, May 31, 2021, restated</span></p>
</td>
<td style="height: 15px; width: 60.9167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">12,307,157</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 6.8px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15px; width: 54.3333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">984,571</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 53.9333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 5.55px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 12.2833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15px; width: 49.6667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 8.43333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15px; width: 69.8833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">38,836,743</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 11.5167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15px; width: 94.6833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">47,956</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 5.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 8.16667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15px; width: 70.85px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">30,546,335</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 4.91667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15px; width: 64.0333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">9,227,023</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 60.9167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.05px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 6.8px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 54.3333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 53.9333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.55px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 12.2833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 49.6667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.43333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 69.8833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 11.5167px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 94.6833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 70.85px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 64.0333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercise of stock options</span></p>
</td>
<td style="height: 15px; width: 60.9167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">1,500</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 6.8px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 54.3333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">120</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 53.9333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 5.55px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 12.2833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 49.6667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 8.43333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 69.8833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">3,775</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 11.5167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 90.8167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 4.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 66.9833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 15px; width: 1.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 6.08333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 60.1667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="0" unitRef="usd">3,895</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 60.9167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.05px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 6.8px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 54.3333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 53.9333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.55px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 12.2833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 49.6667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.43333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 69.8833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 11.5167px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 90.8167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.9833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.05px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 6.08333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 60.1667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net proceeds from ATM</span></p>
</td>
<td style="height: 15px; width: 60.9167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares">201,553</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 6.8px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 54.3333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c27" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">16,124</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 53.9333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 5.55px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 12.2833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 49.6667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 8.43333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 69.8833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">784,586</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 11.5167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 90.8167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 4.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 66.9833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 15px; width: 1.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 6.08333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 60.1667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd">800,710</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 60.9167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.05px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 6.8px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 54.3333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 53.9333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.55px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 12.2833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 49.6667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.43333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 69.8833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 11.5167px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 94.6833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 70.85px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 64.0333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Foreign currency translation</span></p>
</td>
<td style="height: 15px; width: 60.9167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 6.8px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 54.3333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 53.9333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 5.55px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 12.2833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 49.6667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 8.43333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 69.8833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 11.5167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 90.8167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">5,613</ix:nonFraction>) </span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 4.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 66.9833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 15px; width: 4.91667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 64.0333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="0" sign="-" unitRef="usd">5,613</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 60.9167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.05px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 6.8px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 54.3333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 53.9333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.55px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 12.2833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 49.6667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.43333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 69.8833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 11.5167px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 90.8167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.9833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 64.0333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Compensation expense in connection with options granted</span></p>
</td>
<td style="height: 15px; width: 60.9167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 6.8px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 54.3333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 53.9333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 5.55px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 12.2833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 49.6667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 8.43333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 69.8833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd">319,622</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 11.5167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 90.8167px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 4.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 66.9833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 15px; width: 4.91667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 60.1667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd">319,622</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 60.9167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.05px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 6.8px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 54.3333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 53.9333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.55px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 12.2833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 49.6667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.43333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 69.8833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 11.5167px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 90.8167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.9833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 64.0333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 2.16667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 7.91667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 54.3333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 55.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 6.66667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 13.4px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 49.6667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 9.55px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 69.8833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</td>
<td style="height: 15px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 12.6333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 94.6833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">-</span></p>
</td>
<td style="height: 15px; width: 5.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 9.28333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 70.85px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c30" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,542,581</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 4.91667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 64.0333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,542,581</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.35pt;">
<td style="height: 15px; width: 338.417px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 60.9167px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.05px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 6.8px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 54.3333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 53.9333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.55px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 12.2833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 49.6667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.3px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.43333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 69.8833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 1.33333px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 11.5167px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 94.6833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 5.2px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 8.16667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 70.85px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 4.91667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 64.0333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.15pt;">
<td style="height: 16px; width: 338.417px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Balances, August 31, 2021</span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 62.0333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c31" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">12,510,210</ix:nonFraction> </span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 2.16667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 7.91667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$ </span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 54.3333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c31" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">1,000,815</ix:nonFraction> </span></strong></p>
</td>
<td style="height: 16px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 55.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">&#160;- </span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 6.66667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 13.4px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$ </span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 49.6667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">&#160;- </span></strong></p>
</td>
<td style="height: 16px; width: 1.3px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 9.55px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$ </span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 69.8833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c32" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">39,944,726</ix:nonFraction> </span></strong></p>
</td>
<td style="height: 16px; width: 1.33333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 12.6333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$ </span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 94.6833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c33" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">53,569</ix:nonFraction>)</span></strong></p>
</td>
<td style="height: 16px; width: 5.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 9.28333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$ </span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 66.9833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c34" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd">32,088,916</ix:nonFraction>) </span></strong></p>
</td>
<td style="height: 16px; width: 1.05px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 7.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$ </span></strong></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 60.1667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">8,803,056</ix:nonFraction> </span></strong></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 0in 0pt; text-align: left;"><span style="font-family: 'Times New Roman','serif';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The accompanying notes are an integral part of these statements.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">3</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div><span style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><span style="PAGE-BREAK-BEFORE:always; clear: both;"><br/></span></span> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">BIOMERICA, INC. AND SUBSIDIARIES</span></p> <a id="CF"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(UNAUDITED)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;">&#160;</p> <div style="text-align: left;"> <table cellpadding="0" cellspacing="0" style="width: 750pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="1000">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 14%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2020<br/>(As Restated)<br/></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from operating activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,542,581</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,892,394</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Adjustments to reconcile net loss to net cash provided by (used in) operating activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Depreciation and amortization </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="0" unitRef="usd">34,722</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="0" unitRef="usd">32,570</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Change in allowance on accounts receivable </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="0" sign="-" unitRef="usd">94,891</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="0" unitRef="usd">201,375</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Inventory reserve </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="0" unitRef="usd">179,744</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="0" unitRef="usd">5,005</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Stock option expense </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">319,622</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">246,787</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Amortization of right-of-use asset </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="bmra:OperatingLeaseRightofUseAssetAmortization" scale="0" unitRef="usd">62,897</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="bmra:OperatingLeaseRightofUseAssetAmortization" scale="0" unitRef="usd">57,257</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Changes in assets and liabilities: </span></strong></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accounts receivable </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" sign="-" unitRef="usd">777,752</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="0" unitRef="usd">18,924</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Inventories </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="0" sign="-" unitRef="usd">164,732</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="0" unitRef="usd">1,255,573</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Prepaid expenses and other</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" sign="-" unitRef="usd">55,069</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" sign="-" unitRef="usd">1,038,149</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Reduction in lease liability </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="bmra:IncreaseDecreaseInLeaseLiability" scale="0" sign="-" unitRef="usd">55,649</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="bmra:IncreaseDecreaseInLeaseLiability" scale="0" sign="-" unitRef="usd">49,880</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Other assets </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="0" unitRef="usd">2,431</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="0" unitRef="usd">276,438</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accounts payable and accrued expenses </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">58,024</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="0" unitRef="usd">284,202</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accrued compensation </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="0" unitRef="usd">118,826</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="0" unitRef="usd">30,718</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net cash provided by (used in) operating activities </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" unitRef="usd">75,836</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">1,597,146</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from investing activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Increase in intangibles </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" unitRef="usd">72,375</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" unitRef="usd">53,158</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Purchases of property and equipment </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" unitRef="usd">5,141</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" unitRef="usd">39,588</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net cash used in investing activities </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">77,516</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">92,746</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from financing activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Proceeds from sale of common stock, net </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" unitRef="usd">800,710</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-6"><span style="font-size: 10pt; color: black;">-</span></div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Proceeds from exercise of stock options </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" unitRef="usd">3,895</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" unitRef="usd">14,900</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net cash provided by financing activities </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">804,605</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd">14,900</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Effect of exchange rate changes in cash </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd">5,613</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd">1,721</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net increase (decrease)&#160; in cash and cash equivalents </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" unitRef="usd">797,312</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="0" sign="-" unitRef="usd">1,676,713</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at beginning of period</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">4,199,311</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">8,641,027</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at end of period</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">4,996,623</ix:nonFraction> </span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">6,964,314</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15.75pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Supplemental Disclosure of Cash-Flow Information: </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 70%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash paid during the period for:</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 70%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Income taxes </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd">9,017</ix:nonFraction> </span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaid" scale="0" unitRef="usd">1,125</ix:nonFraction> </span></p>
</td>
</tr>

</table></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="font-size: 10pt; font-family: 'Courier New'; margin: 0in 0in 0pt; text-align: left;"><span style="font-family: 'Times New Roman','serif';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The accompanying notes are an integral part of these statements.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">4</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">BIOMERICA, INC. AND SUBSIDIARIES</span></p> <a id="NOTES"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccounting-c0_cont_1" escape="true" name="us-gaap:BasisOfAccounting"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 1: &#160;BASIS OF PRESENTATION</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_2" id="_BasisOfAccounting-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Biomerica Inc. and subsidiaries (collectively the &#8220;Company&#8221;, &#8220;Biomerica&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221;) develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care <span style="COLOR:black">(in home and physicians' offices) </span>and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. <span style="COLOR:black">The</span> Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_3" id="_BasisOfAccounting-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our primary focus is the research and development of revolutionary, patented, diagnostic-guided therapy (&#8220;DGT&#8221;) products to treat gastrointestinal diseases, such as irritable bowel syndrome, and other inflammatory diseases. These products are directed at chronic inflammatory illnesses that are widespread and common, and as such address very large markets. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_4" id="_BasisOfAccounting-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our existing medical diagnostic products that are in the market are sold worldwide primarily in two markets: 1) clinical laboratories and 2) point-of-care (physicians' offices and over-the-counter drugstores like Walmart and Walgreens). Our diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient&#8217;s body, stools, or blood, often in extremely small concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_5" id="_BasisOfAccounting-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Due to the global 2019 SARS-CoV-2 novel coronavirus pandemic, in March 2020 we began redirecting and focusing a majority of our resources to develop, test, validate, seek regulatory approval for, and sell diagnostic products that indicate if a person has been infected by COVID-19. During fiscal 2021, we sold 2 primary types of COVID-19 tests; 1) antibody diagnostic tests that use a patient&#8217;s blood sample to detect if the patient has certain antibodies to COVID-19 that were created as part of their body&#8217;s immune response to a COVID-19 infection, even if the infection was asymptomatic, and 2) antigen tests that use a patient&#8217;s nasal fluid sample to detect if the patient is currently infected with the virus. <span style="COLOR:black">&#160;</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_6" id="_BasisOfAccounting-c0_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">Aside from the COVID-19 products we offer, the other products we sell are primarily focused on gastrointestinal diseases, food intolerances, cancer screening and awareness and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Most of our commercial products are CE marked and/or sold for diagnostic use where they are registered by each country&#8217;s regulatory agency.&#160; In addition, some products are cleared for sale in the U.S. by the FDA.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_7" id="_BasisOfAccounting-c0_cont_6"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The information set forth in these condensed consolidated financial statements is unaudited and reflects all adjustments which, in the opinion of management, are necessary to present a fair statement of the consolidated results of operations of Biomerica, Inc. and subsidiaries, for the periods indicated. It does not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. All adjustments that were made are of a normal recurring nature.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_8" id="_BasisOfAccounting-c0_cont_7"><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">The unaudited, condensed consolidated financial statements and notes are presented as permitted by the requirements for Form 10-Q and do not contain certain information included in the annual financial statements and notes. The condensed consolidated balance sheet data as of May 31, 2021 was derived from audited financial statements. The accompanying interim condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on August 27, 2021 for the fiscal year ended May 31, 2021, which have been restated as described in our Form 10-K/A as filed on October 14, 2021. The results of operations for the interim periods are not necessarily indicative of results to be achieved for the full fiscal year.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_BasisOfAccounting-c0_cont_9" id="_BasisOfAccounting-c0_cont_8"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black">CORRECTION OF AN ERROR</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation>  <a id="_Hlk84588416"></a><ix:continuation id="_BasisOfAccounting-c0_cont_9"><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">As disclosed in our Form 10-K/A for the year ended May&#160;31, 2021, filed on October 14, 2021, during the process of preparing our financial statements for the quarter ended August&#160;31, 2021, we determined that our calculation of non-cash stock-based compensation expense related to issued stock options in previously issued financial statements was incorrect. Our calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro rata over the period the requisite service was provided. As a result of these errors, certain previously reported amounts in the condensed consolidated statement of operations, condensed consolidated statement of stockholders&#8217; equity and condensed consolidated statement of cash flows for the quarter ended August 31, 2020, were materially misstated; accordingly, we have restated the prior period financial statements. </span><span style="font-family: 'Times New Roman','serif';">See Note 8 to the Financial Statements. </span></p></ix:continuation> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">5</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 2: &#160;SIGNIFICANT ACCOUNTING POLICIES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PRINCIPLES OF CONSOLIDATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">ACCOUNTING ESTIMATES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="_MarketsAndMethodsOfDistributionPolicyTextBlock-c0_cont_1" escape="true" name="bmra:MarketsAndMethodsOfDistributionPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">MARKETS AND METHODS OF DISTRIBUTION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:continuation id="_MarketsAndMethodsOfDistributionPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Due to</span><span style="FONT-SIZE:10pt"> the Coronavirus global pandemic, the Company&#8217;s operations have been negatively impacted.<span style="COLOR:black"> The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#8217;s manufacturing or distribution facilities or of the facilities of the Company&#8217;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions can materially negatively impact the Company&#8217;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" continuedAt="_LiquidityPolicyTextBlock-c0_cont_1" escape="true" name="bmra:LiquidityPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LIQUIDITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_9" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:continuation continuedAt="_LiquidityPolicyTextBlock-c0_cont_2" id="_LiquidityPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" sign="-" unitRef="usd">32.1</ix:nonFraction> million as of August 31, 2021.&#160; Management expects to continue to incur significant costs as it advances its trials and development activities.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_10" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:continuation continuedAt="_LiquidityPolicyTextBlock-c0_cont_3" id="_LiquidityPolicyTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $<ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="bmra:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" scale="0" unitRef="usd">15,000,000</ix:nonFraction> to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 </span><span style="FONT-SIZE:10pt">(<span style="COLOR:black">File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_11" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:continuation continuedAt="_LiquidityPolicyTextBlock-c0_cont_4" id="_LiquidityPolicyTextBlock-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_12" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11"><ix:continuation continuedAt="_LiquidityPolicyTextBlock-c0_cont_5" id="_LiquidityPolicyTextBlock-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Under an ATM Agreement, sales of shares are deemed to be &#8220;at the market offerings&#8221; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#8217;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; </span></p></ix:continuation></ix:continuation> <a id="_Hlk80862558"></a><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_13" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:continuation id="_LiquidityPolicyTextBlock-c0_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt"><span style="FONT-SIZE:10pt">As a result of cash and cash equivalents on hand at August 31, 2021, management believes the Company has sufficient funds to operate through November 2022 and the ability to raise additional funds through the ATM Agreement noted above.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_14" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">CONCENTRATION OF CREDIT RISK</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_15" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14"><ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_2" id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of August 31, 2021, the Company had approximately $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashUninsuredAmount" scale="0" unitRef="usd">4,790,000</ix:nonFraction> of uninsured cash.&#160; <span style="COLOR:black">The Company does not believe it is exposed to any significant credit risks.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">6</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_16" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_3" id="_ConcentrationRiskCreditRisk-c0_cont_2"><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">For the three months ended August 31, 2021 and 2020, the Company had two key distributors which accounted for <ix:nonFraction contextRef="c36" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">60</ix:nonFraction>% and <ix:nonFraction contextRef="c37" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">40</ix:nonFraction>% of net consolidated sales, respectively.&#160; At August 31, 2021 and May 31, 2021, the Company had two&#160;key distributors which accounted for a total of <ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">77</ix:nonFraction>% and <ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">73</ix:nonFraction>%, respectively, of gross accounts receivable. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_17" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16"><ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_3"><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">For the three months ended August 31, 2021 and 2020, one key vendor accounted for <ix:nonFraction contextRef="c40" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">17</ix:nonFraction>% and two key vendors accounted for <ix:nonFraction contextRef="c41" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">64</ix:nonFraction>% of the purchases of raw materials, respectively. As of August 31, 2021 and May 31, 2021, the Company had one key vendor which accounted for <ix:nonFraction contextRef="c42" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">25</ix:nonFraction>% and <ix:nonFraction contextRef="c43" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">17</ix:nonFraction>%, respectively, of accounts payable.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_18" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">CASH AND CASH EQUIVALENTS </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_19" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than three months.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_20" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:nonNumeric contextRef="c0" continuedAt="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">ACCOUNTS RECEIVABLE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_21" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:continuation continuedAt="_TradeAndOtherAccountsReceivablePolicy-c0_cont_2" id="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="us-gaap:ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable">ninety days</ix:nonNumeric> old are usually reserved for unless collection is reasonably assured. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_22" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation continuedAt="_TradeAndOtherAccountsReceivablePolicy-c0_cont_3" id="_TradeAndOtherAccountsReceivablePolicy-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. &#160; Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_23" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:continuation id="_TradeAndOtherAccountsReceivablePolicy-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company has established a reserve of approximately $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="0" unitRef="usd">743,000</ix:nonFraction> for doubtful accounts as of August 31, 2021. The majority of this reserve has been established to cover <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure">100</ix:nonFraction>% of outstanding accounts receivable from an international distributor.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_24" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:nonNumeric contextRef="c0" continuedAt="_PrepaidsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="bmra:PrepaidsPolicyPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PREPAID EXPENSES AND OTHER</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_25" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24"><ix:continuation continuedAt="_PrepaidsPolicyPolicyTextBlock-c0_cont_2" id="_PrepaidsPolicyPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_26" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:continuation id="_PrepaidsPolicyPolicyTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">As of August 31, 2021 and May 31, 2021, the prepaid expenses and other were approximately $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="usd">315,000</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="usd">370,000</ix:nonFraction>, respectively. The prepaid expenses and other balance were composed of prepayments to insurance and various other suppliers. &#160;&#160;</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_27" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:nonNumeric contextRef="c0" continuedAt="_InventoryPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INVENTORIES, NET </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_28" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_2" id="_InventoryPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_29" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_3" id="_InventoryPolicyTextBlock-c0_cont_2"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Inventories approximate the following at:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_30" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_4" id="_InventoryPolicyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">May 31, 2021</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Raw materials</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" unitRef="usd">1,493,000</ix:nonFraction></span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" unitRef="usd">1,583,000</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Work in progress</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="0" unitRef="usd">926,000</ix:nonFraction></span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="0" unitRef="usd">1,006,000</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Finished products</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="0" unitRef="usd">443,000</ix:nonFraction></span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="0" unitRef="usd">617,000</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd">2,862,000</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd">3,206,000</ix:nonFraction></span></p>
</td>
</tr>

</table></ix:continuation></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_31" id="_SignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_5" id="_InventoryPolicyTextBlock-c0_cont_4"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">During the first fiscal quarter ended August 31, 2021, the Company wrote-down the carrying value of certain inventory by approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryWriteDown" scale="0" unitRef="usd">179,000</ix:nonFraction> to assign a new carrying value for this inventory of $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherInventory" scale="0" unitRef="usd">211,000</ix:nonFraction>.&#160; As part of a large international order for this product that was to ship in the second quarter of 2022, the Company agreed to sell this product as a small portion of that order at a price below its carrying value, which required a write down.&#160; </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">7</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_32" id="_SignificantAccountingPoliciesTextBlock-c0_cont_31"><ix:continuation id="_InventoryPolicyTextBlock-c0_cont_5"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of August 31, 2021 and May 31, 2021, inventory reserves were approximately $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryValuationReserves" scale="0" unitRef="usd">1,797,000</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryValuationReserves" scale="0" unitRef="usd">1,617,000</ix:nonFraction>, respectively. Of the inventory reserve, approximately $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryLIFOReserve" scale="0" unitRef="usd">1,683,000</ix:nonFraction> was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_33" id="_SignificantAccountingPoliciesTextBlock-c0_cont_32"><ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PROPERTY AND EQUIPMENT, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_34" id="_SignificantAccountingPoliciesTextBlock-c0_cont_33"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in; TEXT-INDENT:0.5in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_35" id="_SignificantAccountingPoliciesTextBlock-c0_cont_34"><ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from <ix:nonNumeric contextRef="c44" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric> to <ix:nonNumeric contextRef="c45" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric> years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment amounted to $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd">27,809</ix:nonFraction> and $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd">26,732</ix:nonFraction> for the three months ended August 31, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">&#160; </span></p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_36" id="_SignificantAccountingPoliciesTextBlock-c0_cont_35"><ix:nonNumeric contextRef="c0" continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INTANGIBLE ASSETS, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <a id="OLE_LINK9"></a><a id="OLE_LINK8"></a><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_37" id="_SignificantAccountingPoliciesTextBlock-c0_cont_36"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_2" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#8211; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation></ix:continuation>  <a id="OLE_LINK6"></a><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_38" id="_SignificantAccountingPoliciesTextBlock-c0_cont_37"><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_3" id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets are being amortized using the straight-line method over the useful life, not to exceed <ix:nonNumeric contextRef="c46" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">18</ix:nonNumeric> years for marketing and distribution rights, <ix:nonNumeric contextRef="c47" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric> years for purchased technology use rights, and <ix:nonNumeric contextRef="c48" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric> years for patents. Amortization expense amounted to $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" unitRef="usd">6,913</ix:nonFraction> and $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" unitRef="usd">5,838</ix:nonFraction> for the three months ended August 31, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_39" id="_SignificantAccountingPoliciesTextBlock-c0_cont_38"><ix:continuation id="_GoodwillAndIntangibleAssetsPolicyTextBlock-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#8217;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of August 31, 2021 or 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_40" id="_SignificantAccountingPoliciesTextBlock-c0_cont_39"><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt; COLOR:black">INVESTMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_41" id="_SignificantAccountingPoliciesTextBlock-c0_cont_40"><ix:continuation id="_InvestmentPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#8217;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#8217;s investment in a Polish based distributor which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the certain of the products sold. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately <ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" unitRef="pure">6</ix:nonFraction>% of the investee, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_42" id="_SignificantAccountingPoliciesTextBlock-c0_cont_41"><ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">SHARE-BASED COMPENSATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_43" id="_SignificantAccountingPoliciesTextBlock-c0_cont_42"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company follows the guidance of the accounting provisions of ASC 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees and others receive shares of stock or equity instruments (options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#8217;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of<b> </b>the expected term.</span></p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">&#160; </span></p></ix:continuation></ix:continuation>
<p style="font-size: 10pt; font-family: 'Courier New'; text-align: center; margin: 0in 0in 0pt;"><span style="font-family: 'Times New Roman','serif';">8</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <div style="text-align: left;"> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_44" id="_SignificantAccountingPoliciesTextBlock-c0_cont_43"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_3" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2"><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the three months ended August 31, 2021:</span></p></ix:continuation></ix:continuation>
<ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_45" id="_SignificantAccountingPoliciesTextBlock-c0_cont_44"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_4" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_3"><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 48pt;">
<td style="height: 48pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Option Shares</span></p>
</td>
<td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercise Price Weighted Average</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Outstanding May 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c51" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">2,081,366</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c51" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">3.59</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Granted </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">24,000</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">4.25</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercised </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">1,500</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">2.68</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cancelled or expired </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares">22,750</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">3.02</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Outstanding August 31, 2021</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c50" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">2,081,116</ix:nonFraction> </span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$</span></strong></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c50" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">3.60</ix:nonFraction> </span></strong></p>
</td>
</tr>

</table></ix:continuation></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_46" id="_SignificantAccountingPoliciesTextBlock-c0_cont_45"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_5" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">During the three months ended August 31, 2021, options to purchase <ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">1,500</ix:nonFraction> shares of common stock were exercised at price of $<ix:nonFraction contextRef="c50" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" unitRef="usdPershares">2.68</ix:nonFraction>. Total net proceeds to the Company were $<ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="0" unitRef="usd">3,895</ix:nonFraction>.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_47" id="_SignificantAccountingPoliciesTextBlock-c0_cont_46"><ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">During the three months ended August 31, 2021, the Company granted <ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">24,000</ix:nonFraction> options to purchase common stock at an average purchase price of $<ix:nonFraction contextRef="c49" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">4.25</ix:nonFraction>. Total net proceeds to the Company were $<ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="bmra:ProceedsFromStockOptionsGranted" scale="0" unitRef="usd">14,900</ix:nonFraction>.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_48" id="_SignificantAccountingPoliciesTextBlock-c0_cont_47"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">REVENUE RECOGNITION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <a id="_Hlk49511094"></a><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_49" id="_SignificantAccountingPoliciesTextBlock-c0_cont_48"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of August 31, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. </span><span style="FONT-SIZE:10pt">Services for some contract works are invoiced and recognized for work that has been performed as the project progresses. <span style="COLOR:black">The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#8217; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_50" id="_SignificantAccountingPoliciesTextBlock-c0_cont_49"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Disaggregation of revenue:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_51" id="_SignificantAccountingPoliciesTextBlock-c0_cont_50"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_4" id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a breakdown of revenues according to markets to which the products are sold:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_52" id="_SignificantAccountingPoliciesTextBlock-c0_cont_51"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_5" id="_RevenueRecognitionPolicyTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="5" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Three Months Ended</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2020</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Clinical lab</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c52" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">886,000</ix:nonFraction></span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c53" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">582,000</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Physician's office</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c54" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">257,000</ix:nonFraction></span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c55" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">197,000</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Over-the-counter</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c56" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">79,000</ix:nonFraction></span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c57" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">185,000</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Contract Manufacturing</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c58" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">40,000</ix:nonFraction></span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c59" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">180,000</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">1,262,000</ix:nonFraction></span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="0" unitRef="usd">1,144,000</ix:nonFraction></span></p>
</td>
</tr>

</table></ix:continuation></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_53" id="_SignificantAccountingPoliciesTextBlock-c0_cont_52"><ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_5"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">See Note 4 for additional information regarding revenue concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_54" id="_SignificantAccountingPoliciesTextBlock-c0_cont_53"><ix:nonNumeric contextRef="c0" continuedAt="_CostOfSalesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">SHIPPING AND HANDLING FEES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_55" id="_SignificantAccountingPoliciesTextBlock-c0_cont_54"><ix:continuation id="_CostOfSalesPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The Company includes shipping and handling fees billed to customers in net sales.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_56" id="_SignificantAccountingPoliciesTextBlock-c0_cont_55"><ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">RESEARCH AND DEVELOPMENT</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_57" id="_SignificantAccountingPoliciesTextBlock-c0_cont_56"><ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Research and development costs are expensed as incurred. The Company expensed approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="0" unitRef="usd">440,000</ix:nonFraction> and $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="0" unitRef="usd">712,000</ix:nonFraction> of research and development costs during the three months ended August 31, 2021 and 2020, respectively.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_58" id="_SignificantAccountingPoliciesTextBlock-c0_cont_57"><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INCOME TAXES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_59" id="_SignificantAccountingPoliciesTextBlock-c0_cont_58"><ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt; color: black;">The Company has provided a valuation allowance on deferred income tax assets of approximately $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd">6,226,000</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd">5,904,000</ix:nonFraction> as of August 31, 2021 and May 31, 2021, respectively. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">9</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_60" id="_SignificantAccountingPoliciesTextBlock-c0_cont_59"><ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">FOREIGN CURRENCY TRANSLATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_61" id="_SignificantAccountingPoliciesTextBlock-c0_cont_60"><ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three months ended August 31, 2021 and 2020. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_62" id="_SignificantAccountingPoliciesTextBlock-c0_cont_61"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt; COLOR:black">RIGHT-OF-USE ASSETS AND LEASE LIABILITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_63" id="_SignificantAccountingPoliciesTextBlock-c0_cont_62"><ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#8217;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_64" id="_SignificantAccountingPoliciesTextBlock-c0_cont_63"><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">NET LOSS PER SHARE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_65" id="_SignificantAccountingPoliciesTextBlock-c0_cont_64"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation for the three months ended August 31, 2021 and 2020 was <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares">2,081,116</ix:nonFraction> and <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares">1,925,750</ix:nonFraction>, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation></ix:continuation>  <ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_66" id="_SignificantAccountingPoliciesTextBlock-c0_cont_65"><ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">RECENT ACCOUNTING PRONOUNCEMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric></ix:continuation>  <ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_66"><ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">Recent ASUs issued by the FASB and guidance issued by the Securities and Exchange Commission (&#8220;SEC&#8221;) did not, or are not believed by management to, have a material effect on the Company&#8217;s present or future consolidated financial statements. </span></p></ix:continuation></ix:continuation> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 18.7pt">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 3:&#160; SHAREHOLDERS&#8217; EQUITY</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Stock option expense during the three months ended August 31, 2021 and 2020 were $<ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd">319,622</ix:nonFraction> and $<ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd">246,787</ix:nonFraction> (as restated, see Note 8 to the Financial Statements), respectively.</span></p></ix:continuation> <a id="_Hlk49188299"></a><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt"><span style="FONT-SIZE:10pt">During the three months ended August 31, 2021, the Company sold <ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">201,553</ix:nonFraction> shares of its common stock at prices ranging from $<ix:nonFraction contextRef="c62" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">4.02</ix:nonFraction> to $<ix:nonFraction contextRef="c63" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">4.47</ix:nonFraction> under its January 22, 2021 prospectus supplement and the ATM Agreement (see Note 2 to Financial Statements) which resulted in gross proceeds of $<ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="0" unitRef="usd">838,332</ix:nonFraction> and net proceeds to the Company of $<ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="0" unitRef="usd">800,710</ix:nonFraction> after deducting commissions for each sale and legal, accounting and other fees related to the filing of the Form S-3.</span></p></ix:continuation> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_GeographicInformationDisclosureTextBlock-c0_cont_1" escape="true" name="bmra:GeographicInformationDisclosureTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 4: &#160;GEOGRAPHIC INFORMATION</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_GeographicInformationDisclosureTextBlock-c0_cont_2" id="_GeographicInformationDisclosureTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company operates as <ix:nonFraction contextRef="c64" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" unitRef="pure">one</ix:nonFraction> segment. Geographic information regarding net sales is approximately as follows: </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_GeographicInformationDisclosureTextBlock-c0_cont_3" id="_GeographicInformationDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock"><table cellpadding="0" cellspacing="0" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="733"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">August 31, 2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">August 31, 2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Revenues from sales to unaffiliated customers:</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Asia</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">675,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">347,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Europe</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">471,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c70" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">591,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">North America</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c71" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">105,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c72" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">134,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Middle East</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">8,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c74" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">29,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">South America</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c75" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">3,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">43,000</ix:nonFraction> </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">1,262,000</ix:nonFraction> </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd">1,144,000</ix:nonFraction> </span></p></td></tr></table></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:continuation id="_GeographicInformationDisclosureTextBlock-c0_cont_3"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">As of August 31, 2021 and May 31, 2021, approximately $<ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryGross" scale="0" unitRef="usd">665,000</ix:nonFraction> and $<ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryGross" scale="0" unitRef="usd">803,000</ix:nonFraction> of Biomerica&#8217;s gross inventory and approximately $<ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">24,000</ix:nonFraction> and $<ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd">25,000</ix:nonFraction>, of Biomerica&#8217;s property and equipment, net of accumulated depreciation and amortization, was located in Mexicali, Mexico, respectively.</span></p></ix:continuation> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">10</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 5:&#160; LEASES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_2" id="_LesseeOperatingLeasesTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On June 18, 2009, the Company entered into an agreement to lease a building in Irvine, California. The lease commenced <ix:nonNumeric contextRef="c77" format="ixt:date-monthname-day-year-en" name="bmra:OperatingLeaseInitiationDate">September 1, 2009</ix:nonNumeric> and ended <ix:nonNumeric contextRef="c77" format="ixt:date-monthname-day-year-en" name="us-gaap:LeaseExpirationDate1">August 31, 2016</ix:nonNumeric>. </span><span style="FONT-SIZE:10pt">&#160;On November 30, 2015, the Company entered into the First Amendment to Lease wherein it exercised its option to extend its lease until <ix:nonNumeric contextRef="c78" format="ixt:date-monthname-day-year-en" name="us-gaap:LeaseExpirationDate1">August 31, 2021</ix:nonNumeric>. The initial base rent for the lease extension was $<ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">21,000</ix:nonFraction> per month, increasing to $<ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LeaseAndRentalExpense" scale="0" unitRef="usd">23,637</ix:nonFraction> through August 31, 2021. On April 9, 2021, the Company exercised its second option to extend its lease for an additional five years through August 2026.&#160; The Company was also granted an additional five years lease extension option through August 2031. The rent is currently $23,637 per month and will increase on September 1, 2021 to $<ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LeaseAndRentalExpense" scale="0" unitRef="usd">25,970</ix:nonFraction> per month and be increased <ix:nonFraction contextRef="c80" decimals="2" format="ixt:num-dot-decimal" name="bmra:RentPercentage" scale="-2" unitRef="pure">3</ix:nonFraction>% each year thereafter. The security deposit of $<ix:nonFraction contextRef="c81" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SecurityDeposit" scale="0" unitRef="usd">22,080</ix:nonFraction> remains the same.<span style="COLOR:black">&#160;</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_3" id="_LesseeOperatingLeasesTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">In November 2016, the Company&#8217;s subsidiary, Biomerica de Mexico, entered into a ten-year lease for approximately 8,104 square feet at a monthly rent of $<ix:nonFraction contextRef="c82" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesRentExpenseMinimumRentals" scale="0" unitRef="usd">2,926</ix:nonFraction>. The Company has one 10-year option to renew at the end of the initial lease period. The yearly rate is subject to an annual adjustment for inflation according to the United States Bureau of Labor Statistics Consumer Price Index for All Urban Consumers. The monthly rate is currently $<ix:nonFraction contextRef="c83" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LeaseAndRentalExpense" scale="0" unitRef="usd">3,262</ix:nonFraction>.&#160; Biomerica, Inc. is not a guarantor of such lease.&#160; Biomerica de Mexico also leases a smaller unit on a month-to-month basis for use in one manufacturing process.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_4" id="_LesseeOperatingLeasesTextBlock-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">In addition, the Company leases a small office in Lindau, Germany on a month-to-month basis, as headquarters for BioEurope GmbH, its Germany subsidiary.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_5" id="_LesseeOperatingLeasesTextBlock-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Rent expense in the U.S. for the three months ended August 31, 2021 and 2020 was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">78,166</ix:nonFraction> and $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">75,764</ix:nonFraction>, respectively.&#160; Rent expense for the Mexico facility for the three months ended August 31, 2021 and 2020 was $<ix:nonFraction contextRef="c64" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">10,421</ix:nonFraction> and $<ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="0" unitRef="usd">10,870</ix:nonFraction>, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_6" id="_LesseeOperatingLeasesTextBlock-c0_cont_5"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">For purposes of determining straight-line rent expense, the lease term is calculated from the date the Company first takes possession of the facility, including any periods of free rent and any renewal options periods that the Company is reasonably certain of exercising. The Company&#8217;s office and equipment leases generally have contractually specified minimum rent and annual rent increases are included in the measurement of the right-of-use asset and related lease liability.&#160; Additionally, under these lease arrangements, the Company may be required to pay directly, or reimburse the lessors, for some maintenance and operating costs. Such amounts are generally variable and therefore not included in the measurement of the right-of-use asset and related lease liability but are instead recognized as variable lease expense in the Consolidated Statements of Operations and Comprehensive Loss when they are incurred.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_7" id="_LesseeOperatingLeasesTextBlock-c0_cont_6"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Supplemental cash flow information related to leases for the three months ended August 31, 2021:&#160; </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_8" id="_LesseeOperatingLeasesTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="0" unitRef="usd">80,697</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Right-of-use assets obtained in exchange for</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">new operating lease liabilities</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-7">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Weighted average remaining lease term (in years)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><ix:nonNumeric contextRef="c3" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1"><span style="font-size: 10pt; color: black;">5.02</span></ix:nonNumeric></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Weighted average discount rate</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure">6.50</ix:nonFraction>%</span></p>
</td>
</tr>

</table></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_9" id="_LesseeOperatingLeasesTextBlock-c0_cont_8"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The maturity of lease liabilities as of August 31, 2021 are as follows:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_10" id="_LesseeOperatingLeasesTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Less than 1 year</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="0" unitRef="usd">342,640</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1 to 2 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" unitRef="usd">352,869</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2 to 3 years</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="0" unitRef="usd">363,404</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3 to 4 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="0" unitRef="usd">374,253</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">4 to 5 years</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="0" unitRef="usd">385,426</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">5 to 10 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="0" unitRef="usd">7,517</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total undiscounted lease payments</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="0" unitRef="usd">1,826,109</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Less imputed interest</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="0" unitRef="usd">262,244</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total operating lease liabilities</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="0" unitRef="usd">1,563,865</ix:nonFraction> </span></p>
</td>
</tr>

</table></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_11" id="_LesseeOperatingLeasesTextBlock-c0_cont_10"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">According to the terms of the lease in Irvine, the Company is also responsible for routine repairs of the building and for certain increases in property tax. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation id="_LesseeOperatingLeasesTextBlock-c0_cont_11"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company also has various insignificant leases for office equipment.</span></p></ix:continuation> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">11</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 6: &#160;COMMITMENTS AND CONTINGENCIES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LITIGATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company is, from time to time, involved in legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible the outcome of such legal proceedings, claims and litigation could have a material effect on quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. There were no legal proceedings pending as of August 31, 2021.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">On July 2, 2020, we received a notice of investigation and subpoena to produce information and documents from the Division of Enforcement of the SEC. The subpoena requested information and documents related to events and circumstances leading up to our March 17, 2020 announcement that we had commenced shipping samples of our COVID-19 IgG/IgM Rapid Test to countries outside of the United States, and had initiated the application process with the United States Food and Drug Administration under the COVID-19 Emergency Use Authorization for approval to market and sell the test in the United States. The subpoena also requested information and documents about the identity of any persons who were aware of the substance of the March 17, 2020 announcement prior to that date. In addition, on December 15, 2020, the SEC sent a second subpoena related to this investigation to Zack Irani, the Company&#8217;s CEO, requesting documents held by Mr. Irani concerning his past purchases of Company stock, his past communications with certain persons and entities, and other personal and Company documents. The Company and Mr. Irani have cooperated fully with the SEC&#8217;s investigation and provided information as requested. At this time, the Company is unable to predict the duration, scope or outcome of these investigations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-SIZE:10pt">Contracts and Licensing Agreements</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation>  <ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5"><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 16.2pt 0pt 0in;"><span style="font-size: 10pt;">On June 21, 2021, the Company signed an exclusive distribution and marketing agreement in Canada for its Helicobacter Pylori (H. Pylori) test.</span></p></ix:continuation> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <a id="Form_8_K"></a><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">NOTE 7:&#160; SUBSEQUENT EVENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p></ix:nonNumeric>  <ix:continuation id="_SubsequentEventsTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">None</span></p></ix:continuation> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:nonNumeric contextRef="c0" continuedAt="_ErrorCorrectionTextBlock-c0_cont_1" escape="true" name="us-gaap:ErrorCorrectionTextBlock"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">NOTE 8:&#160; <span style="COLOR:black">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:nonNumeric>  <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_2" id="_ErrorCorrectionTextBlock-c0_cont_1"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">Subsequent to the issuance of our financial statements for the quarter ended August 31, 2020, the Company determined that errors were included in the previously issued financial statements as described below. As a result, we restated our financial statements for the quarter ended August 31, 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_3" id="_ErrorCorrectionTextBlock-c0_cont_2"><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 16.2pt 0pt 0in;"><span style="font-size: 10pt; color: black;">The Company discovered the errors listed below. The restatement corrects these errors.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation>  <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_4" id="_ErrorCorrectionTextBlock-c0_cont_3"><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">Our non-cash stock based compensation expenses calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro rata over the period the requisite service was provided.<br/><br/></span></p></ix:continuation>
<ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_5" id="_ErrorCorrectionTextBlock-c0_cont_4"><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">Stock-based compensation expense shown on the statement of operations is a non-cash expense, and impacts accumulated deficit and additional paid-in capital on the balance sheet. However, this does not impact the Company&#8217;s cash, revenues or other aspects of ongoing operations.<br/><br/></span></p></ix:continuation>
<ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_6" id="_ErrorCorrectionTextBlock-c0_cont_5"><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">The restatement for the quarter ended August 31, 2020 resulted in no changes in the provision for income taxes.<br/><br/></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation>  <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">12</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_7" id="_ErrorCorrectionTextBlock-c0_cont_6"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of operations for the three months ended August 31, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_8" id="_ErrorCorrectionTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"><table cellpadding="0" cellspacing="0" style="width: 732.2px; border-collapse: collapse; margin-left: auto; margin-right: auto; height: 293px;" width="733">

<tr style="height: 0.5in;">
<td style="height: 0px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 77.6667px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 0px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 76.9167px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 0px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 74.9px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cost of sales </span></p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">960,930</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">64,787</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="0" unitRef="usd">1,025,717</ix:nonFraction></span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Gross Profit </span></p>
</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">182,876</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" sign="-" unitRef="usd">64,787</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="0" unitRef="usd">118,089</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Operating Expenses: </span></p>
</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Selling, general and administrative </span></p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">1,164,564</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">141,380</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">1,305,944</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Research and development </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">674,693</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">36,812</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">711,505</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 451.183px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.3in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total operating expense </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">1,839,257</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">178,192</ix:nonFraction> </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="0" unitRef="usd">2,017,449</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 18px;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">Loss from operations</span></td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(<ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">1,656,381</ix:nonFraction>)</span></td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(<ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">242,979</ix:nonFraction>)</span></td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(<ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd">1,899,360</ix:nonFraction>)</span></td>
</tr>
<tr style="height: 18px;">
<td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;">&#160;</td>
<td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
</tr>
<tr style="height: 18px;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"><span style="font-family: times new roman, times, serif; font-size: 10pt;">Loss before income taxes</span></td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(<ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">1,648,290</ix:nonFraction>)</span></td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(<ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">242,979</ix:nonFraction>)</span></td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(<ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd">1,891,269</ix:nonFraction>)</span></td>
</tr>
<tr style="height: 18px;">
<td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;">&#160;</td>
<td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,649,415</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">242,979</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,892,394</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 16px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Basic net loss per common share </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.14</ix:nonFraction>)</span></p>
</td>
<td style="height: 16px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.02</ix:nonFraction>)</span></p>
</td>
<td style="height: 16px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.16</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Diluted net loss per common share </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.14</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.02</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.16</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Comprehensive loss </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">1,651,136</ix:nonFraction>) </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">242,979</ix:nonFraction>)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="0" sign="-" unitRef="usd">1,894,115</ix:nonFraction>)</span></p>
</td>
</tr>

</table></ix:nonNumeric></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_9" id="_ErrorCorrectionTextBlock-c0_cont_8"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The effect of the restatement on the consolidated balance sheet at May 31, 2021 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></ix:continuation>  <div style="text-align: left;"> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_10" id="_ErrorCorrectionTextBlock-c0_cont_9"><ix:continuation continuedAt="_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock-c0_cont_2" id="_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 33pt;">
<td style="height: 33pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 9.66%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Shareholders' Equity:</span></strong></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 8.58%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 8.58%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Additional paid-in-capital</span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c88" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">36,685,176</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c89" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">2,151,567</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c90" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd">38,836,743</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated deficit</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c88" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">28,394,768</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c89" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">2,151,567</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c90" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd">30,546,335</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Other Equity accounts</span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c91" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityOther" scale="0" unitRef="usd">936,615</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"><div style="-sec-ix-hidden: hidden-fact-8">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c93" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityOther" scale="0" unitRef="usd">936,615</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total Shareholders' Equity</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c88" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">9,227,023</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"><div style="-sec-ix-hidden: hidden-fact-9">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c90" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd">9,227,023</ix:nonFraction> </span></p>
</td>
</tr>

</table></ix:continuation></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">13</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p> <ix:continuation continuedAt="_ErrorCorrectionTextBlock-c0_cont_11" id="_ErrorCorrectionTextBlock-c0_cont_10"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of cash flows for the period ended August 31, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p></ix:continuation>  <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <div style="text-align: left;"> <p>&#160;</p>
<ix:continuation id="_ErrorCorrectionTextBlock-c0_cont_11"><ix:continuation id="_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 37.5pt;">
<td style="height: 37.5pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from operating activities:</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,649,415</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">242,979</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd">1,892,394</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Adjustments to reconcile net loss to net cash used in operating activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Stock option expense</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">3,808</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c86" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">242,979</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockOptionPlanExpense" scale="0" unitRef="usd">246,787</ix:nonFraction> </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net cash used in operating activities </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c85" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">1,597,146</ix:nonFraction>)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-10">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(<ix:nonFraction contextRef="c87" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">1,597,146</ix:nonFraction>)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at end of period</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c94" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">6,964,314</ix:nonFraction> </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">$</span></td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-11">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;"><ix:nonFraction contextRef="c96" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd">6,964,314</ix:nonFraction> </span></p>
</td>
</tr>

</table></ix:continuation></ix:continuation></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <a id="OLE_LINK4"></a><a id="new_id"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 2. &#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">You should read the following discussion and analysis in conjunction with our consolidated financial statements and the accompanying notes thereto included in Part II, Item 8 of this Report. This discussion and analysis contains forward-looking statements that are based on our management&#8217;s current beliefs and assumptions, which statements are subject to substantial risks and uncertainties. Our actual results may differ materially from those expressed or implied by these forward-looking statements as a result of many factors, including those discussed in &#8220;Risk Factors&#8221; included in Part I, Item 1A of this Report.&#160;</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt; COLOR:black">OVERVIEW</span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <a id="_Hlk53571612"></a><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Biomerica, Inc. and its subsidiaries (which includes wholly-owned subsidiaries, Biomerica de Mexico and BioEurope GmbH), is</span><span style="FONT-SIZE:10pt"> a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care <span style="COLOR:black">(in home and physicians' offices)</span> and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases<span style="COLOR:black">. The</span> Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our primary focus is the research and development of revolutionary, patented, diagnostic-guided therapy, or DGT, products to treat gastrointestinal diseases, such as irritable bowel syndrome, and other inflammatory diseases. These products are directed at chronic inflammatory illnesses that are widespread and common, and as such address very large markets. If these DGT products prove effective in their clinical trials, and are ultimately cleared for sale by the U.S. Food and Drug Administration, we believe the revenues potential to the Company is significant.&#160; </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">We are currently finalizing an endpoint determination clinical trial on our InFoods</span><span style="FONT-SIZE:10pt">&#174;<span style="COLOR:black"> IBS product. This trial is and has been conducted at </span>Mayo Clinics in Florida and Arizona, Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, University of Texas Health Science Center at Houston, Houston Methodist, the University of Michigan and other institutions<span style="COLOR:black">. This trial monitors IBS patients over an 8-week period to determine the efficacy of our InFoods&#174; IBS product to improve the patients&#8217; IBS symptoms. We expect our final enrolled patients to complete the trial, and for top-line trial results to be reported at or around the end of December 2021</span>. During the next six months, we also expect to be entertaining partnership/licensing discussions with pharmaceutical and technology companies that could help us commercialize the product, including obtaining final FDA clearance. </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our medical diagnostic products are sold worldwide primarily in two markets: 1) clinical laboratories and 2) point-of-care (physicians' offices and over-the-counter drugstores like Walmart and Walgreens). The diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient&#8217;s body, stools, or blood, often in extremely small concentrations.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Due to the global 2019 SARS-CoV-2 novel coronavirus pandemic, in March 2020 we began redirecting and focusing much of our resources to develop, test, validate, seek regulatory approval for COVID-19 tests. During fiscal 2021, we sold 2 primary types of COVID-19 tests: 1) antibody diagnostic tests that use a patient&#8217;s blood sample to detect if the patient has certain antibodies to COVID-19 that were created as part of their body&#8217;s immune response to a COVID-19 infection, even if the infection was asymptomatic, and 2) antigen tests that use a patient&#8217;s nasal fluid sample to detect if a patient is currently infected with the virus. <span style="color: black;">&#160;During the fiscal year, we sold these products outside of the U.S. under a CE Mark (European Conformity). Because individual orders for these tests have been large in size, this has created volatility and material fluctuations in our monthly and quarterly revenues. Although sales in these products have slowed, we continue to receive and fill orders for our COVID-19 test products. During our fiscal first quarter of 2022, we recorded approximately $226,000 in sales of our COVID-19 antigen test.</span></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">14</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Aside from the COVID-19 products we offer, the other products we sell are primarily focused on gastrointestinal diseases, food intolerances, cancer screening and awareness and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Most of our products are CE marked and/or sold for diagnostic use where they are registered by each country&#8217;s regulatory agency.&#160; In addition, some products are cleared for sale in the U.S. by the FDA.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">While sales continue to occur in our COVID-19 products, </span><span style="FONT-SIZE:10pt">the majority of our research and development efforts are focused on development and commercialization of non-COVID related products such as our H. Pylori product, and our InFoods&#174; IBS product. </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">We also recently added several new employees in its sales and marketing department in order to increase sales of existing non-COVID products during fiscal 2022.&#160; Through these efforts, our EZ Detect colon disease home screening test is seeing a significant increased interest from retailers such as Walmart, distributors, and ministries of health in many countries. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0.1in 0pt 0in">&#160;</p> <a id="_Hlk53149431"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">RESULTS OF OPERATIONS</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white;">As disclosed in Note 8 to the unaudited condensed consolidated financial statements in Item&#160;1, during the process of preparing our financial statements for the quarter ended August&#160;31, 2021, we determined that our calculation of non-cash stock-based compensation expense related to issued stock options in previously issued financial statements was incorrect. <span style="color: black;">Our calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro rata over the period the requisite service was provided. </span>These errors resulted in an understatement of stock compensation expense during the three months ended August 31, 2020, and periods prior to May 31, 2020, resulting in a cumulative adjustment to equity accounts. As a result, our previously issued financial statements for the three months ended August 31, 2020 have been restated.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Net Sales and Cost of Sales</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Consolidated net sales were $1,261,787 for the three months ended August 31, 2021, as compared to $1,143,806 for the three months ended August 31, 2020. This represents an increase of $117,981 or 10%. The increase for the three months ended August 31, 2021, as compared to the three months ended August 31, 2020, was primarily due to the sale of our food intolerance products to a distributor in Asia. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p> <p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">Consolidated cost of sales was $1,350,757, or 107% of net sales, for the three months ended August 31, 2021, as compared to $1,025,717, or 90% of net sales, for the three months ended August 31, 2020. This represents an increase of $325,040 or 32%. <span style="color: black;">Our cost of sales for the three months ended August 31, 2021, were impacted by an adjustment to market or net realizable value for COVID-19 antigen tests of approximately $179,000.</span></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Selling, General and Administrative Expenses</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <a id="_Hlk53409686"></a><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">Consolidated selling, general and administrative expenses were $1,011,535 for the three months ended August 31, 2021, as compared to $1,305,944 for the three months ended August 31, 2020. This represents a decrease of $294,409 or 23%.</span><span style="FONT-SIZE:10pt"><span style="COLOR:black"> The decrease in the three months ended August 31, 2021, was primarily due to a reduction of legal expenses.</span></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Research and Development</span></i></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Consolidated research and development expenses were $439,864 for the three months ended August 31, 2021, as compared to $711,505 for the three months ended August 31, 2020. This represents a decrease of $271,641, or 38%. <span style="COLOR:black">The decrease in the three months ended August 31, 2021, was primarily a result of decreases in costs related to the research, development, and validation of COVID-19 tests.</span></span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Interest Expense</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Interest and dividend income were $6,805 for the three months ended August 31, 2021, as compared to $8,091 for the three months ended August 31, 2020. This represents a decrease of $1,286, or 16%. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">LIQUIDITY AND CAPITAL RESOURCES</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">As of August 31, 2021 and May 31, 2021, we had cash and cash equivalents in the amount of approximately $4,997,000 and $4,199,000, respectively, and working capital of approximately $7,464,000 and $7,931,000, respectively. As a result of cash and cash equivalents on hand at August 31, 2021, and our ability to raise additional funds through our ATM Agreement, management believes we have sufficient funds to operate through the next twelve months or more. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">15</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Operating Activities</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">Cash provided by operating activities of $75,836 during the three months ended August 31, 2021, reflects a net loss of $1,542,581 and non-cash adjustments of $502,094 primarily associated with depreciation, amortization, stock-based compensation, and inventory reserves. In addition, we realized an increase in net working capital of $1,116,322 primarily driven by a decrease in accounts receivable and inventory. For the three months ended August 31, 2020, cash used by operating activities of $1,597,146 reflects a net loss of $1,892,394 and non-cash adjustments of $542,994 primarily associated with depreciation, amortization, stock-based compensation, and inventory reserves. This was partially offset by a decline in net working capital of $247,746 driven by increases in inventory, which was partially offset by a decrease in prepaid expenses.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Investing Activities</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Cash used in investing activities for the three months ended August 31, 2021, was $5,141 for purchases of property and equipment and $72,375 for increased intangibles. Cash used in investing activities for the three months ended August 31, 2020, was $39,588 for purchases of property and equipment and $53,158 for increased intangibles. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><i><span style="FONT-SIZE:10pt; COLOR:black">Financing Activities</span></i></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Cash provided by financing activities for the three months ended August 31, 2021, was $804,605 which was a result of stock option exercises of $3,895 and net proceeds from the sale of common stock of $800,710. Cash provided by financing activities for the three months ended August 31, 2020, was $14,900 which was a result of stock option exercises of $14,900.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-SIZE:10pt; COLOR:black">OFF BALANCE SHEET ARRANGEMENTS</span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">There were no off-balance sheet arrangements as of August 31, 2021.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">CRITICAL ACCOUNTING POLICIES</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of revenues and expenses during the reporting period. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable under the current conditions; however, actual results may differ from these estimates under different future conditions.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in; TEXT-INDENT:0.5in">&#160;</p> <p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">We believe that the estimates and assumptions that are most important to the portrayal of our financial condition and results of operations, in that they require subjective or complex judgments, form the basis for the accounting policies deemed to be most critical to us. These relate to revenue recognition, accounts receivable reserves, inventory valuation, lease liabilities, right-of-use assets, and stock based compensation. We believe estimates and assumptions related to these critical accounting policies are appropriate under the circumstances; however, should future events or occurrences result in unanticipated consequences, there could be a material impact on our future financial conditions or results of operations. We suggest that our significant accounting policies be read in conjunction with this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. See Note 2 to the Financial Statements for information on Significant Accounting Policies.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <a id="ITEM3"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 3. &#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <a id="ITEM4"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 4.&#160; CONTROLS AND PROCEDURES</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; COLOR:black">Our management, including our principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities and Exchange Act of 1934 as of August&#160;31, 2021. Our evaluation tested controls and other procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, or the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on our evaluation, as of August&#160;31, 2021, our management, including our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures were not effective due to a material weakness in our internal control over financial reporting related to the financial reporting described below in the area of accounting for non-cash stock-based compensation.</span></p> <p style="font-size: 10pt; font-family: 'Courier New'; text-align: center; margin: 0in 0in 0pt;"><span style="font-family: 'Times New Roman','serif';"><br/>16</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:13.5pt 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">Changes in Internal Control over Financial Reporting</span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:4.5pt 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Other than as described below, there were no changes to internal controls in the first quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p> <p style="font-size: 12pt; font-family: 'Times New Roman','serif'; background: white; text-align: justify; margin: 9pt 0in 0pt;"><span style="font-size: 10pt; color: black;">During the second quarter ending November&#160;30, 2021 and prior to filing this Quarterly Report, we completed the following steps to address the non-cash stock-based compensation deficiency identified in our Form 10-K/A filed on October 14, 2021:</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p>
<p><span style="font-size: 10pt;">&#8226;&#160;&#160; <span style="font-family: times new roman, times, serif;">implemented a leading industry standard equity and disclosure management software system to calculate non-cash stock-based compensation expense;<br/><br/></span></span></p>
<p><span style="font-size: 10pt;">&#8226;&#160;&#160; <span style="font-family: times new roman, times, serif;">engaged an outside accounting advisory firm to review our revised stock-based compensation amounts and our methods for calculating non-cash stock-based compensation expenses going forward;<br/><br/></span></span></p>
<p><span style="font-size: 10pt;">&#8226;&#160;&#160; <span style="font-family: times new roman, times, serif;">developed and implemented additional procedures to increase the level of review, evaluation and validation of the Company&#8217;s stock-based compensation expense;<br/><br/></span></span></p>
<p><span style="font-size: 10pt;">&#8226;&#160;&#160; <span style="font-family: times new roman, times, serif;">increased the level of knowledge among our executives and accounting staff in the area of stock-based compensation; and<br/><br/></span></span></p>
<p><span style="font-size: 10pt;">&#8226;&#160;&#160; <span style="font-family: times new roman, times, serif;">independently tested the calculations produced by our new equity and disclosure management software system</span></span></p>

<p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <a id="PART2"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">PART II. &#160;OTHER INFORMATION</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <a id="LEGAL"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 1.&#160; LEGAL PROCEEDINGS</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company is, from time to time, involved in legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible the outcome of such legal proceedings, claims and litigation could have a material effect on quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. There were no legal proceedings pending as of August 31, 2021.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">On July 2, 2020, we received a notice of investigation and subpoena to produce information and documents from the Division of Enforcement of the SEC. The subpoena requested information and documents related to events and circumstances leading up to our March 17, 2020 announcement that we had commenced shipping samples of our COVID-19 IgG/IgM Rapid Test to countries outside of the United States, and had initiated the application process with the United States Food and Drug Administration under the COVID-19 Emergency Use Authorization for approval to market and sell the test in the United States. The subpoena also requested information and documents about the identity of any persons who were aware of the substance of the March 17, 2020 announcement prior to that date. In addition, on December 15, 2020, the SEC sent a second subpoena related to this investigation to Zack Irani, the Company&#8217;s CEO, requesting documents held by Mr. Irani concerning his past purchases of Company stock, his past communications with certain persons and entities, and other personal and Company documents. The Company and Mr. Irani have cooperated fully with the SEC&#8217;s investigation and provided information as requested. At this time, the Company is unable to predict the duration, scope or outcome of these investigations.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <a id="RISKS"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 1A. &#160;RISKS AND UNCERTAINTIES.</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">An investment in our common stock involves risks. Before making an investment decision, you should carefully consider all the information within this Quarterly Report, including the information contained in Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations," as well as in our condensed consolidated financial statements and the related notes contained in Part I, Item 1 within this Quarterly Report. In addition, you should carefully consider the risks and uncertainties described in Part I, Item 1A, &#8220;Risk Factors,&#8221; of our 2021 Annual Report on Form 10-K, as well as in our other public filings with the SEC. If any of the identified risks are realized, our business, results of operations, financial condition, liquidity, and prospects could be materially and adversely affected. In that case, the trading price of our common stock may decline, and you could lose all or part of your investment. In addition, other risks of which we are currently unaware, or which we do not currently view as material, could have a material adverse effect on our business, results of operations, financial condition, and prospects.</span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">17</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p> <p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">During the three months ended August 31, 2021, there were no material changes to the risks and uncertainties described in Part I, Item 1A, &#8220;Risk Factors,&#8221; of our 2021 Annual Report on Form 10-K/A.</span></p> <a id="s9B1D8344AA2ED028FBF5BF856A071139"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <a id="OTHERINFO"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 5.&#160; OTHER INFORMATION</span></b></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">See Note 8 to the Financial Statements for discussion of our prior period financial restatements. </span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <a id="EXHIBIT"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">ITEM 6.&#160; EXHIBITS. </span></b></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">The following exhibits are filed or furnished as part of this quarterly report on Form 10-Q: </span></p> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <table cellpadding="0" cellspacing="0" style="WIDTH:750pt" width="1000"> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td></tr> <tr> <td colspan="3" style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:12.32%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 16.2pt 0pt 0in; text-align: center;"><span style="FONT-SIZE:10pt">Exhibit No.</span></p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="BORDER-TOP:0px; BORDER-RIGHT:0px; WIDTH:85.18%; BORDER-BOTTOM:black 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">Description</span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;"><span style="FONT-SIZE:10pt"><a href="exhibit31_1.htm">31.1 </a></span></p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">*</span></p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt"><a href="exhibit31_1.htm">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act &#8212; Zackary S. Irani </a></span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;"><span style="FONT-SIZE:10pt"><a href="exhibit31_2.htm">31.2 </a></span></p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">*</span></p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt"><a href="exhibit31_2.htm">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act &#8212; Steve Sloan </a></span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;"><span style="FONT-SIZE:10pt"><a href="exhibit32_1.htm">32.1 </a></span></p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">*</span></p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt"><a href="exhibit32_1.htm">Certification Pursuant to Section 906 of the Sarbanes-Oxley Act &#8212; Zackary S. Irani </a></span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;"><span style="FONT-SIZE:10pt"><a href="exhibit32_2.htm">32.2 </a></span></p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">*</span></p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt"><a href="exhibit32_2.htm">Certification Pursuant to Section 906 of the Sarbanes-Oxley Act &#8212; Steve Sloan </a></span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;"><span style="FONT-SIZE:10pt">101</span></p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">Interactive data files pursuant to Rule 405 Regulation S-T, as follows:</span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:3.32%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:2.5%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td> <td style="WIDTH:85.18%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td colspan="3" style="WIDTH:91%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 91%; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">101. INS-XBRL Instance Document</span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td colspan="3" style="WIDTH:91%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 91%; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">101. SCH-XBRL Taxonomy Extension Schema Document</span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td colspan="3" style="WIDTH:91%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 91%; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">101. CAL-XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td colspan="3" style="WIDTH:91%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 91%; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">101. DEF&#8211;XBRL Taxonomy Extension Definition Linkbase Document</span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td colspan="3" style="WIDTH:91%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 91%; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">101. LAB-XBRL Taxonomy Extension Label Linkbase Document</span></p></td></tr> <tr> <td style="WIDTH:3.86%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td style="WIDTH:5.14%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 16.2pt 0pt 0in; text-align: right;">&#160;</p></td> <td colspan="3" style="WIDTH:91%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 91%; white-space: nowrap;" valign="top"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt">101.PRE-XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td></tr></table> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in; TEXT-INDENT:0.5in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">&#160;&#160; *Filed herewith.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">18</span></p> <hr/> <div style="PAGE-BREAK-BEFORE: always">&#160;</div><div style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 0in 0pt"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;"><a href="#TOC"><span style="color: #0066cc;">Table of Contents</span>&#160; </a></span></p></div> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <a id="SIGNATURE"></a><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">SIGNATURES</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has fully caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p> <p>&#160;</p>
<table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; margin-left: -0.75pt;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">BIOMERICA, INC.</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Date:&#160; </span><span style="font-size: 10pt;">October 14, 2021</span></p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">By:&#160; </span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 48%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">/S/ Zackary S. Irani</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 0in 0in 2.9pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Zackary S. Irani</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td colspan="2" style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 0in 0in 2.9pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Chief Executive Officer</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td colspan="2" style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(Principal Executive Officer)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Date:&#160; </span><span style="font-size: 10pt;">October 14, 2021</span></p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">By:&#160;</span></p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 48%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">/S/ Steve Sloan</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; border: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Steve Sloan</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">Chief Financial Officer</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt;">(Principal Financial Officer)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 50%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 3%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 48%; white-space: nowrap; padding: 0in 5.4pt 0in 5.4pt;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>

</table>
<p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">&#160; </span></p>
<p style="font-size: 10pt; font-family: 'Courier New'; text-align: center; margin: 0in 0in 0pt;"><span style="font-family: 'Times New Roman','serif';">19</span></p></div><div>
</div><!-- EDGAR Validation Code: 13754CAD --><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c3" id="hidden-fact-0" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-1" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-2" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-3" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-4" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-5" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-6" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-7" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c92" id="hidden-fact-8" name="us-gaap:StockholdersEquityOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c89" id="hidden-fact-9" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c86" id="hidden-fact-10" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c95" id="hidden-fact-11" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:CurrentFiscalYearEndDate">--05-31</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0000073290</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="bmra-20210831.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-10-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:OneVendorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:OneVendorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:OneVendorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bmra:PurchasedTechnologyRightsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMaumQktVVC2Jl18gJA0gt6TJQqKhfHjnLHrdKFbG6+pJgjnp4c4T10X51H4edsKAlLImcIX1aVk87uJx2R0zj0qhJf2+25n9o+WG9hpOzU8fZdUH4u6f6DJ0IAKl7ruM1zUC8QmAns5afQ==] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2009-06-18</xbrli:startDate>
    <xbrli:endDate>2009-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="bmra:LeaseAmendmentAxis">bmra:FirstAmendmentToLeaseMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2009-06-18</xbrli:startDate>
    <xbrli:endDate>2009-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-01</xbrli:startDate>
    <xbrli:endDate>2021-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-09-01</xbrli:startDate>
    <xbrli:endDate>2021-09-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2009-06-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2009-06-18</xbrli:startDate>
    <xbrli:endDate>2009-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2016-11-01</xbrli:startDate>
    <xbrli:endDate>2016-11-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2020-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-06-01</xbrli:startDate>
    <xbrli:endDate>2021-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000073290</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<head> <title>Exhibit 31.1</title></head> <body> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="left"><b>Exhibit 31.1</b></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>CERTIFICATION PURSUANT TO</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">18 U.S.C. SECTION 1350,</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">AS ADOPTED PURSUANT TO</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</b><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">I, Zackary S. Irani, certify that:</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">1. I have reviewed this Quarterly Report on Form 10-Q of Biomerica, Inc.;</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">2.
 Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this report;</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">3.
 Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects, the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report;</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="justify">4.
 The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:</p> <p style="MARGIN:0px" align="justify"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">a)
 designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant,
including its consolidated subsidiaries is made known to us by others
within those entities, particularly during the period in which this
report is being prepared;</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">b)
 designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America;</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">c)
 evaluated the effectiveness of the registrant's disclosure controls and
 procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">d)
 disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth quarter in the case
of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over
financial reporting; and</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px">5.
 The registrant's other certifying officer and I have disclosed, based
on our most recent evaluation of our internal control over financial
reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or other persons performing the
equivalent functions):</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">a)
 all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to
record, process, summarize and report financial information; and</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px; TEXT-INDENT:48px">b)
 any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
control over financial reporting.</p> <p style="MARGIN:0px">&nbsp;</p> <table style="WIDTH:210.75pt; BORDER-COLLAPSE:collapse; MARGIN-LEFT:-0.75pt" width="281" cellspacing="0" cellpadding="0" bordercolor="transparent"> <tr style="HEIGHT:22pt"> <td style="HEIGHT:14.75pt; WIDTH:210.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">Date: October 14, 2021</font></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="BORDER-TOP:0px; HEIGHT:14.75pt; BORDER-RIGHT:0px; WIDTH:210.75pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; BORDER-LEFT:0px; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">/s/ Zackary S. Irani</font></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:210.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">Zackary S. Irani</font></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:210.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">Chief Executive Officer</font></p></td></tr> <tr style="HEIGHT:14.75pt"> <td style="HEIGHT:14.75pt; WIDTH:210.75pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:5.4pt" width="281" nowrap="nowrap"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;; COLOR:black">(Principal Executive Officer)</font></p></td></tr></table> <p style="MARGIN-BOTTOM:9px; MARGIN-TOP:0px">&nbsp;</p></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit31_2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<head><title>Exhibit 31.2</title> </head> <body> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="left"><font style="FONT-SIZE:9pt"><b>EXHIBIT 31.2</b></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><font style="FONT-SIZE:9pt"><b>CERTIFICATION PURSUANT TO</font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><font style="FONT-SIZE:9pt">18 U.S.C. SECTION 1350,</font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><font style="FONT-SIZE:9pt">AS ADOPTED PURSUANT TO</font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><font style="FONT-SIZE:9pt">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</b><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px"><font style="FONT-SIZE:9pt">I, Steve Sloan, certify that:</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px"><font style="FONT-SIZE:9pt">1. I have reviewed this Quarterly Report on Form 10-Q of Biomerica, Inc.;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">2.
 Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this report;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">3.
 Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects, the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this report;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">4.
 The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)
 designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this
report is being prepared;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)
 designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America;</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)
 evaluated the effectiveness of the registrant's disclosure controls and
 procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)
 disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth quarter in the case
of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over
financial reporting; and</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">5.
 The registrant's other certifying officer and I have disclosed, based
on our most recent evaluation of our internal control over financial
reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or other persons performing the
equivalent functions):</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)
 all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to
record, process, summarize and report financial information; and</font></p> <p style="MARGIN:0px"><font style="FONT-SIZE:9pt"><br></font></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify; MARGIN:0px"><font style="FONT-SIZE:9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)
 any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
control over financial reporting.</font></p> <p style="MARGIN:0px">&nbsp;</p> <table style="WIDTH:179pt; BORDER-COLLAPSE:collapse" width="239" cellspacing="0" cellpadding="0" bordercolor="transparent"><tr style="HEIGHT:15pt"> <td style="HEIGHT:22pt; WIDTH:179pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" width="239"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Date: October 14, 2021</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">/s/ Steve Sloan</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Steve Sloan</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Chief Financial Officer</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0pt; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">(Principal Financial Officer)</font></p></td></tr></table> <p style="MARGIN:0px"><br><br></p></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit32_1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<head> <title>Exhibit 32.1</title></head> <body> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px"><b>EXHIBIT 32.1</b></p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>CERTIFICATION PURSUANT TO</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">18 U.S.C. SECTION 1350,</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">AS ADOPTED PURSUANT TO</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify;MARGIN:0px">In connection with the Quarterly Report of Biomerica, Inc. (the "Company") on Form 10-Q for the period ending August 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Zackary Irani, Chief Executive Officer of the Company, certify, to the best of my knowledge, Pursuant to Exchange Act Rule 15d-14(b) and 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes Oxley Act of 2002,</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; MARGIN-BOTTOM:-2px; FONT-FAMILY:'Times New Roman'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">i. &nbsp;&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px; TEXT-INDENT:-2px">The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, and</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; MARGIN-BOTTOM:-2px; FONT-FAMILY:'Times New Roman'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">ii. &nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px; TEXT-INDENT:-2px">The
 information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN:0px"><br></p> <p style="MARGIN:0px"><br></p> <table style="WIDTH:167pt; BORDER-COLLAPSE:collapse" width="223" cellspacing="0" cellpadding="0" bordercolor="transparent"><tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:167pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" width="223"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">/s/ Zackary S. Irani</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Zackary S. Irani</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Chief Executive Officer</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Date: October 14, 2021</font></p></td></tr></table> <p style="MARGIN:0px"><br></p> <p style="MARGIN:0px"><br></p> <p style="MARGIN:0px"><br><br></p></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit32_2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<HTML>
<head> <title>Exhibit 32.2</title></head> <body> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px">&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px"><b>EXHIBIT 32.2</b></p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center"><b>CERTIFICATION PURSUANT TO</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">18 U.S.C. SECTION 1350,</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">AS ADOPTED PURSUANT TO</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px" align="center">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; TEXT-ALIGN:justify;MARGIN:0px">In connection with the Quarterly Report of Biomerica, Inc. (the "Company") on Form 10-Q for the period ending August 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steve Sloan, Chief Financial Officer of the Company, certify, to the best of my knowledge, Pursuant to Exchange Act Rule 15d-14(b) and 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes Oxley Act of 2002,</p> <p style="MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; MARGIN-BOTTOM:-2px; FONT-FAMILY:'Times New Roman'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">i. &nbsp;&nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px; TEXT-INDENT:-2px">The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, and</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:9pt; MARGIN-BOTTOM:-2px; FONT-FAMILY:'Times New Roman'; WIDTH:48px; MARGIN-TOP:0px; FLOAT:left">ii. &nbsp;</p> <p style="FONT-SIZE:9pt; FONT-FAMILY:'Times New Roman'; MARGIN:0px; TEXT-INDENT:-2px">The
 information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN:0px"><br></p>  <table style="WIDTH:179pt; BORDER-COLLAPSE:collapse" width="239" cellspacing="0" cellpadding="0" bordercolor="transparent"><tr style="HEIGHT:15pt"> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:179pt; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in" width="239" valign="bottom"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">/s/ Steve Sloan</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Steve Sloan</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Chief Financial Officer</font></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in" valign="bottom"> <p style="FONT-SIZE:11pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;sans-serif&quot;; MARGIN:0in 0in 0pt; LINE-HEIGHT:normal"><font style="FONT-SIZE:9pt; FONT-FAMILY:&quot;Times New Roman&quot;">Date: October 14, 2021</font></p></td></tr></table><p style="MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:9px; MARGIN-TOP:0px"><br></p> <p style="MARGIN-BOTTOM:9px; MARGIN-TOP:0px"><br><br></p></body>
<!-- EDGAR Validation Code: 237E9F32 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>bmra-20210831.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 14 19:29:04 UTC 2021 -->
<xs:schema xmlns:bmra="http://www.biomerica.com/20210831" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" targetNamespace="http://www.biomerica.com/20210831" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20210831_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20210831_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20210831_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="bmra-20210831_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement" id="bmra_r_ConsolidatedIncomeStatement">
        <link:definition>001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatementAlt0" id="bmra_r_ConsolidatedIncomeStatementAlt0">
        <link:definition>001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet" id="bmra_r_ConsolidatedBalanceSheet">
        <link:definition>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals" id="bmra_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ShareholdersEquityType2or3" id="bmra_r_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow" id="bmra_r_ConsolidatedCashFlow">
        <link:definition>005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/BASISOFPRESENTATION" id="bmra_r_BASISOFPRESENTATION">
        <link:definition>006 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITY" id="bmra_r_SHAREHOLDERSEQUITY">
        <link:definition>008 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATION" id="bmra_r_GEOGRAPHICINFORMATION">
        <link:definition>009 - Disclosure - GEOGRAPHIC INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/LEASES" id="bmra_r_LEASES">
        <link:definition>010 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES" id="bmra_r_COMMITMENTSANDCONTINGENCIES">
        <link:definition>011 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTS" id="bmra_r_SUBSEQUENTEVENTS">
        <link:definition>012 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS" id="bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS">
        <link:definition>013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/AccountingPoliciesByPolicy" id="bmra_r_AccountingPoliciesByPolicy">
        <link:definition>014 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables" id="bmra_r_GEOGRAPHICINFORMATIONTables">
        <link:definition>016 - Disclosure - GEOGRAPHIC INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/LEASESTables" id="bmra_r_LEASESTables">
        <link:definition>017 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables" id="bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables">
        <link:definition>018 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMaumQktVVC2Jl18gJA0gt6TJQqKhfHjnLHrdKFbG6+pJgjnp4c4T10X51H4edsKAlLImcIX1aVk87uJx2R0zj0qhJf2+25n9o+WG9hpOzU8fZXnrhIg5/5oXAawo2LAxr0lyR2ySgqbhHQ==] CSR-->
      <link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/InventoriesTable" id="bmra_r_InventoriesTable">
        <link:definition>020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/OptionsActivityTable" id="bmra_r_OptionsActivityTable">
        <link:definition>021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable" id="bmra_r_RevenuefromcontractswithcustomersTable">
        <link:definition>022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails" id="bmra_r_SHAREHOLDERSEQUITYDetails">
        <link:definition>023 - Disclosure - SHAREHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails" id="bmra_r_GEOGRAPHICINFORMATIONDetails">
        <link:definition>024 - Disclosure - GEOGRAPHIC INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable" id="bmra_r_GeographicinformationregardingnetsalesTable">
        <link:definition>025 - Disclosure - GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/LEASESDetails" id="bmra_r_LEASESDetails">
        <link:definition>026 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable" id="bmra_r_SupplementalcashflowinformationrelatedtoleasesTable">
        <link:definition>027 - Disclosure - LEASES (Details) - Supplemental cash flow information related to leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable" id="bmra_r_ThematurityofleaseliabilitiesTable">
        <link:definition>028 - Disclosure - LEASES (Details) - The maturity of lease liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable" id="bmra_r_RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable">
        <link:definition>029 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <xs:element name="InventoriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_InventoriesAbstract"/>
  <xs:element name="OptionsActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OptionsActivityAbstract"/>
  <xs:element name="RevenueFromContractsWithCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RevenueFromContractsWithCustomersAbstract"/>
  <xs:element name="GeographicInformationDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GeographicInformationDisclosureAbstract"/>
  <xs:element name="GeographicInformationRegardingNetSalesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GeographicInformationRegardingNetSalesAbstract"/>
  <xs:element name="SupplementalCashFlowInformationRelatedToLeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>
  <xs:element name="TheMaturityOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>
  <xs:element name="RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract"/>
  <xs:element name="SupplementalDisclosureOfCashFlowInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SupplementalDisclosureOfCashFlowInformationAbstract"/>
  <xs:element name="CashPaidDuringThePeriodForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_CashPaidDuringThePeriodForAbstract"/>
  <xs:element name="RevenuesFromSalesToUnaffiliatedCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>
  <xs:element name="RightOfUseAssetsObtainedInExchangeForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RightOfUseAssetsObtainedInExchangeForAbstract"/>
  <xs:element name="OperatingLeaseRightOfUseAssetAccumulatedAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
  <xs:element name="PreferredStockUndesignatedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="bmra_PreferredStockUndesignatedShares"/>
  <xs:element name="OperatingLeaseRightofUseAssetAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingLeaseRightofUseAssetAmortization"/>
  <xs:element name="IncreaseDecreaseInLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_IncreaseDecreaseInLeaseLiability"/>
  <xs:element name="GeographicInformationDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GeographicInformationDisclosureTextBlock"/>
  <xs:element name="MarketsAndMethodsOfDistributionPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock"/>
  <xs:element name="LiquidityPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LiquidityPolicyTextBlock"/>
  <xs:element name="PrepaidsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PrepaidsPolicyPolicyTextBlock"/>
  <xs:element name="ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>
  <xs:element name="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable"/>
  <xs:element name="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
  <xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
  <xs:element name="ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue"/>
  <xs:element name="ProceedsFromStockOptionsGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_ProceedsFromStockOptionsGranted"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SHAREHOLDERSEQUITYDetailsTable"/>
  <xs:element name="SHAREHOLDERSEQUITYDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>
  <xs:element name="GEOGRAPHICINFORMATIONDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_GEOGRAPHICINFORMATIONDetailsTable"/>
  <xs:element name="GEOGRAPHICINFORMATIONDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>
  <xs:element name="LeaseAmendmentDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LeaseAmendmentDomain"/>
  <xs:element name="PropertySubjectToOrAvailableForOperatingLease_Domain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
  <xs:element name="LEASESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_LEASESDetailsTable"/>
  <xs:element name="LEASESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LEASESDetailsLineItems"/>
  <xs:element name="OperatingLeaseInitiationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingLeaseInitiationDate"/>
  <xs:element name="RentPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RentPercentage"/>
  <xs:element name="LeaseAmendmentAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="bmra_LeaseAmendmentAxis"/>
  <xs:element name="A5ConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_A5ConvertiblePreferredStockMember"/>
  <xs:element name="BuildingInIrvineCaliforniaMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_BuildingInIrvineCaliforniaMember"/>
  <xs:element name="ClinicalLabMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ClinicalLabMember"/>
  <xs:element name="ContractManufacturingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ContractManufacturingMember"/>
  <xs:element name="FirstAmendmentToLeaseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_FirstAmendmentToLeaseMember"/>
  <xs:element name="OneVendorMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OneVendorMember"/>
  <xs:element name="OverthecounterMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OverthecounterMember"/>
  <xs:element name="PhysiciansOfficeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PhysiciansOfficeMember"/>
  <xs:element name="PurchasedTechnologyRightsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PurchasedTechnologyRightsMember"/>
  <xs:element name="RestatementOfCompanysFinancialStatementsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RestatementOfCompanysFinancialStatementsMember"/>
  <xs:element name="TwoDistributorsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TwoDistributorsMember"/>
  <xs:element name="TwoVendorsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TwoVendorsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>bmra-20210831_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 14 19:29:04 UTC 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedIncomeStatement" roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedBalanceSheet" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedCashFlow" roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_InventoriesTable" roleURI="http://www.biomerica.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ThematurityofleaseliabilitiesTable" roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Investments" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="4" weight="1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMaumQktVVC2Jl18gJA0gt6TJQqKhfHjnLHrdKFbG6+pJgjnp4c4T10X51H4edsKAlLImcIX1aVk87uJx2R0zj0qhJf2+25n9o+WG9hpOzU8fZe/G1JG620HuzWz+Rggr3z0DAFsOlI25Wg==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_StockOptionPlanExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseRightofUseAssetAmortization" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseRightofUseAssetAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="bmra_OperatingLeaseRightofUseAssetAmortization" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="bmra_IncreaseDecreaseInLeaseLiability" xlink:href="bmra-20210831.xsd#bmra_IncreaseDecreaseInLeaseLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="bmra_IncreaseDecreaseInLeaseLiability" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="6" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>bmra-20210831_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 14 19:29:04 UTC 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedIncomeStatement" roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedBalanceSheet" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ShareholdersEquityType2or3" roleURI="http://www.biomerica.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedCashFlow" roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_BASISOFPRESENTATION" roleURI="http://www.biomerica.com/role/BASISOFPRESENTATION"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SHAREHOLDERSEQUITY" roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_GEOGRAPHICINFORMATION" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATION"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_LEASES" roleURI="http://www.biomerica.com/role/LEASES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SUBSEQUENTEVENTS" roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTS"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS" roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_AccountingPoliciesByPolicy" roleURI="http://www.biomerica.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_GEOGRAPHICINFORMATIONTables" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_LEASESTables" roleURI="http://www.biomerica.com/role/LEASESTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables" roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_InventoriesTable" roleURI="http://www.biomerica.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_OptionsActivityTable" roleURI="http://www.biomerica.com/role/OptionsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_RevenuefromcontractswithcustomersTable" roleURI="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_GeographicinformationregardingnetsalesTable" roleURI="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SupplementalcashflowinformationrelatedtoleasesTable" roleURI="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ThematurityofleaseliabilitiesTable" roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable" roleURI="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SHAREHOLDERSEQUITYDetails" roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_GEOGRAPHICINFORMATIONDetails" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_LEASESDetails" roleURI="http://www.biomerica.com/role/LEASESDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#DocumentAndEntityInformation" roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_GrossProfit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_OperatingExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_A5ConvertiblePreferredStockMember" xlink:href="bmra-20210831.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="bmra_A5ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Investments" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_A5ConvertiblePreferredStockMember" xlink:href="bmra-20210831.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="bmra_A5ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockNoParValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PreferredStockUndesignatedShares" xlink:href="bmra-20210831.xsd#bmra_PreferredStockUndesignatedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="bmra_PreferredStockUndesignatedShares" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_A5ConvertiblePreferredStockMember" xlink:href="bmra-20210831.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="bmra_A5ConvertiblePreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseRightofUseAssetAmortization" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseRightofUseAssetAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="bmra_OperatingLeaseRightofUseAssetAmortization" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_IncreaseDecreaseInLeaseLiability" xlink:href="bmra-20210831.xsd#bmra_IncreaseDecreaseInLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="bmra_IncreaseDecreaseInLeaseLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_CashPaidDuringThePeriodForAbstract" xlink:href="bmra-20210831.xsd#bmra_CashPaidDuringThePeriodForAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="bmra_CashPaidDuringThePeriodForAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_CashPaidDuringThePeriodForAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/BASISOFPRESENTATION">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccounting" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATION">
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureAbstract" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureTextBlock" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GeographicInformationDisclosureAbstract" xlink:to="bmra_GeographicInformationDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASES">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SUBSEQUENTEVENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_ErrorCorrectionTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_MarketsAndMethodsOfDistributionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_LiquidityPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_LiquidityPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmra_LiquidityPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_PrepaidsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="bmra_PrepaidsPolicyPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables">
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureAbstract" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GeographicInformationDisclosureAbstract" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:href="bmra-20210831.xsd#bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="bmra_InventoriesAbstract" xlink:href="bmra-20210831.xsd#bmra_InventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_InventoriesAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_InventoriesAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_InventoriesAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_InventoriesAbstract" xlink:to="us-gaap_InventoryNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/OptionsActivityTable">
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMaumQktVVC2Jl18gJA0gt6TJQqKhfHjnLHrdKFbG6+pJgjnp4c4T10X51H4edsKAlLImcIX1aVk87uJx2R0zj0qhJf2+25n9o+WG9hpOzU8fZYsaVhJbdTc4sWhZKQf5PgemyNDMc4aFsg==] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_ClinicalLabMember" xlink:href="bmra-20210831.xsd#bmra_ClinicalLabMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="bmra_ClinicalLabMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PhysiciansOfficeMember" xlink:href="bmra-20210831.xsd#bmra_PhysiciansOfficeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="bmra_PhysiciansOfficeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_OverthecounterMember" xlink:href="bmra-20210831.xsd#bmra_OverthecounterMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="bmra_OverthecounterMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_ContractManufacturingMember" xlink:href="bmra-20210831.xsd#bmra_ContractManufacturingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="bmra_ContractManufacturingMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable">
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_AsiaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_NorthAmericaMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MiddleEastMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="us-gaap_MiddleEastMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SouthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SouthAmericaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SouthAmericaMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:href="bmra-20210831.xsd#bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:to="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable">
    <loc xlink:type="locator" xlink:label="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="bmra-20210831.xsd#bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:href="bmra-20210831.xsd#bmra_RightOfUseAssetsObtainedInExchangeForAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable">
    <loc xlink:type="locator" xlink:label="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:href="bmra-20210831.xsd#bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_RestatementOfCompanysFinancialStatementsMember" xlink:href="bmra-20210831.xsd#bmra_RestatementOfCompanysFinancialStatementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="bmra_RestatementOfCompanysFinancialStatementsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_GrossProfit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_OperatingExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_TwoDistributorsMember" xlink:href="bmra-20210831.xsd#bmra_TwoDistributorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="bmra_TwoDistributorsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_OneVendorMember" xlink:href="bmra-20210831.xsd#bmra_OneVendorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="bmra_OneVendorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_TwoVendorsMember" xlink:href="bmra-20210831.xsd#bmra_TwoVendorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="bmra_TwoVendorsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DistributionRightsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PurchasedTechnologyRightsMember" xlink:href="bmra-20210831.xsd#bmra_PurchasedTechnologyRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="bmra_PurchasedTechnologyRightsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_CostOfGoodsProductLineMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsPayableMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_SupplierConcentrationRiskMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:href="bmra-20210831.xsd#bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CashUninsuredAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryWriteDown" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_OtherInventory" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryValuationReserves" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryLIFOReserve" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_ProceedsFromStockOptionsGranted" xlink:href="bmra-20210831.xsd#bmra_ProceedsFromStockOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="bmra_ProceedsFromStockOptionsGranted" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="25" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails">
    <loc xlink:type="locator" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:href="bmra-20210831.xsd#bmra_SHAREHOLDERSEQUITYDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="bmra_SHAREHOLDERSEQUITYDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails">
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsTable" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_MX" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_InventoryGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASESDetails">
    <loc xlink:type="locator" xlink:label="bmra_LEASESDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_LEASESDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="bmra_LEASESDetailsTable" xlink:href="bmra-20210831.xsd#bmra_LEASESDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="bmra_LEASESDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_LEASESDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentAxis" xlink:href="bmra-20210831.xsd#bmra_LeaseAmendmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_LEASESDetailsTable" xlink:to="bmra_LeaseAmendmentAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentDomain" xlink:href="bmra-20210831.xsd#bmra_LeaseAmendmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="bmra_LeaseAmendmentAxis" xlink:to="bmra_LeaseAmendmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentDomain_0" xlink:href="bmra-20210831.xsd#bmra_LeaseAmendmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="bmra_LeaseAmendmentAxis" xlink:to="bmra_LeaseAmendmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_LEASESDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:href="bmra-20210831.xsd#bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain_0" xlink:href="bmra-20210831.xsd#bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="bmra_LEASESDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_BuildingInIrvineCaliforniaMember" xlink:href="bmra-20210831.xsd#bmra_BuildingInIrvineCaliforniaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:to="bmra_BuildingInIrvineCaliforniaMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyAvailableForOperatingLeaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:to="us-gaap_PropertyAvailableForOperatingLeaseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_FirstAmendmentToLeaseMember" xlink:href="bmra-20210831.xsd#bmra_FirstAmendmentToLeaseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LeaseAmendmentDomain" xlink:to="bmra_FirstAmendmentToLeaseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_MX" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseInitiationDate" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseInitiationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="bmra_OperatingLeaseInitiationDate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="bmra_RentPercentage" xlink:href="bmra-20210831.xsd#bmra_RentPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="bmra_RentPercentage" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_SecurityDeposit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12gTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12gTitle" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="29" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bmra-20210831_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 14 19:29:04 UTC 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Net sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Net Sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross (Loss) Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Total operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend_lbl" xml:lang="en-US">Dividend and interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net loss per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net loss per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl0" xml:lang="en-US">Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, less allowance for doubtful accounts of $742,524 and $837,415 as of August 31, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net of accumulated depreciation and amortization of $2,000,167 and $1,972,357 as of August 31, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation and amortization (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right of use assets, net of accumulated amortization of $531,974 and $469,077 as of August 31, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization, Right of Use Assets (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net of accumulated amortization of $83,683 and $126,769 as of August 31, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization, Intangible Assets (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Lease liability, current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Lease liability, net of current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Notes 1 and 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl" xml:lang="en-US">Equity Interest Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, Series A 5% convertible, $0.08 par value, 571,429 shares authorized, none issued and outstanding as of August 31, 2021 and May 31, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Preferred stock, undesignated, no par value, 4,428,571 shares authorized, none issued and outstanding as of August 31, 2021 and May 31, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockNoParValue_lbl" xml:lang="en-US">Preferred Stock, No Par Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockNoParValue" xlink:to="us-gaap_PreferredStockNoParValue_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PreferredStockUndesignatedShares" xlink:href="bmra-20210831.xsd#bmra_PreferredStockUndesignatedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PreferredStockUndesignatedShares_lbl" xml:lang="en-US">Preferred Stock, undesignated shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PreferredStockUndesignatedShares" xlink:to="bmra_PreferredStockUndesignatedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.08 par value, 25,000,000 shares authorized, 12,510,210 and 12,307,157 issued and outstanding at August 31, 2021 and May 31, 2021, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in-capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid-in-capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Total Shareholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Shareholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balances (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Balances (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Option Exercised, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Compensation expense in connection with options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Net proceeds from ATM</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Net proceeds from ATM (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Change in allowance on accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge_lbl" xml:lang="en-US">Inventory reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseRightofUseAssetAmortization" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseRightofUseAssetAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OperatingLeaseRightofUseAssetAmortization_lbl" xml:lang="en-US">Amortization of right-of-use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseRightofUseAssetAmortization" xlink:to="bmra_OperatingLeaseRightofUseAssetAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_IncreaseDecreaseInLeaseLiability" xlink:href="bmra-20210831.xsd#bmra_IncreaseDecreaseInLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_IncreaseDecreaseInLeaseLiability_lbl" xml:lang="en-US">Reduction in lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_IncreaseDecreaseInLeaseLiability" xlink:to="bmra_IncreaseDecreaseInLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Accrued compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Increase in intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_InventoriesAbstract" xlink:href="bmra-20210831.xsd#bmra_InventoriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_InventoriesAbstract_lbl" xml:lang="en-US">Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_InventoriesAbstract" xlink:to="bmra_InventoriesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US">Raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US">Work in progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US">Finished products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OptionsActivityAbstract" xlink:href="bmra-20210831.xsd#bmra_OptionsActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OptionsActivityAbstract_lbl" xml:lang="en-US">Options Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OptionsActivityAbstract" xlink:to="bmra_OptionsActivityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options Outstanding, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Options Outstanding, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option Outstanding, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Option Outstanding, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Option Granted, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option Granted, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option Exercised, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Option Cancelled or expired, Shares | shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Option Cancelled or expired, Exercise Price Weighted Average | $ / shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RevenueFromContractsWithCustomersAbstract" xlink:href="bmra-20210831.xsd#bmra_RevenueFromContractsWithCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US">Revenue from contracts with customers [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RevenueFromContractsWithCustomersAbstract" xlink:to="bmra_RevenueFromContractsWithCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue From Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureAbstract" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GeographicInformationDisclosureAbstract_lbl" xml:lang="en-US">Geographic Information Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationDisclosureAbstract" xlink:to="bmra_GeographicInformationDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationRegardingNetSalesAbstract" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationRegardingNetSalesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GeographicInformationRegardingNetSalesAbstract_lbl" xml:lang="en-US">Geographic information regarding net sales [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationRegardingNetSalesAbstract" xlink:to="bmra_GeographicInformationRegardingNetSalesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="bmra-20210831.xsd#bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract_lbl" xml:lang="en-US">Supplemental cash flow information related to leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating cash flows from operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:href="bmra-20210831.xsd#bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TheMaturityOfLeaseLiabilitiesAbstract_lbl" xml:lang="en-US">The maturity of lease liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="bmra_TheMaturityOfLeaseLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">Less than 1 year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">1 to 2 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2 to 3 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">3 to 4 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">4 to 5 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">5 to 10 years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total undiscounted lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract_lbl" xml:lang="en-US">Prior Period Adjustment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_PriorPeriodAdjustmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract" xlink:href="bmra-20210831.xsd#bmra_RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract" xlink:to="bmra_RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityOther_lbl" xml:lang="en-US">Other Equity accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_lbl" xml:lang="en-US">Error Correction, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12gTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other Income:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average number of common and common equivalent shares:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other comprehensive loss, net of tax:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Shareholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&apos; Equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:href="bmra-20210831.xsd#bmra_SupplementalDisclosureOfCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_SupplementalDisclosureOfCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Cash-Flow Information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="bmra_SupplementalDisclosureOfCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_CashPaidDuringThePeriodForAbstract" xlink:href="bmra-20210831.xsd#bmra_CashPaidDuringThePeriodForAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_CashPaidDuringThePeriodForAbstract_lbl" xml:lang="en-US">Cash paid during the period for:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_CashPaidDuringThePeriodForAbstract" xlink:to="bmra_CashPaidDuringThePeriodForAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_A5ConvertiblePreferredStockMember" xlink:href="bmra-20210831.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_A5ConvertiblePreferredStockMember_lbl" xml:lang="en-US">5% Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_A5ConvertiblePreferredStockMember" xlink:to="bmra_A5ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US">Basis of Accounting [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GeographicInformationDisclosureTextBlock" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_GeographicInformationDisclosureTextBlock_lbl" xml:lang="en-US">Geographic Information Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationDisclosureTextBlock" xlink:to="bmra_GeographicInformationDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:href="bmra-20210831.xsd#bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract_lbl" xml:lang="en-US">Revenues from sales to unaffiliated customers:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:to="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:href="bmra-20210831.xsd#bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl" xml:lang="en-US">Schedule Of Cash Flow Supplemental Disclosures Related To Lease [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:to="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:href="bmra-20210831.xsd#bmra_RightOfUseAssetsObtainedInExchangeForAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_RightOfUseAssetsObtainedInExchangeForAbstract_lbl" xml:lang="en-US">Right-of-use assets obtained in exchange for</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:to="bmra_RightOfUseAssetsObtainedInExchangeForAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl" xml:lang="en-US">Error Correction [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ClinicalLabMember" xlink:href="bmra-20210831.xsd#bmra_ClinicalLabMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ClinicalLabMember_lbl" xml:lang="en-US">Clinical Lab [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ClinicalLabMember" xlink:to="bmra_ClinicalLabMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PhysiciansOfficeMember" xlink:href="bmra-20210831.xsd#bmra_PhysiciansOfficeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_PhysiciansOfficeMember_lbl" xml:lang="en-US">Physicians Office [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PhysiciansOfficeMember" xlink:to="bmra_PhysiciansOfficeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OverthecounterMember" xlink:href="bmra-20210831.xsd#bmra_OverthecounterMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_OverthecounterMember_lbl" xml:lang="en-US">Over-the-counter [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OverthecounterMember" xlink:to="bmra_OverthecounterMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ContractManufacturingMember" xlink:href="bmra-20210831.xsd#bmra_ContractManufacturingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ContractManufacturingMember_lbl" xml:lang="en-US">Contract Manufacturing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ContractManufacturingMember" xlink:to="bmra_ContractManufacturingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_AsiaMember_lbl" xml:lang="en-US">Asia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_NorthAmericaMember_lbl" xml:lang="en-US">North America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MiddleEastMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MiddleEastMember_lbl" xml:lang="en-US">Middle East [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MiddleEastMember" xlink:to="us-gaap_MiddleEastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SouthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SouthAmericaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_SouthAmericaMember_lbl" xml:lang="en-US">South America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SouthAmericaMember" xlink:to="srt_SouthAmericaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_lbl" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RestatementOfCompanysFinancialStatementsMember" xlink:href="bmra-20210831.xsd#bmra_RestatementOfCompanysFinancialStatementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_RestatementOfCompanysFinancialStatementsMember_lbl" xml:lang="en-US">Restatement Of Companys Financial Statements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RestatementOfCompanysFinancialStatementsMember" xlink:to="bmra_RestatementOfCompanysFinancialStatementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMaumQktVVC2Jl18gJA0gt6TJQqKhfHjnLHrdKFbG6+pJgjnp4c4T10X51H4edsKAlLImcIX1aVk87uJx2R0zj0qhJf2+25n9o+WG9hpOzU8fZYgrvdFMpCZKxG2bOMgkq9nz0ol9apS+cA==] CSR-->
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl" xml:lang="en-US">Property Subject to or Available for Operating Lease [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentAxis" xlink:href="bmra-20210831.xsd#bmra_LeaseAmendmentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_LeaseAmendmentAxis_lbl" xml:lang="en-US">Lease Amendment [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LeaseAmendmentAxis" xlink:to="bmra_LeaseAmendmentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:href="bmra-20210831.xsd#bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl" xml:lang="en-US">Shelf Registration Statement, Maximum Authorized Common Stock Issuance, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:to="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashUninsuredAmount_lbl" xml:lang="en-US">Cash, Uninsured Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable_lbl" xml:lang="en-US">Threshold Period Past Due for Write-off of Trade Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:to="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_lbl" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Inventory Write-down</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInventory_lbl" xml:lang="en-US">Other Inventory, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventory" xlink:to="us-gaap_OtherInventory_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Inventory Valuation Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryLIFOReserve_lbl" xml:lang="en-US">Inventory, LIFO Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReserve" xlink:to="us-gaap_InventoryLIFOReserve_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_ProceedsFromStockOptionsGranted" xlink:href="bmra-20210831.xsd#bmra_ProceedsFromStockOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_ProceedsFromStockOptionsGranted_lbl" xml:lang="en-US">Proceeds from Stock Options Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ProceedsFromStockOptionsGranted" xlink:to="bmra_ProceedsFromStockOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Other Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share-based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of Stock, Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Inventory, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OperatingLeaseInitiationDate" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseInitiationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_OperatingLeaseInitiationDate_lbl" xml:lang="en-US">Operating Lease Initiation Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseInitiationDate" xlink:to="bmra_OperatingLeaseInitiationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_RentPercentage" xlink:href="bmra-20210831.xsd#bmra_RentPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_RentPercentage_lbl" xml:lang="en-US">Rent Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RentPercentage" xlink:to="bmra_RentPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl" xml:lang="en-US">Operating Leases, Rent Expense, Minimum Rentals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_MarketsAndMethodsOfDistributionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl" xml:lang="en-US">Markets And Methods Of Distribution [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:to="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LiquidityPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_LiquidityPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_LiquidityPolicyTextBlock_lbl" xml:lang="en-US">Liquidity [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LiquidityPolicyTextBlock" xlink:to="bmra_LiquidityPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_PrepaidsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Prepaids Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PrepaidsPolicyPolicyTextBlock" xlink:to="bmra_PrepaidsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TwoDistributorsMember" xlink:href="bmra-20210831.xsd#bmra_TwoDistributorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_TwoDistributorsMember_lbl" xml:lang="en-US">Two Distributors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TwoDistributorsMember" xlink:to="bmra_TwoDistributorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfGoodsProductLineMember_lbl" xml:lang="en-US">Cost of Goods and Service, Product and Service Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsProductLineMember" xlink:to="us-gaap_CostOfGoodsProductLineMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl" xml:lang="en-US">Supplier Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_OneVendorMember" xlink:href="bmra-20210831.xsd#bmra_OneVendorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_OneVendorMember_lbl" xml:lang="en-US">One Vendor [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OneVendorMember" xlink:to="bmra_OneVendorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_TwoVendorsMember" xlink:href="bmra-20210831.xsd#bmra_TwoVendorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_TwoVendorsMember_lbl" xml:lang="en-US">Two Vendors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TwoVendorsMember" xlink:to="bmra_TwoVendorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DistributionRightsMember_lbl" xml:lang="en-US">Distribution Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionRightsMember" xlink:to="us-gaap_DistributionRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PurchasedTechnologyRightsMember" xlink:href="bmra-20210831.xsd#bmra_PurchasedTechnologyRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_PurchasedTechnologyRightsMember_lbl" xml:lang="en-US">Purchased Technology Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PurchasedTechnologyRightsMember" xlink:to="bmra_PurchasedTechnologyRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_MX_lbl" xml:lang="en-US">MEXICO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_MX" xlink:to="country_MX_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_BuildingInIrvineCaliforniaMember" xlink:href="bmra-20210831.xsd#bmra_BuildingInIrvineCaliforniaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_BuildingInIrvineCaliforniaMember_lbl" xml:lang="en-US">Building In Irvine California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_BuildingInIrvineCaliforniaMember" xlink:to="bmra_BuildingInIrvineCaliforniaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_FirstAmendmentToLeaseMember" xlink:href="bmra-20210831.xsd#bmra_FirstAmendmentToLeaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="bmra_FirstAmendmentToLeaseMember_lbl" xml:lang="en-US">First Amendment To Lease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_FirstAmendmentToLeaseMember" xlink:to="bmra_FirstAmendmentToLeaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyAvailableForOperatingLeaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember_lbl" xml:lang="en-US">Property Available for Operating Lease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:to="us-gaap_PropertyAvailableForOperatingLeaseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentDomain_lbl" xml:lang="en-US">Segments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForErrorCorrectionDomain_lbl" xml:lang="en-US">Error Correction, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="us-gaap_AdjustmentsForErrorCorrectionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_lbl" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US">Concentration Risk Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:href="bmra-20210831.xsd#bmra_SHAREHOLDERSEQUITYDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsTable_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsTable" xlink:to="bmra_SHAREHOLDERSEQUITYDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SHAREHOLDERSEQUITYDetailsLineItems_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="bmra_SHAREHOLDERSEQUITYDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsTable" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsTable_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsTable" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GEOGRAPHICINFORMATIONDetailsLineItems_lbl" xml:lang="en-US">GEOGRAPHIC INFORMATION (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="bmra_GEOGRAPHICINFORMATIONDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LeaseAmendmentDomain" xlink:href="bmra-20210831.xsd#bmra_LeaseAmendmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LeaseAmendmentDomain_lbl" xml:lang="en-US">LeaseAmendment [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LeaseAmendmentDomain" xlink:to="bmra_LeaseAmendmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:href="bmra-20210831.xsd#bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain_lbl" xml:lang="en-US">PropertySubjectToOrAvailableForOperatingLease_ [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:to="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LEASESDetailsTable" xlink:href="bmra-20210831.xsd#bmra_LEASESDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LEASESDetailsTable_lbl" xml:lang="en-US">LEASES (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LEASESDetailsTable" xlink:to="bmra_LEASESDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="bmra_LEASESDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_LEASESDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LEASESDetailsLineItems_lbl" xml:lang="en-US">LEASES (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LEASESDetailsLineItems" xlink:to="bmra_LEASESDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_GeographicInformationDisclosureTextBlock_lbl0" xml:lang="en-US">The entire disclosure for reporting segments according to the geographic areas.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationDisclosureTextBlock" xlink:to="bmra_GeographicInformationDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_IncreaseDecreaseInLeaseLiability_lbl0" xml:lang="en-US">The increase (decrease) during the reporting period in LeaseLiability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_IncreaseDecreaseInLeaseLiability" xlink:to="bmra_IncreaseDecreaseInLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_LiquidityPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for liquidity position during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LiquidityPolicyTextBlock" xlink:to="bmra_LiquidityPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for Markets And Methods Of Distribution during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:to="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_OperatingLeaseInitiationDate_lbl0" xml:lang="en-US">Date the operating lease was initiated, in CCYY-MM-DD format.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseInitiationDate" xlink:to="bmra_OperatingLeaseInitiationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl0" xml:lang="en-US">Amount of accumulated amortization of right-of-use asset from operating lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_OperatingLeaseRightofUseAssetAmortization_lbl0" xml:lang="en-US">Amortization of Right of Use Asset for Operating Lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseRightofUseAssetAmortization" xlink:to="bmra_OperatingLeaseRightofUseAssetAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_PreferredStockUndesignatedShares_lbl0" xml:lang="en-US">Number of preferred shares undesignated during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PreferredStockUndesignatedShares" xlink:to="bmra_PreferredStockUndesignatedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for prepaids.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PrepaidsPolicyPolicyTextBlock" xlink:to="bmra_PrepaidsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_ProceedsFromStockOptionsGranted_lbl0" xml:lang="en-US">Amount of cash inflow from granted of option under share-based payment arrangement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ProceedsFromStockOptionsGranted" xlink:to="bmra_ProceedsFromStockOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_RentPercentage_lbl0" xml:lang="en-US">Rent percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RentPercentage" xlink:to="bmra_RentPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of supplemental cash flow information related to lease for the periods.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:to="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl0" xml:lang="en-US">Amount related with Maximum Authorized Common Stock Issuance of Shelf Registration Statement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:to="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ClinicalLabMember_lbl0" xml:lang="en-US">ClinicalLabMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ClinicalLabMember" xlink:to="bmra_ClinicalLabMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OneVendorMember_lbl0" xml:lang="en-US">OneVendorMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OneVendorMember" xlink:to="bmra_OneVendorMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl1" xml:lang="en-US">ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:to="bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OperatingLeaseInitiationDate_lbl1" xml:lang="en-US">OperatingLeaseInitiationDate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OperatingLeaseInitiationDate" xlink:to="bmra_OperatingLeaseInitiationDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract_lbl0" xml:lang="en-US">RevenuesFromSalesToUnaffiliatedCustomersAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:to="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PhysiciansOfficeMember_lbl0" xml:lang="en-US">PhysiciansOfficeMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PhysiciansOfficeMember" xlink:to="bmra_PhysiciansOfficeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PrepaidsPolicyPolicyTextBlock_lbl1" xml:lang="en-US">PrepaidsPolicyPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PrepaidsPolicyPolicyTextBlock" xlink:to="bmra_PrepaidsPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ProceedsFromStockOptionsGranted_lbl1" xml:lang="en-US">ProceedsFromStockOptionsGranted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ProceedsFromStockOptionsGranted" xlink:to="bmra_ProceedsFromStockOptionsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_FirstAmendmentToLeaseMember_lbl0" xml:lang="en-US">FirstAmendmentToLeaseMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_FirstAmendmentToLeaseMember" xlink:to="bmra_FirstAmendmentToLeaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RentPercentage_lbl1" xml:lang="en-US">RentPercentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RentPercentage" xlink:to="bmra_RentPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TwoVendorsMember_lbl0" xml:lang="en-US">TwoVendorsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TwoVendorsMember" xlink:to="bmra_TwoVendorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl1" xml:lang="en-US">MarketsAndMethodsOfDistributionPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:to="bmra_MarketsAndMethodsOfDistributionPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LeaseAmendmentAxis_lbl0" xml:lang="en-US">LeaseAmendmentAxis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LeaseAmendmentAxis" xlink:to="bmra_LeaseAmendmentAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_CashPaidDuringThePeriodForAbstract_lbl0" xml:lang="en-US">CashPaidDuringThePeriodForAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_CashPaidDuringThePeriodForAbstract" xlink:to="bmra_CashPaidDuringThePeriodForAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl1" xml:lang="en-US">ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:to="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RightOfUseAssetsObtainedInExchangeForAbstract_lbl0" xml:lang="en-US">RightOfUseAssetsObtainedInExchangeForAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RightOfUseAssetsObtainedInExchangeForAbstract" xlink:to="bmra_RightOfUseAssetsObtainedInExchangeForAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_GeographicInformationDisclosureTextBlock_lbl1" xml:lang="en-US">GeographicInformationDisclosureTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_GeographicInformationDisclosureTextBlock" xlink:to="bmra_GeographicInformationDisclosureTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_BuildingInIrvineCaliforniaMember_lbl0" xml:lang="en-US">BuildingInIrvineCaliforniaMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_BuildingInIrvineCaliforniaMember" xlink:to="bmra_BuildingInIrvineCaliforniaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_TwoDistributorsMember_lbl0" xml:lang="en-US">TwoDistributorsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_TwoDistributorsMember" xlink:to="bmra_TwoDistributorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_LiquidityPolicyTextBlock_lbl1" xml:lang="en-US">LiquidityPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_LiquidityPolicyTextBlock" xlink:to="bmra_LiquidityPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_ContractManufacturingMember_lbl0" xml:lang="en-US">ContractManufacturingMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_ContractManufacturingMember" xlink:to="bmra_ContractManufacturingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_OverthecounterMember_lbl0" xml:lang="en-US">OverthecounterMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_OverthecounterMember" xlink:to="bmra_OverthecounterMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_PurchasedTechnologyRightsMember_lbl0" xml:lang="en-US">PurchasedTechnologyRightsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_PurchasedTechnologyRightsMember" xlink:to="bmra_PurchasedTechnologyRightsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_SupplementalDisclosureOfCashFlowInformationAbstract_lbl0" xml:lang="en-US">SupplementalDisclosureOfCashFlowInformationAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_SupplementalDisclosureOfCashFlowInformationAbstract" xlink:to="bmra_SupplementalDisclosureOfCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_RestatementOfCompanysFinancialStatementsMember_lbl0" xml:lang="en-US">RestatementOfCompanysFinancialStatementsMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_RestatementOfCompanysFinancialStatementsMember" xlink:to="bmra_RestatementOfCompanysFinancialStatementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bmra_A5ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">A5ConvertiblePreferredStockMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bmra_A5ConvertiblePreferredStockMember" xlink:to="bmra_A5ConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl0" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_lbl0" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl0" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_lbl0" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaMember_lbl0" xml:lang="en-US">Asia [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl0" xml:lang="en-US">Other Income and Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl0" xml:lang="en-US">Lease Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl0" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember_lbl0" xml:lang="en-US">Property Available for Operating Lease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:to="us-gaap_PropertyAvailableForOperatingLeaseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl0" xml:lang="en-US">Entity Address, State or Province</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl1" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl0" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl0" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventory_lbl0" xml:lang="en-US">Other Inventory, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventory" xlink:to="us-gaap_OtherInventory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl0" xml:lang="en-US">Error Correction [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MiddleEastMember_lbl0" xml:lang="en-US">Middle East [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MiddleEastMember" xlink:to="us-gaap_MiddleEastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl0" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl0" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_lbl0" xml:lang="en-US">Inventory, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Other Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl0" xml:lang="en-US">Supplier Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl0" xml:lang="en-US">Accounts Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl0" xml:lang="en-US">Security Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl0" xml:lang="en-US">Title of 12(g) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl0" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl0" xml:lang="en-US">Operating Leases, Rent Expense, Minimum Rentals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SouthAmericaMember_lbl0" xml:lang="en-US">South America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SouthAmericaMember" xlink:to="srt_SouthAmericaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0" xml:lang="en-US">Payments to Acquire Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl0" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl0" xml:lang="en-US">Inventory Write-down</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashUninsuredAmount_lbl0" xml:lang="en-US">Cash, Uninsured Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl0" xml:lang="en-US">Inventory Valuation Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_MX_lbl0" xml:lang="en-US">MEXICO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_MX" xlink:to="country_MX_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccounting_lbl0" xml:lang="en-US">Basis of Accounting [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl0" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl0" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EuropeMember_lbl0" xml:lang="en-US">Europe [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl0" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl0" xml:lang="en-US">Entity Tax Identification Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl0" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NorthAmericaMember_lbl0" xml:lang="en-US">North America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl0" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl0" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl0" xml:lang="en-US">Accounts Payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsProductLineMember_lbl0" xml:lang="en-US">Cost of Goods and Service, Product and Service Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsProductLineMember" xlink:to="us-gaap_CostOfGoodsProductLineMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl0" xml:lang="en-US">Document Quarterly Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLIFOReserve_lbl0" xml:lang="en-US">Inventory, LIFO Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReserve" xlink:to="us-gaap_InventoryLIFOReserve_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl0" xml:lang="en-US">Concentration Risk, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable_lbl0" xml:lang="en-US">Threshold Period Past Due for Write-off of Trade Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:to="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DistributionRightsMember_lbl0" xml:lang="en-US">Distribution Rights [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionRightsMember" xlink:to="us-gaap_DistributionRightsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>bmra-20210831_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Oct 14 19:29:04 UTC 2021 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedIncomeStatement" roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedBalanceSheet" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ShareholdersEquityType2or3" roleURI="http://www.biomerica.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ConsolidatedCashFlow" roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_BASISOFPRESENTATION" roleURI="http://www.biomerica.com/role/BASISOFPRESENTATION"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SHAREHOLDERSEQUITY" roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITY"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_GEOGRAPHICINFORMATION" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATION"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_LEASES" roleURI="http://www.biomerica.com/role/LEASES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_COMMITMENTSANDCONTINGENCIES" roleURI="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SUBSEQUENTEVENTS" roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTS"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS" roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_AccountingPoliciesByPolicy" roleURI="http://www.biomerica.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_GEOGRAPHICINFORMATIONTables" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_LEASESTables" roleURI="http://www.biomerica.com/role/LEASESTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables" roleURI="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_InventoriesTable" roleURI="http://www.biomerica.com/role/InventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_OptionsActivityTable" roleURI="http://www.biomerica.com/role/OptionsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_RevenuefromcontractswithcustomersTable" roleURI="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_GeographicinformationregardingnetsalesTable" roleURI="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SupplementalcashflowinformationrelatedtoleasesTable" roleURI="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_ThematurityofleaseliabilitiesTable" roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable" roleURI="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_SHAREHOLDERSEQUITYDetails" roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_GEOGRAPHICINFORMATIONDetails" roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#bmra_r_LEASESDetails" roleURI="http://www.biomerica.com/role/LEASESDetails"/>
  <roleRef xlink:type="simple" xlink:href="bmra-20210831.xsd#DocumentAndEntityInformation" roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_GrossProfit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_OperatingExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InvestmentIncomeInterestAndDividend" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A5ConvertiblePreferredStockMember" xlink:href="bmra-20210831.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="A5ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Investments" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Assets" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="A5ConvertiblePreferredStockMember" xlink:href="bmra-20210831.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="A5ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OperatingLeaseRightOfUseAssetAccumulatedAmortization" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNoParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockNoParValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PreferredStockUndesignatedShares" xlink:href="bmra-20210831.xsd#bmra_PreferredStockUndesignatedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="PreferredStockUndesignatedShares" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="A5ConvertiblePreferredStockMember" xlink:href="bmra-20210831.xsd#bmra_A5ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="A5ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProvisionForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryLIFOReservePeriodCharge" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseRightofUseAssetAmortization" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseRightofUseAssetAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OperatingLeaseRightofUseAssetAmortization" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInLeaseLiability" xlink:href="bmra-20210831.xsd#bmra_IncreaseDecreaseInLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="CashPaidDuringThePeriodForAbstract" xlink:href="bmra-20210831.xsd#bmra_CashPaidDuringThePeriodForAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="CashPaidDuringThePeriodForAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringThePeriodForAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/BASISOFPRESENTATION">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccounting" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SHAREHOLDERSEQUITY">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATION">
    <loc xlink:type="locator" xlink:label="GeographicInformationDisclosureAbstract" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="GeographicInformationDisclosureTextBlock" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicInformationDisclosureAbstract" xlink:to="GeographicInformationDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASES">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SUBSEQUENTEVENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS">
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_ErrorCorrectionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MarketsAndMethodsOfDistributionPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_MarketsAndMethodsOfDistributionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="MarketsAndMethodsOfDistributionPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LiquidityPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_LiquidityPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="LiquidityPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaidsPolicyPolicyTextBlock" xlink:href="bmra-20210831.xsd#bmra_PrepaidsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="PrepaidsPolicyPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables">
    <loc xlink:type="locator" xlink:label="GeographicInformationDisclosureAbstract" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicInformationDisclosureAbstract" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASESTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" xlink:href="bmra-20210831.xsd#bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodAdjustmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PriorPeriodAdjustmentAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/InventoriesTable">
    <loc xlink:type="locator" xlink:label="InventoriesAbstract" xlink:href="bmra-20210831.xsd#bmra_InventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesAbstract" xlink:to="us-gaap_InventoryNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/OptionsActivityTable">
    <loc xlink:type="locator" xlink:label="OptionsActivityAbstract" xlink:href="bmra-20210831.xsd#bmra_OptionsActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt+1Vq3zhhUlfDeP/RQUzUZihDO8dLtQrMZMNe4t6pAivP0axfdFZpsLdRcC6V+fMaumQktVVC2Jl18gJA0gt6TJQqKhfHjnLHrdKFbG6+pJgjnp4c4T10X51H4edsKAlLImcIX1aVk87uJx2R0zj0qhJf2+25n9o+WG9hpOzU8fZUVjOqRXacolo0NHTj0H4W5vQU5XADxsug==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsActivityAbstract" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable">
    <loc xlink:type="locator" xlink:label="RevenueFromContractsWithCustomersAbstract" xlink:href="bmra-20210831.xsd#bmra_RevenueFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractsWithCustomersAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ClinicalLabMember" xlink:href="bmra-20210831.xsd#bmra_ClinicalLabMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="ClinicalLabMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PhysiciansOfficeMember" xlink:href="bmra-20210831.xsd#bmra_PhysiciansOfficeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="PhysiciansOfficeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OverthecounterMember" xlink:href="bmra-20210831.xsd#bmra_OverthecounterMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="OverthecounterMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractManufacturingMember" xlink:href="bmra-20210831.xsd#bmra_ContractManufacturingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="ContractManufacturingMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable">
    <loc xlink:type="locator" xlink:label="GeographicInformationRegardingNetSalesAbstract" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationRegardingNetSalesAbstract"/>
    <loc xlink:type="locator" xlink:label="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable"/>
    <loc xlink:type="locator" xlink:label="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicInformationRegardingNetSalesAbstract" xlink:to="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_AsiaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_AsiaMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_EuropeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NorthAmericaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_NorthAmericaMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MiddleEastMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MiddleEastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="us-gaap_MiddleEastMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_SouthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SouthAmericaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SouthAmericaMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable" xlink:to="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:href="bmra-20210831.xsd#bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems" xlink:to="RevenuesFromSalesToUnaffiliatedCustomersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesFromSalesToUnaffiliatedCustomersAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable">
    <loc xlink:type="locator" xlink:label="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:href="bmra-20210831.xsd#bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RightOfUseAssetsObtainedInExchangeForAbstract" xlink:href="bmra-20210831.xsd#bmra_RightOfUseAssetsObtainedInExchangeForAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="RightOfUseAssetsObtainedInExchangeForAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightOfUseAssetsObtainedInExchangeForAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationRelatedToLeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable">
    <loc xlink:type="locator" xlink:label="TheMaturityOfLeaseLiabilitiesAbstract" xlink:href="bmra-20210831.xsd#bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheMaturityOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable">
    <loc xlink:type="locator" xlink:label="RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract" xlink:href="bmra-20210831.xsd#bmra_RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RestatementOfCompanysFinancialStatementsMember" xlink:href="bmra-20210831.xsd#bmra_RestatementOfCompanysFinancialStatementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="RestatementOfCompanysFinancialStatementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_GrossProfit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_OperatingExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss_0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss_0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionPlanExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_StockOptionPlanExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_SupplierConcentrationRiskMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_DistributionRightsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasedTechnologyRightsMember" xlink:href="bmra-20210831.xsd#bmra_PurchasedTechnologyRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="PurchasedTechnologyRightsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsReceivableMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsProductLineMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_CostOfGoodsProductLineMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsPayableMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoDistributorsMember" xlink:href="bmra-20210831.xsd#bmra_TwoDistributorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="TwoDistributorsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OneVendorMember" xlink:href="bmra-20210831.xsd#bmra_OneVendorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="OneVendorMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoVendorsMember" xlink:href="bmra-20210831.xsd#bmra_TwoVendorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="TwoVendorsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" xlink:to="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" order="7.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" xlink:href="bmra-20210831.xsd#bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_CashUninsuredAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryWriteDown" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_OtherInventory" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryValuationReserves" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryLIFOReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_InventoryLIFOReserve" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromStockOptionsGranted" xlink:href="bmra-20210831.xsd#bmra_ProceedsFromStockOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="ProceedsFromStockOptionsGranted" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsTable" xlink:href="bmra-20210831.xsd#bmra_SHAREHOLDERSEQUITYDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SHAREHOLDERSEQUITYDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="SHAREHOLDERSEQUITYDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_EquityInterestIssuedOrIssuableTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsTable" xlink:to="SHAREHOLDERSEQUITYDetailsLineItems" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SHAREHOLDERSEQUITYDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails">
    <loc xlink:type="locator" xlink:label="GeographicInformationDisclosureAbstract" xlink:href="bmra-20210831.xsd#bmra_GeographicInformationDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="GEOGRAPHICINFORMATIONDetailsTable" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsTable"/>
    <loc xlink:type="locator" xlink:label="GEOGRAPHICINFORMATIONDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeographicInformationDisclosureAbstract" xlink:to="GEOGRAPHICINFORMATIONDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_MX" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsTable" xlink:to="GEOGRAPHICINFORMATIONDetailsLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_InventoryGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GEOGRAPHICINFORMATIONDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/LEASESDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="LEASESDetailsTable" xlink:href="bmra-20210831.xsd#bmra_LEASESDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LEASESDetailsLineItems" xlink:href="bmra-20210831.xsd#bmra_LEASESDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="LEASESDetailsTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_MX" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_MX"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_MX" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseAmendmentAxis" xlink:href="bmra-20210831.xsd#bmra_LeaseAmendmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="LeaseAmendmentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseAmendmentDomain" xlink:href="bmra-20210831.xsd#bmra_LeaseAmendmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseAmendmentAxis" xlink:to="LeaseAmendmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstAmendmentToLeaseMember" xlink:href="bmra-20210831.xsd#bmra_FirstAmendmentToLeaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseAmendmentAxis" xlink:to="FirstAmendmentToLeaseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PropertySubjectToOrAvailableForOperatingLease_Domain" xlink:href="bmra-20210831.xsd#bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="PropertySubjectToOrAvailableForOperatingLease_Domain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BuildingInIrvineCaliforniaMember" xlink:href="bmra-20210831.xsd#bmra_BuildingInIrvineCaliforniaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="BuildingInIrvineCaliforniaMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyAvailableForOperatingLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyAvailableForOperatingLeaseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis" xlink:to="us-gaap_PropertyAvailableForOperatingLeaseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsTable" xlink:to="LEASESDetailsLineItems" order="5.0"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseInitiationDate" xlink:href="bmra-20210831.xsd#bmra_OperatingLeaseInitiationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="OperatingLeaseInitiationDate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RentPercentage" xlink:href="bmra-20210831.xsd#bmra_RentPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="RentPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_SecurityDeposit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LEASESDetailsLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseMinimumRentals" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.biomerica.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="bmra-20210831.xsd#bmra_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12gTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12gTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>bmra-20210831_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bmra="http://www.biomerica.com/20210831"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bmra-20210831.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2021-10-14</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">bmra:A5ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
        </entity>
        <period>
            <instant>2021-01-22</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:OneVendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:TwoVendorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:OneVendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bmra:OneVendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">bmra:PurchasedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ClinicalLabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:PhysiciansOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:OverthecounterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">bmra:ContractManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:MiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:SouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2009-06-18</startDate>
            <endDate>2009-06-18</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmra:LeaseAmendmentAxis">bmra:FirstAmendmentToLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2009-06-18</startDate>
            <endDate>2009-06-18</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">bmra:BuildingInIrvineCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-06-18</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2009-06-18</startDate>
            <endDate>2009-06-18</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseAxis">us-gaap:PropertyAvailableForOperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2016-11-01</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000073290</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">bmra:RestatementOfCompanysFinancialStatementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c0">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2021-08-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0">001-37863</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">BIOMERICA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0">95-2645573</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0">17571 Von Karman Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0">92614</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0">645-2111</dei:LocalPhoneNumber>
    <dei:Security12gTitle contextRef="c0">Common, par value $.08</dei:Security12gTitle>
    <dei:TradingSymbol contextRef="c0">BMRA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c1" decimals="INF" unitRef="shares">12511210</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues contextRef="c0" decimals="INF" unitRef="usd">1261787</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c2" decimals="INF" unitRef="usd">1143806</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="INF" unitRef="usd">1350757</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c2" decimals="INF" unitRef="usd">1025717</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c0" decimals="INF" unitRef="usd">-88970</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c2" decimals="INF" unitRef="usd">118089</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="INF" unitRef="usd">1011535</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c2" decimals="INF" unitRef="usd">1305944</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="INF" unitRef="usd">439864</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c2" decimals="INF" unitRef="usd">711505</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="INF" unitRef="usd">1451399</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c2" decimals="INF" unitRef="usd">2017449</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-1540369</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c2" decimals="INF" unitRef="usd">-1899360</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c0" decimals="INF" unitRef="usd">6805</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c2" decimals="INF" unitRef="usd">8091</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="INF" unitRef="usd">-1533564</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c2" decimals="INF" unitRef="usd">-1891269</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="INF" unitRef="usd">9017</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c2" decimals="INF" unitRef="usd">1125</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-1542581</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="INF" unitRef="usd">-1892394</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c0" decimals="INF" unitRef="usdPershares">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c2" decimals="INF" unitRef="usdPershares">-0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="c0" decimals="INF" unitRef="usdPershares">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c2" decimals="INF" unitRef="usdPershares">-0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c0" decimals="INF" unitRef="shares">12426784</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c2" decimals="INF" unitRef="shares">11748377</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c0" decimals="INF" unitRef="shares">12426784</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">11748377</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-1542581</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="INF" unitRef="usd">-1892394</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c0" decimals="INF" unitRef="usd">-5613</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c2" decimals="INF" unitRef="usd">-1721</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="INF" unitRef="usd">-1548194</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c2" decimals="INF" unitRef="usd">-1894115</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="INF" unitRef="usd">4996623</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="INF" unitRef="usd">4199311</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c3" decimals="INF" unitRef="usd">742524</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c4" decimals="INF" unitRef="usd">837415</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c3" decimals="INF" unitRef="usd">772190</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c4" decimals="INF" unitRef="usd">1455051</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c3" decimals="INF" unitRef="usd">2861779</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c4" decimals="INF" unitRef="usd">3206255</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="INF" unitRef="usd">315221</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="INF" unitRef="usd">370290</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="INF" unitRef="usd">8945813</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c4" decimals="INF" unitRef="usd">9230907</us-gaap:AssetsCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c3" decimals="INF" unitRef="usd">2000167</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c4" decimals="INF" unitRef="usd">1972357</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="INF" unitRef="usd">287852</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="INF" unitRef="usd">310520</us-gaap:PropertyPlantAndEquipmentNet>
    <bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization contextRef="c3" decimals="INF" unitRef="usd">531974</bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization contextRef="c4" decimals="INF" unitRef="usd">469077</bmra:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="INF" unitRef="usd">1490184</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="INF" unitRef="usd">1553081</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Investments contextRef="c3" decimals="INF" unitRef="usd">165324</us-gaap:Investments>
    <us-gaap:Investments contextRef="c4" decimals="INF" unitRef="usd">165324</us-gaap:Investments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c3" decimals="INF" unitRef="usd">83683</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c4" decimals="INF" unitRef="usd">126769</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="INF" unitRef="usd">360292</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c4" decimals="INF" unitRef="usd">294830</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="c3" decimals="INF" unitRef="usd">266582</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c4" decimals="INF" unitRef="usd">264151</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c3" decimals="INF" unitRef="usd">11516047</us-gaap:Assets>
    <us-gaap:Assets contextRef="c4" decimals="INF" unitRef="usd">11818813</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c3" decimals="INF" unitRef="usd">641404</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c4" decimals="INF" unitRef="usd">583380</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c3" decimals="INF" unitRef="usd">507722</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c4" decimals="INF" unitRef="usd">388896</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c3" decimals="INF" unitRef="usd">332967</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="INF" unitRef="usd">327944</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="INF" unitRef="usd">1482093</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c4" decimals="INF" unitRef="usd">1300220</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c3" decimals="INF" unitRef="usd">1230898</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c4" decimals="INF" unitRef="usd">1291570</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c3" decimals="INF" unitRef="usd">2712991</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c4" decimals="INF" unitRef="usd">2591790</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c5" decimals="INF" unitRef="usdPershares">0.08</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c6" decimals="INF" unitRef="usdPershares">0.08</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c5" decimals="INF" unitRef="shares">571429</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c6" decimals="INF" unitRef="shares">571429</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c5" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c6" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c5" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c6" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockNoParValue contextRef="c3" decimals="INF" unitRef="usdPershares">0</us-gaap:PreferredStockNoParValue>
    <us-gaap:PreferredStockNoParValue contextRef="c4" decimals="INF" unitRef="usdPershares">0</us-gaap:PreferredStockNoParValue>
    <bmra:PreferredStockUndesignatedShares contextRef="c3" decimals="INF" unitRef="shares">4428571</bmra:PreferredStockUndesignatedShares>
    <bmra:PreferredStockUndesignatedShares contextRef="c4" decimals="INF" unitRef="shares">4428571</bmra:PreferredStockUndesignatedShares>
    <us-gaap:PreferredStockSharesIssued contextRef="c3" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c4" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c4" decimals="INF" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="INF" unitRef="usdPershares">0.08</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c4" decimals="INF" unitRef="usdPershares">0.08</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c4" decimals="INF" unitRef="shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="INF" unitRef="shares">12510210</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">12510210</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c4" decimals="INF" unitRef="shares">12307157</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c4" decimals="INF" unitRef="shares">12307157</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c3" decimals="INF" unitRef="usd">1000815</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c4" decimals="INF" unitRef="usd">984571</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="INF" unitRef="usd">39944726</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c4" decimals="INF" unitRef="usd">38836743</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c3" decimals="INF" unitRef="usd">-53569</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c4" decimals="INF" unitRef="usd">-47956</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="INF" unitRef="usd">-32088916</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="INF" unitRef="usd">-30546335</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="INF" unitRef="usd">8803056</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="INF" unitRef="usd">9227023</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="INF" unitRef="usd">11516047</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c4" decimals="INF" unitRef="usd">11818813</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued contextRef="c7" decimals="INF" unitRef="shares">11740089</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c7" decimals="INF" unitRef="usd">939205</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued contextRef="c8" decimals="INF" unitRef="shares">321429</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c8" decimals="INF" unitRef="usd">25714</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="INF" unitRef="usd">36388056</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="INF" unitRef="usd">-39841</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="INF" unitRef="usd">-23100081</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c12" decimals="INF" unitRef="usd">14213053</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c13" decimals="INF" unitRef="shares">12500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c13" decimals="INF" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c14" decimals="INF" unitRef="usd">13900</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c2" decimals="INF" unitRef="usd">14900</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c15" decimals="INF" unitRef="usd">-1721</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c2" decimals="INF" unitRef="usd">-1721</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c14" decimals="INF" unitRef="usd">246787</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c2" decimals="INF" unitRef="usd">246787</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss contextRef="c16" decimals="INF" unitRef="usd">-1892394</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="INF" unitRef="usd">-1892394</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued contextRef="c17" decimals="INF" unitRef="shares">11752589</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="INF" unitRef="usd">940205</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued contextRef="c18" decimals="INF" unitRef="shares">321429</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c18" decimals="INF" unitRef="usd">25714</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c19" decimals="INF" unitRef="usd">36648743</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c20" decimals="INF" unitRef="usd">-41562</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c21" decimals="INF" unitRef="usd">-24992475</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="INF" unitRef="usd">12580625</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued contextRef="c23" decimals="INF" unitRef="shares">12307157</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="INF" unitRef="usd">984571</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="INF" unitRef="usd">38836743</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="INF" unitRef="usd">-47956</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c26" decimals="INF" unitRef="usd">-30546335</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="INF" unitRef="usd">9227023</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c27" decimals="INF" unitRef="shares">1500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c27" decimals="INF" unitRef="usd">120</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c28" decimals="INF" unitRef="usd">3775</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c0" decimals="INF" unitRef="usd">3895</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c27" decimals="INF" unitRef="shares">201553</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c27" decimals="INF" unitRef="usd">16124</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c28" decimals="INF" unitRef="usd">784586</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="INF" unitRef="usd">800710</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c29" decimals="INF" unitRef="usd">-5613</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c0" decimals="INF" unitRef="usd">-5613</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c28" decimals="INF" unitRef="usd">319622</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c0" decimals="INF" unitRef="usd">319622</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss contextRef="c30" decimals="INF" unitRef="usd">-1542581</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-1542581</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued contextRef="c31" decimals="INF" unitRef="shares">12510210</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity contextRef="c31" decimals="INF" unitRef="usd">1000815</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c32" decimals="INF" unitRef="usd">39944726</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c33" decimals="INF" unitRef="usd">-53569</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c34" decimals="INF" unitRef="usd">-32088916</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="INF" unitRef="usd">8803056</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="INF" unitRef="usd">-1542581</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="INF" unitRef="usd">-1892394</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c0" decimals="INF" unitRef="usd">34722</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c2" decimals="INF" unitRef="usd">32570</us-gaap:DepreciationAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c0" decimals="INF" unitRef="usd">-94891</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c2" decimals="INF" unitRef="usd">201375</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryLIFOReservePeriodCharge contextRef="c0" decimals="INF" unitRef="usd">179744</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge contextRef="c2" decimals="INF" unitRef="usd">5005</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:StockOptionPlanExpense contextRef="c0" decimals="INF" unitRef="usd">319622</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c2" decimals="INF" unitRef="usd">246787</us-gaap:StockOptionPlanExpense>
    <bmra:OperatingLeaseRightofUseAssetAmortization contextRef="c0" decimals="INF" unitRef="usd">62897</bmra:OperatingLeaseRightofUseAssetAmortization>
    <bmra:OperatingLeaseRightofUseAssetAmortization contextRef="c2" decimals="INF" unitRef="usd">57257</bmra:OperatingLeaseRightofUseAssetAmortization>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c0" decimals="INF" unitRef="usd">-777752</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c2" decimals="INF" unitRef="usd">18924</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="INF" unitRef="usd">-164732</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c2" decimals="INF" unitRef="usd">1255573</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="INF" unitRef="usd">-55069</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c2" decimals="INF" unitRef="usd">-1038149</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <bmra:IncreaseDecreaseInLeaseLiability contextRef="c0" decimals="INF" unitRef="usd">-55649</bmra:IncreaseDecreaseInLeaseLiability>
    <bmra:IncreaseDecreaseInLeaseLiability contextRef="c2" decimals="INF" unitRef="usd">-49880</bmra:IncreaseDecreaseInLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c0" decimals="INF" unitRef="usd">2431</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c2" decimals="INF" unitRef="usd">276438</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c0" decimals="INF" unitRef="usd">58024</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c2" decimals="INF" unitRef="usd">284202</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c0" decimals="INF" unitRef="usd">118826</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c2" decimals="INF" unitRef="usd">30718</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="INF" unitRef="usd">75836</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c2" decimals="INF" unitRef="usd">-1597146</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c0" decimals="INF" unitRef="usd">72375</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c2" decimals="INF" unitRef="usd">53158</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="INF" unitRef="usd">5141</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c2" decimals="INF" unitRef="usd">39588</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="INF" unitRef="usd">-77516</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c2" decimals="INF" unitRef="usd">-92746</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c0" decimals="INF" unitRef="usd">800710</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c0" decimals="INF" unitRef="usd">3895</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c2" decimals="INF" unitRef="usd">14900</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="INF" unitRef="usd">804605</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c2" decimals="INF" unitRef="usd">14900</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="c0" decimals="INF" unitRef="usd">-5613</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="c2" decimals="INF" unitRef="usd">-1721</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="INF" unitRef="usd">797312</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c2" decimals="INF" unitRef="usd">-1676713</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="INF" unitRef="usd">4199311</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c12" decimals="INF" unitRef="usd">8641027</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="INF" unitRef="usd">4996623</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c22" decimals="INF" unitRef="usd">6964314</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IncomeTaxesPaid contextRef="c0" decimals="INF" unitRef="usd">9017</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c2" decimals="INF" unitRef="usd">1125</us-gaap:IncomeTaxesPaid>
    <us-gaap:BasisOfAccounting contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 1: &#160;BASIS OF PRESENTATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Biomerica Inc. and subsidiaries (collectively the &#x201c;Company&#x201d;, &#x201c;Biomerica&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, or &#x201c;our&#x201d;) develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care &lt;span style="COLOR:black"&gt;(in home and physicians' offices) &lt;/span&gt;and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. &lt;span style="COLOR:black"&gt;The&lt;/span&gt; Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Our primary focus is the research and development of revolutionary, patented, diagnostic-guided therapy (&#x201c;DGT&#x201d;) products to treat gastrointestinal diseases, such as irritable bowel syndrome, and other inflammatory diseases. These products are directed at chronic inflammatory illnesses that are widespread and common, and as such address very large markets. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Our existing medical diagnostic products that are in the market are sold worldwide primarily in two markets: 1) clinical laboratories and 2) point-of-care (physicians' offices and over-the-counter drugstores like Walmart and Walgreens). Our diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient&#x2019;s body, stools, or blood, often in extremely small concentrations.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Due to the global 2019 SARS-CoV-2 novel coronavirus pandemic, in March 2020 we began redirecting and focusing a majority of our resources to develop, test, validate, seek regulatory approval for, and sell diagnostic products that indicate if a person has been infected by COVID-19. During fiscal 2021, we sold 2 primary types of COVID-19 tests; 1) antibody diagnostic tests that use a patient&#x2019;s blood sample to detect if the patient has certain antibodies to COVID-19 that were created as part of their body&#x2019;s immune response to a COVID-19 infection, even if the infection was asymptomatic, and 2) antigen tests that use a patient&#x2019;s nasal fluid sample to detect if the patient is currently infected with the virus. &lt;span style="COLOR:black"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Aside from the COVID-19 products we offer, the other products we sell are primarily focused on gastrointestinal diseases, food intolerances, cancer screening and awareness and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Most of our commercial products are CE marked and/or sold for diagnostic use where they are registered by each country&#x2019;s regulatory agency.&#160; In addition, some products are cleared for sale in the U.S. by the FDA.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;The information set forth in these condensed consolidated financial statements is unaudited and reflects all adjustments which, in the opinion of management, are necessary to present a fair statement of the consolidated results of operations of Biomerica, Inc. and subsidiaries, for the periods indicated. It does not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. All adjustments that were made are of a normal recurring nature.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif';"&gt;The unaudited, condensed consolidated financial statements and notes are presented as permitted by the requirements for Form 10-Q and do not contain certain information included in the annual financial statements and notes. The condensed consolidated balance sheet data as of May 31, 2021 was derived from audited financial statements. The accompanying interim condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on August 27, 2021 for the fiscal year ended May 31, 2021, which have been restated as described in our Form 10-K/A as filed on October 14, 2021. The results of operations for the interim periods are not necessarily indicative of results to be achieved for the full fiscal year.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; BACKGROUND:white; COLOR:black"&gt;CORRECTION OF AN ERROR&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif'; background: white; color: black;"&gt;As disclosed in our Form 10-K/A for the year ended May&#160;31, 2021, filed on October 14, 2021, during the process of preparing our financial statements for the quarter ended August&#160;31, 2021, we determined that our calculation of non-cash stock-based compensation expense related to issued stock options in previously issued financial statements was incorrect. Our calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro rata over the period the requisite service was provided. As a result of these errors, certain previously reported amounts in the condensed consolidated statement of operations, condensed consolidated statement of stockholders&#x2019; equity and condensed consolidated statement of cash flows for the quarter ended August 31, 2020, were materially misstated; accordingly, we have restated the prior period financial statements. &lt;/span&gt;&lt;span style="font-family: 'Times New Roman','serif';"&gt;See Note 8 to the Financial Statements. &lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 2: &#160;SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PRINCIPLES OF CONSOLIDATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;ACCOUNTING ESTIMATES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;MARKETS AND METHODS OF DISTRIBUTION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Due to&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt; the Coronavirus global pandemic, the Company&#x2019;s operations have been negatively impacted.&lt;span style="COLOR:black"&gt; The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#x2019;s manufacturing or distribution facilities or of the facilities of the Company&#x2019;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions can materially negatively impact the Company&#x2019;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;LIQUIDITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $32.1 million as of August 31, 2021.&#160; Management expects to continue to incur significant costs as it advances its trials and development activities.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $15,000,000 to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;(&lt;span style="COLOR:black"&gt;File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Under an ATM Agreement, sales of shares are deemed to be &#x201c;at the market offerings&#x201d; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#x2019;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;As a result of cash and cash equivalents on hand at August 31, 2021, management believes the Company has sufficient funds to operate through November 2022 and the ability to raise additional funds through the ATM Agreement noted above.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CONCENTRATION OF CREDIT RISK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of August 31, 2021, the Company had approximately $4,790,000 of uninsured cash.&#160; &lt;span style="COLOR:black"&gt;The Company does not believe it is exposed to any significant credit risks.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-size: 10pt;"&gt;For the three months ended August 31, 2021 and 2020, the Company had two key distributors which accounted for 60% and 40% of net consolidated sales, respectively.&#160; At August 31, 2021 and May 31, 2021, the Company had two&#160;key distributors which accounted for a total of 77% and 73%, respectively, of gross accounts receivable. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-size: 10pt;"&gt;For the three months ended August 31, 2021 and 2020, one key vendor accounted for 17% and two key vendors accounted for 64% of the purchases of raw materials, respectively. As of August 31, 2021 and May 31, 2021, the Company had one key vendor which accounted for 25% and 17%, respectively, of accounts payable.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than three months.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over ninety days old are usually reserved for unless collection is reasonably assured. &#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. &#160; Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company has established a reserve of approximately $743,000 for doubtful accounts as of August 31, 2021. The majority of this reserve has been established to cover 100% of outstanding accounts receivable from an international distributor.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PREPAID EXPENSES AND OTHER&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;As of August 31, 2021 and May 31, 2021, the prepaid expenses and other were approximately $315,000 and $370,000, respectively. The prepaid expenses and other balance were composed of prepayments to insurance and various other suppliers. &#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INVENTORIES, NET &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Inventories approximate the following at:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;May 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,493,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,583,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Work in progress&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;926,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,006,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Finished products&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;443,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;617,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,862,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3,206,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;During the first fiscal quarter ended August 31, 2021, the Company wrote-down the carrying value of certain inventory by approximately $179,000 to assign a new carrying value for this inventory of $211,000.&#160; As part of a large international order for this product that was to ship in the second quarter of 2022, the Company agreed to sell this product as a small portion of that order at a price below its carrying value, which required a write down.&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of August 31, 2021 and May 31, 2021, inventory reserves were approximately $1,797,000 and $1,617,000, respectively. Of the inventory reserve, approximately $1,683,000 was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in; TEXT-INDENT:0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from 5 to 10 years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment amounted to $27,809 and $26,732 for the three months ended August 31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#x2013; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Intangible assets are being amortized using the straight-line method over the useful life, not to exceed 18 years for marketing and distribution rights, 10 years for purchased technology use rights, and 20 years for patents. Amortization expense amounted to $6,913 and $5,838 for the three months ended August 31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#x2019;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of August 31, 2021 or 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;INVESTMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#x2019;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#x2019;s investment in a Polish based distributor which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the certain of the products sold. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately 6% of the investee, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;SHARE-BASED COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company follows the guidance of the accounting provisions of ASC 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees and others receive shares of stock or equity instruments (options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#x2019;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#x201c;simplified method&#x201d; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of&lt;b&gt; &lt;/b&gt;the expected term.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif';"&gt;&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif';"&gt;The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the three months ended August 31, 2021:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 48pt;"&gt;
&lt;td style="height: 48pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Option Shares&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Exercise Price Weighted Average&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Outstanding May 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,081,366 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.59 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Granted &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;24,000 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;4.25 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Exercised &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,500)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2.68 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cancelled or expired &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(22,750)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.02 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Outstanding August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,081,116 &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.60 &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the three months ended August 31, 2021, options to purchase 1,500 shares of common stock were exercised at price of $2.68. Total net proceeds to the Company were $3,895.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the three months ended August 31, 2021, the Company granted 24,000 options to purchase common stock at an average purchase price of $4.25. Total net proceeds to the Company were $14,900.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of August 31, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;Services for some contract works are invoiced and recognized for work that has been performed as the project progresses. &lt;span style="COLOR:black"&gt;The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#x2019; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Disaggregation of revenue:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The following is a breakdown of revenues according to markets to which the products are sold:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="5" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Three Months Ended&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2020&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Clinical lab&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;886,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;582,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Physician's office&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;257,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;197,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Over-the-counter&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;79,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;185,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Contract Manufacturing&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;40,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;180,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,262,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,144,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;See Note 4 for additional information regarding revenue concentrations.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;SHIPPING AND HANDLING FEES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company includes shipping and handling fees billed to customers in net sales.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;RESEARCH AND DEVELOPMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Research and development costs are expensed as incurred. The Company expensed approximately $440,000 and $712,000 of research and development costs during the three months ended August 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;The Company has provided a valuation allowance on deferred income tax assets of approximately $6,226,000 and $5,904,000 as of August 31, 2021 and May 31, 2021, respectively. &#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;FOREIGN CURRENCY TRANSLATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three months ended August 31, 2021 and 2020. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;RIGHT-OF-USE ASSETS AND LEASE LIABILITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#x2019;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;NET LOSS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation for the three months ended August 31, 2021 and 2020 was 2,081,116 and 1,925,750, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Recent ASUs issued by the FASB and guidance issued by the Securities and Exchange Commission (&#x201c;SEC&#x201d;) did not, or are not believed by management to, have a material effect on the Company&#x2019;s present or future consolidated financial statements. &lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PRINCIPLES OF CONSOLIDATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;ACCOUNTING ESTIMATES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <bmra:MarketsAndMethodsOfDistributionPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;MARKETS AND METHODS OF DISTRIBUTION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Due to&lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt; the Coronavirus global pandemic, the Company&#x2019;s operations have been negatively impacted.&lt;span style="COLOR:black"&gt; The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#x2019;s manufacturing or distribution facilities or of the facilities of the Company&#x2019;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions can materially negatively impact the Company&#x2019;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;</bmra:MarketsAndMethodsOfDistributionPolicyTextBlock>
    <bmra:LiquidityPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;LIQUIDITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $32.1 million as of August 31, 2021.&#160; Management expects to continue to incur significant costs as it advances its trials and development activities.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $15,000,000 to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;(&lt;span style="COLOR:black"&gt;File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Under an ATM Agreement, sales of shares are deemed to be &#x201c;at the market offerings&#x201d; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#x2019;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;As a result of cash and cash equivalents on hand at August 31, 2021, management believes the Company has sufficient funds to operate through November 2022 and the ability to raise additional funds through the ATM Agreement noted above.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</bmra:LiquidityPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-5" unitRef="usd">-32100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <bmra:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue contextRef="c35" decimals="0" unitRef="usd">15000000</bmra:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CONCENTRATION OF CREDIT RISK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of August 31, 2021, the Company had approximately $4,790,000 of uninsured cash.&#160; &lt;span style="COLOR:black"&gt;The Company does not believe it is exposed to any significant credit risks.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-size: 10pt;"&gt;For the three months ended August 31, 2021 and 2020, the Company had two key distributors which accounted for 60% and 40% of net consolidated sales, respectively.&#160; At August 31, 2021 and May 31, 2021, the Company had two&#160;key distributors which accounted for a total of 77% and 73%, respectively, of gross accounts receivable. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-size: 10pt;"&gt;For the three months ended August 31, 2021 and 2020, one key vendor accounted for 17% and two key vendors accounted for 64% of the purchases of raw materials, respectively. As of August 31, 2021 and May 31, 2021, the Company had one key vendor which accounted for 25% and 17%, respectively, of accounts payable.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashUninsuredAmount contextRef="c3" decimals="0" unitRef="usd">4790000</us-gaap:CashUninsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c36" decimals="2" unitRef="pure">0.60</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c37" decimals="2" unitRef="pure">0.40</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c38" decimals="2" unitRef="pure">0.77</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c39" decimals="2" unitRef="pure">0.73</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c40" decimals="2" unitRef="pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c41" decimals="2" unitRef="pure">0.64</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c42" decimals="2" unitRef="pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c43" decimals="2" unitRef="pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;CASH AND CASH EQUIVALENTS &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than three months.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over ninety days old are usually reserved for unless collection is reasonably assured. &#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. &#160; Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company has established a reserve of approximately $743,000 for doubtful accounts as of August 31, 2021. The majority of this reserve has been established to cover 100% of outstanding accounts receivable from an international distributor.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable contextRef="c0">P90D</us-gaap:ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent contextRef="c3" decimals="0" unitRef="usd">743000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c0" decimals="2" unitRef="pure">1</us-gaap:ConcentrationRiskPercentage1>
    <bmra:PrepaidsPolicyPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PREPAID EXPENSES AND OTHER&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;As of August 31, 2021 and May 31, 2021, the prepaid expenses and other were approximately $315,000 and $370,000, respectively. The prepaid expenses and other balance were composed of prepayments to insurance and various other suppliers. &#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</bmra:PrepaidsPolicyPolicyTextBlock>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c3" decimals="0" unitRef="usd">315000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c4" decimals="0" unitRef="usd">370000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:InventoryPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INVENTORIES, NET &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Inventories approximate the following at:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;May 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,493,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,583,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Work in progress&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;926,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,006,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Finished products&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;443,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;617,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,862,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3,206,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;During the first fiscal quarter ended August 31, 2021, the Company wrote-down the carrying value of certain inventory by approximately $179,000 to assign a new carrying value for this inventory of $211,000.&#160; As part of a large international order for this product that was to ship in the second quarter of 2022, the Company agreed to sell this product as a small portion of that order at a price below its carrying value, which required a write down.&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of August 31, 2021 and May 31, 2021, inventory reserves were approximately $1,797,000 and $1,617,000, respectively. Of the inventory reserve, approximately $1,683,000 was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;May 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Raw materials&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,493,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,583,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Work in progress&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;926,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,006,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Finished products&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;443,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;617,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,862,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3,206,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c3" decimals="-3" unitRef="usd">1493000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c4" decimals="-3" unitRef="usd">1583000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c3" decimals="-3" unitRef="usd">926000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c4" decimals="-3" unitRef="usd">1006000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c3" decimals="-3" unitRef="usd">443000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c4" decimals="-3" unitRef="usd">617000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" unitRef="usd">2862000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c4" decimals="-3" unitRef="usd">3206000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown contextRef="c0" decimals="0" unitRef="usd">179000</us-gaap:InventoryWriteDown>
    <us-gaap:OtherInventory contextRef="c3" decimals="0" unitRef="usd">211000</us-gaap:OtherInventory>
    <us-gaap:InventoryValuationReserves contextRef="c3" decimals="0" unitRef="usd">1797000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="c4" decimals="0" unitRef="usd">1617000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryLIFOReserve contextRef="c3" decimals="0" unitRef="usd">1683000</us-gaap:InventoryLIFOReserve>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in; TEXT-INDENT:0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from 5 to 10 years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment amounted to $27,809 and $26,732 for the three months ended August 31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;&#160; &lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c44">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c45">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c0" decimals="0" unitRef="usd">27809</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c2" decimals="0" unitRef="usd">26732</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#x2013; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Intangible assets are being amortized using the straight-line method over the useful life, not to exceed 18 years for marketing and distribution rights, 10 years for purchased technology use rights, and 20 years for patents. Amortization expense amounted to $6,913 and $5,838 for the three months ended August 31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#x2019;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of August 31, 2021 or 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c46">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c47">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c48">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c0" decimals="0" unitRef="usd">6913</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c2" decimals="0" unitRef="usd">5838</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;INVESTMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#x2019;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#x2019;s investment in a Polish based distributor which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the certain of the products sold. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately 6% of the investee, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c3" decimals="2" unitRef="pure">0.06</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;SHARE-BASED COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company follows the guidance of the accounting provisions of ASC 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees and others receive shares of stock or equity instruments (options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#x2019;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#x201c;simplified method&#x201d; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of&lt;b&gt; &lt;/b&gt;the expected term.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif';"&gt;&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif';"&gt;The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the three months ended August 31, 2021:&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 48pt;"&gt;
&lt;td style="height: 48pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Option Shares&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Exercise Price Weighted Average&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Outstanding May 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,081,366 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.59 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Granted &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;24,000 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;4.25 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Exercised &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,500)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2.68 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cancelled or expired &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(22,750)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.02 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Outstanding August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,081,116 &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.60 &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the three months ended August 31, 2021, options to purchase 1,500 shares of common stock were exercised at price of $2.68. Total net proceeds to the Company were $3,895.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the three months ended August 31, 2021, the Company granted 24,000 options to purchase common stock at an average purchase price of $4.25. Total net proceeds to the Company were $14,900.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 48pt;"&gt;
&lt;td style="height: 48pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Option Shares&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Exercise Price Weighted Average&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Outstanding May 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,081,366 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.59 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Granted &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;24,000 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;4.25 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Exercised &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,500)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2.68 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cancelled or expired &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(22,750)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.02 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Outstanding August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,081,116 &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3.60 &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c51" decimals="INF" unitRef="shares">2081366</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c51" decimals="INF" unitRef="usdPershares">3.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c49" decimals="INF" unitRef="shares">24000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c49" decimals="INF" unitRef="usdPershares">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c49" decimals="INF" unitRef="shares">1500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="c49" decimals="INF" unitRef="usdPershares">2.68</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c49" decimals="INF" unitRef="shares">22750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="c49" decimals="INF" unitRef="usdPershares">3.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c50" decimals="INF" unitRef="shares">2081116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c50" decimals="INF" unitRef="usdPershares">3.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c49" decimals="0" unitRef="shares">1500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c50" decimals="2" unitRef="usdPershares">2.68</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c49" decimals="0" unitRef="usd">3895</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c49" decimals="0" unitRef="shares">24000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c49" decimals="2" unitRef="usdPershares">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <bmra:ProceedsFromStockOptionsGranted contextRef="c49" decimals="0" unitRef="usd">14900</bmra:ProceedsFromStockOptionsGranted>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of August 31, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;Services for some contract works are invoiced and recognized for work that has been performed as the project progresses. &lt;span style="COLOR:black"&gt;The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#x2019; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Disaggregation of revenue:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The following is a breakdown of revenues according to markets to which the products are sold:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="5" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Three Months Ended&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2020&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Clinical lab&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;886,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;582,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Physician's office&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;257,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;197,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Over-the-counter&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;79,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;185,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Contract Manufacturing&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;40,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;180,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,262,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,144,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;See Note 4 for additional information regarding revenue concentrations.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="5" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Three Months Ended&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2021&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;August 31, 2020&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Clinical lab&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;886,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;582,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Physician's office&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;257,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;197,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Over-the-counter&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;79,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;185,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Contract Manufacturing&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;40,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;180,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,262,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,144,000&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c52" decimals="INF" unitRef="usd">886000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c53" decimals="INF" unitRef="usd">582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c54" decimals="INF" unitRef="usd">257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c55" decimals="INF" unitRef="usd">197000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c56" decimals="INF" unitRef="usd">79000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c57" decimals="INF" unitRef="usd">185000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c58" decimals="INF" unitRef="usd">40000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c59" decimals="INF" unitRef="usd">180000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c0" decimals="INF" unitRef="usd">1262000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c2" decimals="INF" unitRef="usd">1144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;SHIPPING AND HANDLING FEES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company includes shipping and handling fees billed to customers in net sales.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;RESEARCH AND DEVELOPMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Research and development costs are expensed as incurred. The Company expensed approximately $440,000 and $712,000 of research and development costs during the three months ended August 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c0" decimals="0" unitRef="usd">440000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c2" decimals="0" unitRef="usd">712000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;The Company has provided a valuation allowance on deferred income tax assets of approximately $6,226,000 and $5,904,000 as of August 31, 2021 and May 31, 2021, respectively. &#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c3" decimals="0" unitRef="usd">6226000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c4" decimals="0" unitRef="usd">5904000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;FOREIGN CURRENCY TRANSLATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three months ended August 31, 2021 and 2020. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;RIGHT-OF-USE ASSETS AND LEASE LIABILITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#x2019;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;NET LOSS PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation for the three months ended August 31, 2021 and 2020 was 2,081,116 and 1,925,750, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c0" decimals="0" unitRef="shares">2081116</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c2" decimals="0" unitRef="shares">1925750</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Recent ASUs issued by the FASB and guidance issued by the Securities and Exchange Commission (&#x201c;SEC&#x201d;) did not, or are not believed by management to, have a material effect on the Company&#x2019;s present or future consolidated financial statements. &lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 3:&#160; SHAREHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;Stock option expense during the three months ended August 31, 2021 and 2020 were $319,622 and $246,787 (as restated, see Note 8 to the Financial Statements), respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;During the three months ended August 31, 2021, the Company sold 201,553 shares of its common stock at prices ranging from $4.02 to $4.47 under its January 22, 2021 prospectus supplement and the ATM Agreement (see Note 2 to Financial Statements) which resulted in gross proceeds of $838,332 and net proceeds to the Company of $800,710 after deducting commissions for each sale and legal, accounting and other fees related to the filing of the Form S-3.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c49" decimals="0" unitRef="usd">319622</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c60" decimals="0" unitRef="usd">246787</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c61" decimals="0" unitRef="shares">201553</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c62" decimals="2" unitRef="usdPershares">4.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="c63" decimals="2" unitRef="usdPershares">4.47</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c61" decimals="0" unitRef="usd">838332</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c61" decimals="0" unitRef="usd">800710</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <bmra:GeographicInformationDisclosureTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 4: &#160;GEOGRAPHIC INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company operates as one segment. Geographic information regarding net sales is approximately as follows: &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Three Months Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;August 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;August 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Revenues from sales to unaffiliated customers:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"/&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Asia&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;675,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;347,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Europe&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;471,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;591,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;North America&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;105,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;134,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Middle East&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;8,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;29,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;South America&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;43,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,262,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,144,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;As of August 31, 2021 and May 31, 2021, approximately $665,000 and $803,000 of Biomerica&#x2019;s gross inventory and approximately $24,000 and $25,000, of Biomerica&#x2019;s property and equipment, net of accumulated depreciation and amortization, was located in Mexicali, Mexico, respectively.&lt;/span&gt;&lt;/p&gt;</bmra:GeographicInformationDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments contextRef="c64" decimals="0" unitRef="pure">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Three Months Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;August 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;August 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Revenues from sales to unaffiliated customers:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"/&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Asia&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;675,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;347,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Europe&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;471,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;591,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;North America&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;105,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;134,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Middle East&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;8,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;29,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15pt"&gt; &lt;td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;South America&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;3,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;43,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="HEIGHT:15.75pt"&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,262,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"&gt; &lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;1,144,000 &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues contextRef="c67" decimals="-3" unitRef="usd">675000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c68" decimals="-3" unitRef="usd">347000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c69" decimals="-3" unitRef="usd">471000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c70" decimals="-3" unitRef="usd">591000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c71" decimals="-3" unitRef="usd">105000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c72" decimals="-3" unitRef="usd">134000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c73" decimals="-3" unitRef="usd">8000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c74" decimals="-3" unitRef="usd">29000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c75" decimals="-3" unitRef="usd">3000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c76" decimals="-3" unitRef="usd">43000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">1262000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c2" decimals="-3" unitRef="usd">1144000</us-gaap:Revenues>
    <us-gaap:InventoryGross contextRef="c65" decimals="0" unitRef="usd">665000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="c66" decimals="0" unitRef="usd">803000</us-gaap:InventoryGross>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c65" decimals="0" unitRef="usd">24000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c66" decimals="0" unitRef="usd">25000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 5:&#160; LEASES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;On June 18, 2009, the Company entered into an agreement to lease a building in Irvine, California. The lease commenced September 1, 2009 and ended August 31, 2016. &lt;/span&gt;&lt;span style="FONT-SIZE:10pt"&gt;&#160;On November 30, 2015, the Company entered into the First Amendment to Lease wherein it exercised its option to extend its lease until August 31, 2021. The initial base rent for the lease extension was $21,000 per month, increasing to $23,637 through August 31, 2021. On April 9, 2021, the Company exercised its second option to extend its lease for an additional five years through August 2026.&#160; The Company was also granted an additional five years lease extension option through August 2031. The rent is currently $23,637 per month and will increase on September 1, 2021 to $25,970 per month and be increased 3% each year thereafter. The security deposit of $22,080 remains the same.&lt;span style="COLOR:black"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;In November 2016, the Company&#x2019;s subsidiary, Biomerica de Mexico, entered into a ten-year lease for approximately 8,104 square feet at a monthly rent of $2,926. The Company has one 10-year option to renew at the end of the initial lease period. The yearly rate is subject to an annual adjustment for inflation according to the United States Bureau of Labor Statistics Consumer Price Index for All Urban Consumers. The monthly rate is currently $3,262.&#160; Biomerica, Inc. is not a guarantor of such lease.&#160; Biomerica de Mexico also leases a smaller unit on a month-to-month basis for use in one manufacturing process.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt"&gt;In addition, the Company leases a small office in Lindau, Germany on a month-to-month basis, as headquarters for BioEurope GmbH, its Germany subsidiary.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Rent expense in the U.S. for the three months ended August 31, 2021 and 2020 was $78,166 and $75,764, respectively.&#160; Rent expense for the Mexico facility for the three months ended August 31, 2021 and 2020 was $10,421 and $10,870, respectively. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;For purposes of determining straight-line rent expense, the lease term is calculated from the date the Company first takes possession of the facility, including any periods of free rent and any renewal options periods that the Company is reasonably certain of exercising. The Company&#x2019;s office and equipment leases generally have contractually specified minimum rent and annual rent increases are included in the measurement of the right-of-use asset and related lease liability.&#160; Additionally, under these lease arrangements, the Company may be required to pay directly, or reimburse the lessors, for some maintenance and operating costs. Such amounts are generally variable and therefore not included in the measurement of the right-of-use asset and related lease liability but are instead recognized as variable lease expense in the Consolidated Statements of Operations and Comprehensive Loss when they are incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Supplemental cash flow information related to leases for the three months ended August 31, 2021:&#160; &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;80,697&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Right-of-use assets obtained in exchange for&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;new operating lease liabilities&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-7"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;5.02&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;6.50%&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;The maturity of lease liabilities as of August 31, 2021 are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Less than 1 year&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;342,640 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1 to 2 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;352,869 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2 to 3 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;363,404 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3 to 4 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;374,253 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;4 to 5 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;385,426 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;5 to 10 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;7,517 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,826,109 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;262,244 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,563,865 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;According to the terms of the lease in Irvine, the Company is also responsible for routine repairs of the building and for certain increases in property tax. &lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company also has various insignificant leases for office equipment.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <bmra:OperatingLeaseInitiationDate contextRef="c77">2009-09-01</bmra:OperatingLeaseInitiationDate>
    <us-gaap:LeaseExpirationDate1 contextRef="c77">2016-08-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1 contextRef="c78">2021-08-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:PaymentsForRent contextRef="c77" decimals="0" unitRef="usd">21000</us-gaap:PaymentsForRent>
    <us-gaap:LeaseAndRentalExpense contextRef="c79" decimals="0" unitRef="usd">23637</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense contextRef="c80" decimals="0" unitRef="usd">25970</us-gaap:LeaseAndRentalExpense>
    <bmra:RentPercentage contextRef="c80" decimals="2" unitRef="pure">0.03</bmra:RentPercentage>
    <us-gaap:SecurityDeposit contextRef="c81" decimals="0" unitRef="usd">22080</us-gaap:SecurityDeposit>
    <us-gaap:OperatingLeasesRentExpenseMinimumRentals contextRef="c82" decimals="0" unitRef="usd">2926</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
    <us-gaap:LeaseAndRentalExpense contextRef="c83" decimals="0" unitRef="usd">3262</us-gaap:LeaseAndRentalExpense>
    <us-gaap:PaymentsForRent contextRef="c0" decimals="0" unitRef="usd">78166</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c2" decimals="0" unitRef="usd">75764</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c64" decimals="0" unitRef="usd">10421</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c84" decimals="0" unitRef="usd">10870</us-gaap:PaymentsForRent>
    <bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;80,697&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Right-of-use assets obtained in exchange for&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;new operating lease liabilities&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-7"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;5.02&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Weighted average discount rate&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;6.50%&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c0" decimals="INF" unitRef="usd">80697</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c3">P5Y7D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c3" decimals="4" unitRef="pure">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Less than 1 year&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;342,640 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1 to 2 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;352,869 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2 to 3 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;363,404 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3 to 4 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;374,253 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;4 to 5 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;385,426 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;5 to 10 years&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;7,517 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,826,109 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;262,244 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15.75pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,563,865 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c3" decimals="INF" unitRef="usd">342640</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c3" decimals="INF" unitRef="usd">352869</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c3" decimals="INF" unitRef="usd">363404</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c3" decimals="INF" unitRef="usd">374253</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c3" decimals="INF" unitRef="usd">385426</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c3" decimals="INF" unitRef="usd">7517</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c3" decimals="INF" unitRef="usd">1826109</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c3" decimals="INF" unitRef="usd">262244</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c3" decimals="INF" unitRef="usd">1563865</us-gaap:OperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0">&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;NOTE 6: &#160;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:10pt; FONT-FAMILY:&amp;quot;Courier New&amp;quot;; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;LITIGATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The Company is, from time to time, involved in legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible the outcome of such legal proceedings, claims and litigation could have a material effect on quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. There were no legal proceedings pending as of August 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;On July 2, 2020, we received a notice of investigation and subpoena to produce information and documents from the Division of Enforcement of the SEC. The subpoena requested information and documents related to events and circumstances leading up to our March 17, 2020 announcement that we had commenced shipping samples of our COVID-19 IgG/IgM Rapid Test to countries outside of the United States, and had initiated the application process with the United States Food and Drug Administration under the COVID-19 Emergency Use Authorization for approval to market and sell the test in the United States. The subpoena also requested information and documents about the identity of any persons who were aware of the substance of the March 17, 2020 announcement prior to that date. In addition, on December 15, 2020, the SEC sent a second subpoena related to this investigation to Zack Irani, the Company&#x2019;s CEO, requesting documents held by Mr. Irani concerning his past purchases of Company stock, his past communications with certain persons and entities, and other personal and Company documents. The Company and Mr. Irani have cooperated fully with the SEC&#x2019;s investigation and provided information as requested. At this time, the Company is unable to predict the duration, scope or outcome of these investigations.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;Contracts and Licensing Agreements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 16.2pt 0pt 0in;"&gt;&lt;span style="font-size: 10pt;"&gt;On June 21, 2021, the Company signed an exclusive distribution and marketing agreement in Canada for its Helicobacter Pylori (H. Pylori) test.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;NOTE 7:&#160; SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt"&gt;None&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ErrorCorrectionTextBlock contextRef="c0">&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&lt;b&gt;&lt;span style="FONT-SIZE:10pt"&gt;NOTE 8:&#160; &lt;span style="COLOR:black"&gt;RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;Subsequent to the issuance of our financial statements for the quarter ended August 31, 2020, the Company determined that errors were included in the previously issued financial statements as described below. As a result, we restated our financial statements for the quarter ended August 31, 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 16.2pt 0pt 0in;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;The Company discovered the errors listed below. The restatement corrects these errors.&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif'; background: white; color: black;"&gt;Our non-cash stock based compensation expenses calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro rata over the period the requisite service was provided.&lt;br/&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif'; background: white; color: black;"&gt;Stock-based compensation expense shown on the statement of operations is a non-cash expense, and impacts accumulated deficit and additional paid-in capital on the balance sheet. However, this does not impact the Company&#x2019;s cash, revenues or other aspects of ongoing operations.&lt;br/&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"&gt;&lt;span style="font-family: 'Times New Roman','serif'; background: white; color: black;"&gt;The restatement for the quarter ended August 31, 2020 resulted in no changes in the provision for income taxes.&lt;br/&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black"&gt;The effect of the restatement on the consolidated statement of operations for the three months ended August 31, 2020 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 732.2px; border-collapse: collapse; margin-left: auto; margin-right: auto; height: 293px;" width="733"&gt;

&lt;tr style="height: 0.5in;"&gt;
&lt;td style="height: 0px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 77.6667px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 0px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 76.9167px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 0px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 74.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cost of sales &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;960,930 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;64,787 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,025,717&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Gross Profit &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;182,876 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(64,787)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;118,089 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Operating Expenses: &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 465.583px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Selling, general and administrative &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,164,564 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;141,380 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,305,944 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Research and development &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;674,693 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;36,812 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;711,505 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 451.183px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.3in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total operating expense &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,839,257 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;178,192 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,017,449 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 18px;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(1,656,381)&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(242,979)&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(1,899,360)&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 18px;"&gt;
&lt;td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 18px;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&lt;span style="font-family: times new roman, times, serif; font-size: 10pt;"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(1,648,290)&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(242,979)&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(1,891,269)&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 18px;"&gt;
&lt;td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Net loss &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,649,415)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(242,979)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,892,394)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 16.5pt;"&gt;
&lt;td style="height: 16px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 16px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 16.5pt;"&gt;
&lt;td style="height: 16px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Basic net loss per common share &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.14)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 16px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.02)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 16px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.16)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Diluted net loss per common share &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.14)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.02)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.16)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Comprehensive loss &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,651,136) &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(242,979)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,894,115)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&lt;span style="FONT-SIZE:10pt; COLOR:black"&gt;The effect of the restatement on the consolidated balance sheet at May 31, 2021 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 33pt;"&gt;
&lt;td style="height: 33pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 9.66%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Shareholders' Equity:&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 8.58%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 8.58%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Additional paid-in-capital&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;36,685,176 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,151,567 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;38,836,743 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Accumulated deficit&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(28,394,768)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(2,151,567)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(30,546,335)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Other Equity accounts&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;936,615 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-8"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;936,615 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total Shareholders' Equity&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;9,227,023 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-9"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;9,227,023 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 0in 0pt"&gt;&lt;span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black"&gt;The effect of the restatement on the consolidated statement of cash flows for the period ended August 31, 2020 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE:12pt; FONT-FAMILY:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; MARGIN:0in 2.7pt 0pt 0in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 37.5pt;"&gt;
&lt;td style="height: 37.5pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,649,415)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(242,979)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,892,394)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments to reconcile net loss to net cash used in operating activities: &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Stock option expense&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3,808 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;242,979 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;246,787 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Net cash used in operating activities &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,597,146)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-10"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,597,146)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cash and cash equivalents at end of period&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;6,964,314 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-11"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;6,964,314 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ErrorCorrectionTextBlock>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="width: 732.2px; border-collapse: collapse; margin-left: auto; margin-right: auto; height: 293px;" width="733"&gt;

&lt;tr style="height: 0.5in;"&gt;
&lt;td style="height: 0px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 77.6667px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 0px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 76.9167px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 0px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 74.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cost of sales &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;960,930 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;64,787 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,025,717&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Gross Profit &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;182,876 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(64,787)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;118,089 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Operating Expenses: &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 465.583px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Selling, general and administrative &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,164,564 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;141,380 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,305,944 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Research and development &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;674,693 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;36,812 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;711,505 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 451.183px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.3in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total operating expense &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;1,839,257 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;178,192 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,017,449 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 18px;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(1,656,381)&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(242,979)&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(1,899,360)&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 18px;"&gt;
&lt;td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 18px;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&lt;span style="font-family: times new roman, times, serif; font-size: 10pt;"&gt;Loss before income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(1,648,290)&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(242,979)&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;(1,891,269)&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 18px;"&gt;
&lt;td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Net loss &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,649,415)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(242,979)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,892,394)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 16.5pt;"&gt;
&lt;td style="height: 16px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 16px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 16px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 16.5pt;"&gt;
&lt;td style="height: 16px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Basic net loss per common share &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.14)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 16px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.02)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 16px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.16)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Diluted net loss per common share &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.14)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.02)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(0.16)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15.75pt;"&gt;
&lt;td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Comprehensive loss &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,651,136) &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(242,979)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$ &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,894,115)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 33pt;"&gt;
&lt;td style="height: 33pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 9.66%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Shareholders' Equity:&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 8.58%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 8.58%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Additional paid-in-capital&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;36,685,176 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;2,151,567 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;38,836,743 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Accumulated deficit&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(28,394,768)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(2,151,567)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(30,546,335)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Other Equity accounts&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;936,615 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-8"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;936,615 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Total Shareholders' Equity&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;9,227,023 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-9"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;9,227,023 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733"&gt;

&lt;tr style="height: 37.5pt;"&gt;
&lt;td style="height: 37.5pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Previously Reported&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;As Restated&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cash flows from operating activities:&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,649,415)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(242,979)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,892,394)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;strong&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Adjustments to reconcile net loss to net cash used in operating activities: &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Stock option expense&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;3,808 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;242,979 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;246,787 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Net cash used in operating activities &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,597,146)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-10"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;(1,597,146)&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&#160;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height: 15pt;"&gt;
&lt;td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;Cash and cash equivalents at end of period&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;6,964,314 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&lt;span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-11"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;&#160;- &lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;$&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom"&gt;
&lt;p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"&gt;&lt;span style="font-size: 10pt; color: black;"&gt;6,964,314 &lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c85" decimals="INF" unitRef="usd">960930</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c86" decimals="INF" unitRef="usd">64787</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c87" decimals="INF" unitRef="usd">1025717</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c85" decimals="INF" unitRef="usd">182876</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c86" decimals="INF" unitRef="usd">-64787</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c87" decimals="INF" unitRef="usd">118089</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c85" decimals="INF" unitRef="usd">1164564</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c86" decimals="INF" unitRef="usd">141380</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c87" decimals="INF" unitRef="usd">1305944</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c85" decimals="INF" unitRef="usd">674693</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c86" decimals="INF" unitRef="usd">36812</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c87" decimals="INF" unitRef="usd">711505</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c85" decimals="INF" unitRef="usd">1839257</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c86" decimals="INF" unitRef="usd">178192</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c87" decimals="INF" unitRef="usd">2017449</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c85" decimals="INF" unitRef="usd">-1656381</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c86" decimals="INF" unitRef="usd">-242979</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c87" decimals="INF" unitRef="usd">-1899360</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c85" decimals="INF" unitRef="usd">-1648290</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c86" decimals="INF" unitRef="usd">-242979</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c87" decimals="INF" unitRef="usd">-1891269</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c85" decimals="INF" unitRef="usd">-1649415</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c86" decimals="INF" unitRef="usd">-242979</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c87" decimals="INF" unitRef="usd">-1892394</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c85" decimals="INF" unitRef="usdPershares">-0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c86" decimals="INF" unitRef="usdPershares">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c87" decimals="INF" unitRef="usdPershares">-0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="c85" decimals="INF" unitRef="usdPershares">-0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c86" decimals="INF" unitRef="usdPershares">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="c87" decimals="INF" unitRef="usdPershares">-0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c85" decimals="INF" unitRef="usd">-1651136</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c86" decimals="INF" unitRef="usd">-242979</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c87" decimals="INF" unitRef="usd">-1894115</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:AdditionalPaidInCapital contextRef="c88" decimals="INF" unitRef="usd">36685176</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c89" decimals="INF" unitRef="usd">2151567</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c90" decimals="INF" unitRef="usd">38836743</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c88" decimals="INF" unitRef="usd">-28394768</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c89" decimals="INF" unitRef="usd">-2151567</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c90" decimals="INF" unitRef="usd">-30546335</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityOther contextRef="c91" decimals="INF" unitRef="usd">936615</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther contextRef="c93" decimals="INF" unitRef="usd">936615</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquity contextRef="c88" decimals="INF" unitRef="usd">9227023</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c90" decimals="INF" unitRef="usd">9227023</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c85" decimals="INF" unitRef="usd">-1649415</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c86" decimals="INF" unitRef="usd">-242979</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c87" decimals="INF" unitRef="usd">-1892394</us-gaap:NetIncomeLoss>
    <us-gaap:StockOptionPlanExpense contextRef="c85" decimals="INF" unitRef="usd">3808</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c86" decimals="INF" unitRef="usd">242979</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c87" decimals="INF" unitRef="usd">246787</us-gaap:StockOptionPlanExpense>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c85" decimals="INF" unitRef="usd">-1597146</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c87" decimals="INF" unitRef="usd">-1597146</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c94" decimals="INF" unitRef="usd">6964314</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c96" decimals="INF" unitRef="usd">6964314</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c4"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c5"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c6"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c3"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c4"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c2"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c0"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="c92"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c89"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c86"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c95"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--05-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0000073290</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066641480296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Oct. 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOMERICA, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMRA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--05-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,511,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000073290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-2645573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">17571 Von Karman Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">645-2111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12gTitle', window );">Title of 12(g) Security</a></td>
<td class="text">Common, par value $.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12gTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(g) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection g<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12gTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066641843976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 1,261,787<span></span>
</td>
<td class="nump">$ 1,143,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="num">(1,350,757)<span></span>
</td>
<td class="num">(1,025,717)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross (Loss) Profit</a></td>
<td class="num">(88,970)<span></span>
</td>
<td class="nump">118,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">1,011,535<span></span>
</td>
<td class="nump">1,305,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">439,864<span></span>
</td>
<td class="nump">711,505<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="nump">1,451,399<span></span>
</td>
<td class="nump">2,017,449<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,540,369)<span></span>
</td>
<td class="num">(1,899,360)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Dividend and interest income</a></td>
<td class="nump">6,805<span></span>
</td>
<td class="nump">8,091<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(1,533,564)<span></span>
</td>
<td class="num">(1,891,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(9,017)<span></span>
</td>
<td class="num">(1,125)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,542,581)<span></span>
</td>
<td class="num">$ (1,892,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of common and common equivalent shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in Shares)</a></td>
<td class="nump">12,426,784<span></span>
</td>
<td class="nump">11,748,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in Shares)</a></td>
<td class="nump">12,426,784<span></span>
</td>
<td class="nump">11,748,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,542,581)<span></span>
</td>
<td class="num">$ (1,892,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(5,613)<span></span>
</td>
<td class="num">(1,721)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (1,548,194)<span></span>
</td>
<td class="num">$ (1,894,115)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066640202952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,996,623<span></span>
</td>
<td class="nump">$ 4,199,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance for doubtful accounts of $742,524 and $837,415 as of August 31, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">772,190<span></span>
</td>
<td class="nump">1,455,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">2,861,779<span></span>
</td>
<td class="nump">3,206,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">315,221<span></span>
</td>
<td class="nump">370,290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">8,945,813<span></span>
</td>
<td class="nump">9,230,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation and amortization of $2,000,167 and $1,972,357 as of August 31, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">287,852<span></span>
</td>
<td class="nump">310,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets, net of accumulated amortization of $531,974 and $469,077 as of August 31, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">1,490,184<span></span>
</td>
<td class="nump">1,553,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">165,324<span></span>
</td>
<td class="nump">165,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of accumulated amortization of $83,683 and $126,769 as of August 31, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">360,292<span></span>
</td>
<td class="nump">294,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">266,582<span></span>
</td>
<td class="nump">264,151<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">11,516,047<span></span>
</td>
<td class="nump">11,818,813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">641,404<span></span>
</td>
<td class="nump">583,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">507,722<span></span>
</td>
<td class="nump">388,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="nump">332,967<span></span>
</td>
<td class="nump">327,944<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,482,093<span></span>
</td>
<td class="nump">1,300,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="nump">1,230,898<span></span>
</td>
<td class="nump">1,291,570<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">2,712,991<span></span>
</td>
<td class="nump">2,591,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Notes 1 and 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, Series A 5% convertible, $0.08 par value, 571,429 shares authorized, none issued and outstanding as of August 31, 2021 and May 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, undesignated, no par value, 4,428,571 shares authorized, none issued and outstanding as of August 31, 2021 and May 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.08 par value, 25,000,000 shares authorized, 12,510,210 and 12,307,157 issued and outstanding at August 31, 2021 and May 31, 2021, respectively</a></td>
<td class="nump">1,000,815<span></span>
</td>
<td class="nump">984,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">39,944,726<span></span>
</td>
<td class="nump">38,836,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(53,569)<span></span>
</td>
<td class="num">(47,956)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(32,088,916)<span></span>
</td>
<td class="num">(30,546,335)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="nump">8,803,056<span></span>
</td>
<td class="nump">9,227,023<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders' Equity</a></td>
<td class="nump">11,516,047<span></span>
</td>
<td class="nump">11,818,813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember', window );">5% Convertible Preferred Stock [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, Series A 5% convertible, $0.08 par value, 571,429 shares authorized, none issued and outstanding as of August 31, 2021 and May 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, undesignated, no par value, 4,428,571 shares authorized, none issued and outstanding as of August 31, 2021 and May 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066640930008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts (in Dollars)</a></td>
<td class="nump">$ 742,524<span></span>
</td>
<td class="nump">$ 837,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization (in Dollars)</a></td>
<td class="nump">2,000,167<span></span>
</td>
<td class="nump">1,972,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated amortization, Right of Use Assets (in Dollars)</a></td>
<td class="nump">531,974<span></span>
</td>
<td class="nump">469,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, Intangible Assets (in Dollars)</a></td>
<td class="nump">$ 83,683<span></span>
</td>
<td class="nump">$ 126,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNoParValue', window );">Preferred Stock, No Par Value (in Dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_PreferredStockUndesignatedShares', window );">Preferred Stock, undesignated shares</a></td>
<td class="nump">4,428,571<span></span>
</td>
<td class="nump">4,428,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value (in Dollars per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">12,510,210<span></span>
</td>
<td class="nump">12,307,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">12,510,210<span></span>
</td>
<td class="nump">12,307,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember', window );">5% Convertible Preferred Stock [Member] | Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value (in Dollars per share)</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, shares authorized</a></td>
<td class="nump">571,429<span></span>
</td>
<td class="nump">571,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from operating lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_PreferredStockUndesignatedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of preferred shares undesignated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_PreferredStockUndesignatedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=bmra_A5ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066641422840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)<br></strong></div></th>
<th class="th">
<div>Series A Preferred Stock [Member] </div>
<div>5% Convertible Preferred Stock [Member]</div>
</th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at May. 31, 2020</a></td>
<td class="nump">$ 25,714<span></span>
</td>
<td class="nump">$ 939,205<span></span>
</td>
<td class="nump">$ 36,388,056<span></span>
</td>
<td class="num">$ (39,841)<span></span>
</td>
<td class="num">$ (23,100,081)<span></span>
</td>
<td class="nump">$ 14,213,053<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balances (in Shares) at May. 31, 2020</a></td>
<td class="nump">321,429<span></span>
</td>
<td class="nump">11,740,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">13,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,721)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,721)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation expense in connection with options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,892,394)<span></span>
</td>
<td class="num">(1,892,394)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Aug. 31, 2020</a></td>
<td class="nump">$ 25,714<span></span>
</td>
<td class="nump">$ 940,205<span></span>
</td>
<td class="nump">36,648,743<span></span>
</td>
<td class="num">(41,562)<span></span>
</td>
<td class="num">(24,992,475)<span></span>
</td>
<td class="nump">12,580,625<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balances (in Shares) at Aug. 31, 2020</a></td>
<td class="nump">321,429<span></span>
</td>
<td class="nump">11,752,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at May. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 984,571<span></span>
</td>
<td class="nump">38,836,743<span></span>
</td>
<td class="num">(47,956)<span></span>
</td>
<td class="num">(30,546,335)<span></span>
</td>
<td class="nump">9,227,023<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balances (in Shares) at May. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,307,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">3,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,124<span></span>
</td>
<td class="nump">784,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from ATM (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,613)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,613)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Compensation expense in connection with options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">319,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">319,622<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,542,581)<span></span>
</td>
<td class="num">(1,542,581)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Aug. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,815<span></span>
</td>
<td class="nump">$ 39,944,726<span></span>
</td>
<td class="num">$ (53,569)<span></span>
</td>
<td class="num">$ (32,088,916)<span></span>
</td>
<td class="nump">$ 8,803,056<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balances (in Shares) at Aug. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,510,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066640969448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,542,581)<span></span>
</td>
<td class="num">$ (1,892,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">34,722<span></span>
</td>
<td class="nump">32,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Change in allowance on accounts receivable</a></td>
<td class="num">(94,891)<span></span>
</td>
<td class="nump">201,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Inventory reserve</a></td>
<td class="nump">179,744<span></span>
</td>
<td class="nump">5,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">319,622<span></span>
</td>
<td class="nump">246,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_OperatingLeaseRightofUseAssetAmortization', window );">Amortization of right-of-use asset</a></td>
<td class="nump">62,897<span></span>
</td>
<td class="nump">57,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">777,752<span></span>
</td>
<td class="num">(18,924)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">164,732<span></span>
</td>
<td class="num">(1,255,573)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">55,069<span></span>
</td>
<td class="nump">1,038,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_IncreaseDecreaseInLeaseLiability', window );">Reduction in lease liability</a></td>
<td class="num">(55,649)<span></span>
</td>
<td class="num">(49,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(2,431)<span></span>
</td>
<td class="num">(276,438)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">58,024<span></span>
</td>
<td class="nump">284,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation</a></td>
<td class="nump">118,826<span></span>
</td>
<td class="nump">30,718<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">75,836<span></span>
</td>
<td class="num">(1,597,146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Increase in intangibles</a></td>
<td class="num">(72,375)<span></span>
</td>
<td class="num">(53,158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(5,141)<span></span>
</td>
<td class="num">(39,588)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(77,516)<span></span>
</td>
<td class="num">(92,746)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net</a></td>
<td class="nump">800,710<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">3,895<span></span>
</td>
<td class="nump">14,900<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">804,605<span></span>
</td>
<td class="nump">14,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes in cash</a></td>
<td class="num">(5,613)<span></span>
</td>
<td class="num">(1,721)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">797,312<span></span>
</td>
<td class="num">(1,676,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">4,199,311<span></span>
</td>
<td class="nump">8,641,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">4,996,623<span></span>
</td>
<td class="nump">6,964,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_CashPaidDuringThePeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">$ 9,017<span></span>
</td>
<td class="nump">$ 1,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_CashPaidDuringThePeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_CashPaidDuringThePeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_IncreaseDecreaseInLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in LeaseLiability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_IncreaseDecreaseInLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_OperatingLeaseRightofUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Right of Use Asset for Operating Lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_OperatingLeaseRightofUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066645531240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Accounting [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 1: &#160;BASIS OF PRESENTATION</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Biomerica Inc. and subsidiaries (collectively the &#8220;Company&#8221;, &#8220;Biomerica&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221;) develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care <span style="COLOR:black">(in home and physicians' offices) </span>and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. <span style="COLOR:black">The</span> Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our primary focus is the research and development of revolutionary, patented, diagnostic-guided therapy (&#8220;DGT&#8221;) products to treat gastrointestinal diseases, such as irritable bowel syndrome, and other inflammatory diseases. These products are directed at chronic inflammatory illnesses that are widespread and common, and as such address very large markets. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Our existing medical diagnostic products that are in the market are sold worldwide primarily in two markets: 1) clinical laboratories and 2) point-of-care (physicians' offices and over-the-counter drugstores like Walmart and Walgreens). Our diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient&#8217;s body, stools, or blood, often in extremely small concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Due to the global 2019 SARS-CoV-2 novel coronavirus pandemic, in March 2020 we began redirecting and focusing a majority of our resources to develop, test, validate, seek regulatory approval for, and sell diagnostic products that indicate if a person has been infected by COVID-19. During fiscal 2021, we sold 2 primary types of COVID-19 tests; 1) antibody diagnostic tests that use a patient&#8217;s blood sample to detect if the patient has certain antibodies to COVID-19 that were created as part of their body&#8217;s immune response to a COVID-19 infection, even if the infection was asymptomatic, and 2) antigen tests that use a patient&#8217;s nasal fluid sample to detect if the patient is currently infected with the virus. <span style="COLOR:black">&#160;</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">Aside from the COVID-19 products we offer, the other products we sell are primarily focused on gastrointestinal diseases, food intolerances, cancer screening and awareness and certain esoteric tests. These diagnostic test products utilize immunoassay technology. Most of our commercial products are CE marked and/or sold for diagnostic use where they are registered by each country&#8217;s regulatory agency.&#160; In addition, some products are cleared for sale in the U.S. by the FDA.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The information set forth in these condensed consolidated financial statements is unaudited and reflects all adjustments which, in the opinion of management, are necessary to present a fair statement of the consolidated results of operations of Biomerica, Inc. and subsidiaries, for the periods indicated. It does not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America. All adjustments that were made are of a normal recurring nature.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">The unaudited, condensed consolidated financial statements and notes are presented as permitted by the requirements for Form 10-Q and do not contain certain information included in the annual financial statements and notes. The condensed consolidated balance sheet data as of May 31, 2021 was derived from audited financial statements. The accompanying interim condensed consolidated financial statements should be read in conjunction with the financial statements and related notes included in the Annual Report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on August 27, 2021 for the fiscal year ended May 31, 2021, which have been restated as described in our Form 10-K/A as filed on October 14, 2021. The results of operations for the interim periods are not necessarily indicative of results to be achieved for the full fiscal year.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; BACKGROUND:white; COLOR:black">CORRECTION OF AN ERROR</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">As disclosed in our Form 10-K/A for the year ended May&#160;31, 2021, filed on October 14, 2021, during the process of preparing our financial statements for the quarter ended August&#160;31, 2021, we determined that our calculation of non-cash stock-based compensation expense related to issued stock options in previously issued financial statements was incorrect. Our calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro rata over the period the requisite service was provided. As a result of these errors, certain previously reported amounts in the condensed consolidated statement of operations, condensed consolidated statement of stockholders&#8217; equity and condensed consolidated statement of cash flows for the quarter ended August 31, 2020, were materially misstated; accordingly, we have restated the prior period financial statements. </span><span style="font-family: 'Times New Roman','serif';">See Note 8 to the Financial Statements. </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066638820024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 2: &#160;SIGNIFICANT ACCOUNTING POLICIES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PRINCIPLES OF CONSOLIDATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">ACCOUNTING ESTIMATES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">MARKETS AND METHODS OF DISTRIBUTION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Due to</span><span style="FONT-SIZE:10pt"> the Coronavirus global pandemic, the Company&#8217;s operations have been negatively impacted.<span style="COLOR:black"> The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#8217;s manufacturing or distribution facilities or of the facilities of the Company&#8217;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions can materially negatively impact the Company&#8217;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LIQUIDITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $32.1 million as of August 31, 2021.&#160; Management expects to continue to incur significant costs as it advances its trials and development activities.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $15,000,000 to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 </span><span style="FONT-SIZE:10pt">(<span style="COLOR:black">File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Under an ATM Agreement, sales of shares are deemed to be &#8220;at the market offerings&#8221; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#8217;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt"><span style="FONT-SIZE:10pt">As a result of cash and cash equivalents on hand at August 31, 2021, management believes the Company has sufficient funds to operate through November 2022 and the ability to raise additional funds through the ATM Agreement noted above.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">CONCENTRATION OF CREDIT RISK</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of August 31, 2021, the Company had approximately $4,790,000 of uninsured cash.&#160; <span style="COLOR:black">The Company does not believe it is exposed to any significant credit risks.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">For the three months ended August 31, 2021 and 2020, the Company had two key distributors which accounted for 60% and 40% of net consolidated sales, respectively.&#160; At August 31, 2021 and May 31, 2021, the Company had two&#160;key distributors which accounted for a total of 77% and 73%, respectively, of gross accounts receivable. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">For the three months ended August 31, 2021 and 2020, one key vendor accounted for 17% and two key vendors accounted for 64% of the purchases of raw materials, respectively. As of August 31, 2021 and May 31, 2021, the Company had one key vendor which accounted for 25% and 17%, respectively, of accounts payable.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">CASH AND CASH EQUIVALENTS </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than three months.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">ACCOUNTS RECEIVABLE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over ninety days old are usually reserved for unless collection is reasonably assured. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. &#160; Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company has established a reserve of approximately $743,000 for doubtful accounts as of August 31, 2021. The majority of this reserve has been established to cover 100% of outstanding accounts receivable from an international distributor.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PREPAID EXPENSES AND OTHER</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">As of August 31, 2021 and May 31, 2021, the prepaid expenses and other were approximately $315,000 and $370,000, respectively. The prepaid expenses and other balance were composed of prepayments to insurance and various other suppliers. &#160;&#160;</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INVENTORIES, NET </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Inventories approximate the following at:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">May 31, 2021</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Raw materials</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,493,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,583,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Work in progress</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">926,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,006,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Finished products</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">443,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">617,000</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,862,000</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3,206,000</span></p>
</td>
</tr>

</table><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">During the first fiscal quarter ended August 31, 2021, the Company wrote-down the carrying value of certain inventory by approximately $179,000 to assign a new carrying value for this inventory of $211,000.&#160; As part of a large international order for this product that was to ship in the second quarter of 2022, the Company agreed to sell this product as a small portion of that order at a price below its carrying value, which required a write down.&#160; </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of August 31, 2021 and May 31, 2021, inventory reserves were approximately $1,797,000 and $1,617,000, respectively. Of the inventory reserve, approximately $1,683,000 was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PROPERTY AND EQUIPMENT, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in; TEXT-INDENT:0.5in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from 5 to 10 years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment amounted to $27,809 and $26,732 for the three months ended August 31, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">&#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INTANGIBLE ASSETS, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#8211; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets are being amortized using the straight-line method over the useful life, not to exceed 18 years for marketing and distribution rights, 10 years for purchased technology use rights, and 20 years for patents. Amortization expense amounted to $6,913 and $5,838 for the three months ended August 31, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#8217;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of August 31, 2021 or 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt; COLOR:black">INVESTMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#8217;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#8217;s investment in a Polish based distributor which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the certain of the products sold. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately 6% of the investee, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">SHARE-BASED COMPENSATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company follows the guidance of the accounting provisions of ASC 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees and others receive shares of stock or equity instruments (options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#8217;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of<b> </b>the expected term.</span></p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">&#160; </span></p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the three months ended August 31, 2021:</span></p><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 48pt;">
<td style="height: 48pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Option Shares</span></p>
</td>
<td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercise Price Weighted Average</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Outstanding May 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,081,366 </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3.59 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Granted </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">24,000 </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">4.25 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercised </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,500)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2.68 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cancelled or expired </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(22,750)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3.02 </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Outstanding August 31, 2021</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">2,081,116 </span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$</span></strong></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">3.60 </span></strong></p>
</td>
</tr>

</table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">During the three months ended August 31, 2021, options to purchase 1,500 shares of common stock were exercised at price of $2.68. Total net proceeds to the Company were $3,895.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">During the three months ended August 31, 2021, the Company granted 24,000 options to purchase common stock at an average purchase price of $4.25. Total net proceeds to the Company were $14,900.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">REVENUE RECOGNITION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of August 31, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. </span><span style="FONT-SIZE:10pt">Services for some contract works are invoiced and recognized for work that has been performed as the project progresses. <span style="COLOR:black">The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#8217; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Disaggregation of revenue:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a breakdown of revenues according to markets to which the products are sold:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="5" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Three Months Ended</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2020</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Clinical lab</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">886,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">582,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Physician's office</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">257,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">197,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Over-the-counter</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">79,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">185,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Contract Manufacturing</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">40,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">180,000</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,262,000</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,144,000</span></p>
</td>
</tr>

</table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">See Note 4 for additional information regarding revenue concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">SHIPPING AND HANDLING FEES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The Company includes shipping and handling fees billed to customers in net sales.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">RESEARCH AND DEVELOPMENT</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Research and development costs are expensed as incurred. The Company expensed approximately $440,000 and $712,000 of research and development costs during the three months ended August 31, 2021 and 2020, respectively.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INCOME TAXES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt; color: black;">The Company has provided a valuation allowance on deferred income tax assets of approximately $6,226,000 and $5,904,000 as of August 31, 2021 and May 31, 2021, respectively. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">FOREIGN CURRENCY TRANSLATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three months ended August 31, 2021 and 2020. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt; COLOR:black">RIGHT-OF-USE ASSETS AND LEASE LIABILITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#8217;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">NET LOSS PER SHARE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation for the three months ended August 31, 2021 and 2020 was 2,081,116 and 1,925,750, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">RECENT ACCOUNTING PRONOUNCEMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">Recent ASUs issued by the FASB and guidance issued by the Securities and Exchange Commission (&#8220;SEC&#8221;) did not, or are not believed by management to, have a material effect on the Company&#8217;s present or future consolidated financial statements. </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066638679224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 3:&#160; SHAREHOLDERS&#8217; EQUITY</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Stock option expense during the three months ended August 31, 2021 and 2020 were $319,622 and $246,787 (as restated, see Note 8 to the Financial Statements), respectively.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt"><span style="FONT-SIZE:10pt">During the three months ended August 31, 2021, the Company sold 201,553 shares of its common stock at prices ranging from $4.02 to $4.47 under its January 22, 2021 prospectus supplement and the ATM Agreement (see Note 2 to Financial Statements) which resulted in gross proceeds of $838,332 and net proceeds to the Company of $800,710 after deducting commissions for each sale and legal, accounting and other fees related to the filing of the Form S-3.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066638683992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_GeographicInformationDisclosureAbstract', window );"><strong>Geographic Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_GeographicInformationDisclosureTextBlock', window );">Geographic Information Disclosure [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 4: &#160;GEOGRAPHIC INFORMATION</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company operates as one segment. Geographic information regarding net sales is approximately as follows: </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="733"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">August 31, 2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">August 31, 2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Revenues from sales to unaffiliated customers:</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"/></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Asia</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">675,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">347,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Europe</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">471,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">591,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">North America</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">105,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">134,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Middle East</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">8,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">29,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">South America</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">43,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,262,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,144,000 </span></p></td></tr></table><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">As of August 31, 2021 and May 31, 2021, approximately $665,000 and $803,000 of Biomerica&#8217;s gross inventory and approximately $24,000 and $25,000, of Biomerica&#8217;s property and equipment, net of accumulated depreciation and amortization, was located in Mexicali, Mexico, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_GeographicInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_GeographicInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_GeographicInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments according to the geographic areas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_GeographicInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066636912536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 5:&#160; LEASES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On June 18, 2009, the Company entered into an agreement to lease a building in Irvine, California. The lease commenced September 1, 2009 and ended August 31, 2016. </span><span style="FONT-SIZE:10pt">&#160;On November 30, 2015, the Company entered into the First Amendment to Lease wherein it exercised its option to extend its lease until August 31, 2021. The initial base rent for the lease extension was $21,000 per month, increasing to $23,637 through August 31, 2021. On April 9, 2021, the Company exercised its second option to extend its lease for an additional five years through August 2026.&#160; The Company was also granted an additional five years lease extension option through August 2031. The rent is currently $23,637 per month and will increase on September 1, 2021 to $25,970 per month and be increased 3% each year thereafter. The security deposit of $22,080 remains the same.<span style="COLOR:black">&#160;</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">In November 2016, the Company&#8217;s subsidiary, Biomerica de Mexico, entered into a ten-year lease for approximately 8,104 square feet at a monthly rent of $2,926. The Company has one 10-year option to renew at the end of the initial lease period. The yearly rate is subject to an annual adjustment for inflation according to the United States Bureau of Labor Statistics Consumer Price Index for All Urban Consumers. The monthly rate is currently $3,262.&#160; Biomerica, Inc. is not a guarantor of such lease.&#160; Biomerica de Mexico also leases a smaller unit on a month-to-month basis for use in one manufacturing process.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">In addition, the Company leases a small office in Lindau, Germany on a month-to-month basis, as headquarters for BioEurope GmbH, its Germany subsidiary.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Rent expense in the U.S. for the three months ended August 31, 2021 and 2020 was $78,166 and $75,764, respectively.&#160; Rent expense for the Mexico facility for the three months ended August 31, 2021 and 2020 was $10,421 and $10,870, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">For purposes of determining straight-line rent expense, the lease term is calculated from the date the Company first takes possession of the facility, including any periods of free rent and any renewal options periods that the Company is reasonably certain of exercising. The Company&#8217;s office and equipment leases generally have contractually specified minimum rent and annual rent increases are included in the measurement of the right-of-use asset and related lease liability.&#160; Additionally, under these lease arrangements, the Company may be required to pay directly, or reimburse the lessors, for some maintenance and operating costs. Such amounts are generally variable and therefore not included in the measurement of the right-of-use asset and related lease liability but are instead recognized as variable lease expense in the Consolidated Statements of Operations and Comprehensive Loss when they are incurred.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Supplemental cash flow information related to leases for the three months ended August 31, 2021:&#160; </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">80,697</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Right-of-use assets obtained in exchange for</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">new operating lease liabilities</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-7">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Weighted average remaining lease term (in years)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">5.02</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Weighted average discount rate</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">6.50%</span></p>
</td>
</tr>

</table><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">The maturity of lease liabilities as of August 31, 2021 are as follows:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Less than 1 year</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">342,640 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1 to 2 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">352,869 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2 to 3 years</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">363,404 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3 to 4 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">374,253 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">4 to 5 years</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">385,426 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">5 to 10 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">7,517 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total undiscounted lease payments</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,826,109 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Less imputed interest</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">262,244 </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total operating lease liabilities</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,563,865 </span></p>
</td>
</tr>

</table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">According to the terms of the lease in Irvine, the Company is also responsible for routine repairs of the building and for certain increases in property tax. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company also has various insignificant leases for office equipment.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066638710200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies Disclosure [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">NOTE 6: &#160;COMMITMENTS AND CONTINGENCIES</span></b></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LITIGATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company is, from time to time, involved in legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible the outcome of such legal proceedings, claims and litigation could have a material effect on quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. There were no legal proceedings pending as of August 31, 2021.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">On July 2, 2020, we received a notice of investigation and subpoena to produce information and documents from the Division of Enforcement of the SEC. The subpoena requested information and documents related to events and circumstances leading up to our March 17, 2020 announcement that we had commenced shipping samples of our COVID-19 IgG/IgM Rapid Test to countries outside of the United States, and had initiated the application process with the United States Food and Drug Administration under the COVID-19 Emergency Use Authorization for approval to market and sell the test in the United States. The subpoena also requested information and documents about the identity of any persons who were aware of the substance of the March 17, 2020 announcement prior to that date. In addition, on December 15, 2020, the SEC sent a second subpoena related to this investigation to Zack Irani, the Company&#8217;s CEO, requesting documents held by Mr. Irani concerning his past purchases of Company stock, his past communications with certain persons and entities, and other personal and Company documents. The Company and Mr. Irani have cooperated fully with the SEC&#8217;s investigation and provided information as requested. At this time, the Company is unable to predict the duration, scope or outcome of these investigations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in"><b><span style="FONT-SIZE:10pt">Contracts and Licensing Agreements</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 16.2pt 0pt 0in;"><span style="font-size: 10pt;">On June 21, 2021, the Company signed an exclusive distribution and marketing agreement in Canada for its Helicobacter Pylori (H. Pylori) test.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066637197544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">NOTE 7:&#160; SUBSEQUENT EVENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">None</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066638762712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodAdjustmentAbstract', window );"><strong>Prior Period Adjustment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionTextBlock', window );">Error Correction [Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">NOTE 8:&#160; <span style="COLOR:black">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">Subsequent to the issuance of our financial statements for the quarter ended August 31, 2020, the Company determined that errors were included in the previously issued financial statements as described below. As a result, we restated our financial statements for the quarter ended August 31, 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 16.2pt 0pt 0in;"><span style="font-size: 10pt; color: black;">The Company discovered the errors listed below. The restatement corrects these errors.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">Our non-cash stock based compensation expenses calculation applied forfeiture adjustments to both vested and unvested outstanding options, including those for which the employee had provided the requisite service, which resulted in an understatement of stock compensation expense. Additionally, our calculation expensed the option at vesting dates versus pro rata over the period the requisite service was provided.<br/><br/></span></p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">Stock-based compensation expense shown on the statement of operations is a non-cash expense, and impacts accumulated deficit and additional paid-in capital on the balance sheet. However, this does not impact the Company&#8217;s cash, revenues or other aspects of ongoing operations.<br/><br/></span></p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif'; background: white; color: black;">The restatement for the quarter ended August 31, 2020 resulted in no changes in the provision for income taxes.<br/><br/></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of operations for the three months ended August 31, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 732.2px; border-collapse: collapse; margin-left: auto; margin-right: auto; height: 293px;" width="733">

<tr style="height: 0.5in;">
<td style="height: 0px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 77.6667px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 0px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 76.9167px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 0px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 74.9px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cost of sales </span></p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">960,930 </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">64,787 </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,025,717</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Gross Profit </span></p>
</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">182,876 </span></p>
</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(64,787)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">118,089 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Operating Expenses: </span></p>
</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Selling, general and administrative </span></p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,164,564 </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">141,380 </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,305,944 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Research and development </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">674,693 </span></p>
</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">36,812 </span></p>
</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">711,505 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 451.183px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.3in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total operating expense </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,839,257 </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">178,192 </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,017,449 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 18px;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">Loss from operations</span></td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(1,656,381)</span></td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(242,979)</span></td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(1,899,360)</span></td>
</tr>
<tr style="height: 18px;">
<td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;">&#160;</td>
<td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
</tr>
<tr style="height: 18px;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"><span style="font-family: times new roman, times, serif; font-size: 10pt;">Loss before income taxes</span></td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(1,648,290)</span></td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(242,979)</span></td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(1,891,269)</span></td>
</tr>
<tr style="height: 18px;">
<td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;">&#160;</td>
<td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,649,415)</span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(242,979)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,892,394)</span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 16px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Basic net loss per common share </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.14)</span></p>
</td>
<td style="height: 16px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.02)</span></p>
</td>
<td style="height: 16px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.16)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Diluted net loss per common share </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.14)</span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.02)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.16)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Comprehensive loss </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,651,136) </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(242,979)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,894,115)</span></p>
</td>
</tr>

</table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The effect of the restatement on the consolidated balance sheet at May 31, 2021 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 33pt;">
<td style="height: 33pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 9.66%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Shareholders' Equity:</span></strong></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 8.58%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 8.58%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Additional paid-in-capital</span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">36,685,176 </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,151,567 </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">38,836,743 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated deficit</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(28,394,768)</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(2,151,567)</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(30,546,335)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Other Equity accounts</span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">936,615 </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"><div style="-sec-ix-hidden: hidden-fact-8">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">936,615 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total Shareholders' Equity</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">9,227,023 </span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"><div style="-sec-ix-hidden: hidden-fact-9">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">9,227,023 </span></p>
</td>
</tr>

</table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; BACKGROUND:white; COLOR:black">The effect of the restatement on the consolidated statement of cash flows for the period ended August 31, 2020 is as follows:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 37.5pt;">
<td style="height: 37.5pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from operating activities:</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,649,415)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(242,979)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,892,394)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Adjustments to reconcile net loss to net cash used in operating activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Stock option expense</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3,808 </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">242,979 </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">246,787 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net cash used in operating activities </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,597,146)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-10">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,597,146)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at end of period</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">6,964,314 </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">$</span></td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-11">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">6,964,314 </span></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting error correction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066647568008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PRINCIPLES OF CONSOLIDATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The condensed consolidated financial statements include the accounts of Biomerica, Inc. as well as its German subsidiary (BioEurope GmbH) and Mexican subsidiary (Biomerica de Mexico). All significant intercompany accounts and transactions have been eliminated in consolidation. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">ACCOUNTING ESTIMATES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reported period. Estimates that are made include the allowance for doubtful accounts, which is estimated based on current as well as historical past practices with a customer; stock option forfeiture rates, which are calculated based on historical data; inventory obsolescence, which is based on projected and historical usage of materials; and lease liability and right-of-use assets, which are calculated based on certain assumptions such as borrowing rate, the likelihood of lease extensions to occur, asset valuation, among other things; and other items that may be necessary to estimate using current, historical and judgment based information. Actual results could materially differ from those estimates. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_MarketsAndMethodsOfDistributionPolicyTextBlock', window );">Markets And Methods Of Distribution [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">MARKETS AND METHODS OF DISTRIBUTION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">Due to</span><span style="FONT-SIZE:10pt"> the Coronavirus global pandemic, the Company&#8217;s operations have been negatively impacted.<span style="COLOR:black"> The Company has faced disruptions in certain of the following areas, and may face further challenges from supply chain disruptions, loss of contracts and/or customers, closure of the Company&#8217;s manufacturing or distribution facilities or of the facilities of the Company&#8217;s suppliers, partners and customers, travel, shipping and logistical disruptions, government responses of all types, international business risks in countries where the Company makes and/or sells its products, loss of human capital or personnel at the Company, its partners and its customers, interruptions of production, customer credit risk, and general economic calamities. These ongoing pandemic related disruptions can materially negatively impact the Company&#8217;s operations and financial performance and may continue to have significant material negative impacts on the Company.&#160;&#160; </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LiquidityPolicyTextBlock', window );">Liquidity [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><span style="FONT-SIZE:10pt; COLOR:black">LIQUIDITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The Company has incurred net losses and negative cash flows from operations and has an accumulated deficit of approximately $32.1 million as of August 31, 2021.&#160; Management expects to continue to incur significant costs as it advances its trials and development activities.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">On January 22, 2021, the Company filed a prospectus supplement for purposes of raising up to $15,000,000 to the base prospectus filed with the SEC on July 21, 2020 and included in the registration statement on Form S-3 </span><span style="FONT-SIZE:10pt">(<span style="COLOR:black">File No. 333-239980) that was declared effective by the SEC on September 30, 2020. The shares included in the prospectus supplement may be sold pursuant to the terms of an At Market Issuance Sales Agreement between the Company and B. Riley Securities, Inc., as sales agent, the ATM Agreement.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt">The Company intends to use the net proceeds from such offering for general corporate purposes, including, without limitation, sales and marketing activities, clinical studies and product development, making acquisitions of assets, businesses, companies or securities, capital expenditures, and for working capital needs.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Under an ATM Agreement, sales of shares are deemed to be &#8220;at the market offerings&#8221; as defined in Rule 415 promulgated under the Securities Act.&#160; The sales agent under the ATM Agreement agrees to use commercially reasonable efforts to sell on the Company&#8217;s behalf all of the shares requested to be sold from time to time by the Company, consistent with its normal trading and sales practices, on mutually agreed terms between the sales agent and the Company. The Company has no obligation to sell any of the shares under the ATM Agreement, and may at any time suspend offers under, or terminate the ATM Agreement.&#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:12pt 0in 0pt"><span style="FONT-SIZE:10pt">As a result of cash and cash equivalents on hand at August 31, 2021, management believes the Company has sufficient funds to operate through November 2022 and the ability to raise additional funds through the ATM Agreement noted above.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration Risk, Credit Risk, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">CONCENTRATION OF CREDIT RISK</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company maintains cash balances at certain financial institutions in excess of amounts insured by federal agencies. As of August 31, 2021, the Company had approximately $4,790,000 of uninsured cash.&#160; <span style="COLOR:black">The Company does not believe it is exposed to any significant credit risks.</span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">For the three months ended August 31, 2021 and 2020, the Company had two key distributors which accounted for 60% and 40% of net consolidated sales, respectively.&#160; At August 31, 2021 and May 31, 2021, the Company had two&#160;key distributors which accounted for a total of 77% and 73%, respectively, of gross accounts receivable. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt;">For the three months ended August 31, 2021 and 2020, one key vendor accounted for 17% and two key vendors accounted for 64% of the purchases of raw materials, respectively. As of August 31, 2021 and May 31, 2021, the Company had one key vendor which accounted for 25% and 17%, respectively, of accounts payable.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">CASH AND CASH EQUIVALENTS </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Cash and cash equivalents consist of demand deposits and money market accounts with original maturities of less than three months.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">ACCOUNTS RECEIVABLE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company extends unsecured credit to its customers on a regular basis. &#160;International accounts are usually required to prepay until they establish a history with the Company and at that time, they are extended credit at levels based on a number of criteria. &#160;Based on various criteria,&#160;initial credit levels for individual distributors are approved by designated officers and managers of the Company. All increases in credit limits are also approved by designated upper-level management. &#160;Management evaluates receivables on a quarterly basis and adjusts the allowance for doubtful accounts accordingly. &#160;Balances over ninety days old are usually reserved for unless collection is reasonably assured. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Occasionally certain long-standing customers, who routinely place large orders, will have unusually large receivables balances relative to the total gross receivables. &#160; Management monitors the payments for these large balances closely and very often requires payment of existing invoices before shipping new sales orders.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company has established a reserve of approximately $743,000 for doubtful accounts as of August 31, 2021. The majority of this reserve has been established to cover 100% of outstanding accounts receivable from an international distributor.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_PrepaidsPolicyPolicyTextBlock', window );">Prepaids Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PREPAID EXPENSES AND OTHER</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company occasionally prepays for items such as inventory, insurance and other items.&#160; These items are reported as prepaid expenses and other, until either the inventory is physically received or the insurance and other items are expensed.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">As of August 31, 2021 and May 31, 2021, the prepaid expenses and other were approximately $315,000 and $370,000, respectively. The prepaid expenses and other balance were composed of prepayments to insurance and various other suppliers. &#160;&#160;</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INVENTORIES, NET </span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company values inventory at the lower of cost (determined using a combination of specific lot identification and the first-in, first-out methods) or net realizable value. Management periodically reviews inventory for excess quantities and obsolescence. Management evaluates quantities on hand, physical condition, and technical functionality as these characteristics may be impacted by anticipated customer demand for current products and new product introductions. The reserve is adjusted based on such evaluation, with a corresponding provision included in cost of sales. Abnormal amounts of idle facility expenses, freight, handling costs and wasted material are recognized as current period charges and the allocation of fixed production overhead is based on the normal capacity of the production facilities.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Inventories approximate the following at:</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">May 31, 2021</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Raw materials</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,493,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,583,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Work in progress</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">926,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,006,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Finished products</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">443,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">617,000</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,862,000</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3,206,000</span></p>
</td>
</tr>

</table><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">During the first fiscal quarter ended August 31, 2021, the Company wrote-down the carrying value of certain inventory by approximately $179,000 to assign a new carrying value for this inventory of $211,000.&#160; As part of a large international order for this product that was to ship in the second quarter of 2022, the Company agreed to sell this product as a small portion of that order at a price below its carrying value, which required a write down.&#160; </span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;">Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory carrying value to estimated realizable value or to specifically reserve for obsolete inventory that the Company intends to dispose of. As of August 31, 2021 and May 31, 2021, inventory reserves were approximately $1,797,000 and $1,617,000, respectively. Of the inventory reserve, approximately $1,683,000 was related to a market downturn in our COVID-19 antibody test and materials, as the market shifted to COVID-19 PCR viral tests and antigen tests.</span></p><p style="FONT-SIZE:10pt; FONT-FAMILY:&quot;Courier New&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">PROPERTY AND EQUIPMENT, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Property and equipment are stated at cost. Expenditures for additions and major improvements are capitalized. Repairs and maintenance costs are charged to operations as incurred. When property and equipment are sold, retired or otherwise disposed of, the related cost and accumulated depreciation or amortization are removed from the accounts, and gains or losses from sales, retirements and dispositions are credited or charged to income. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in; TEXT-INDENT:0.5in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Depreciation and amortization are provided over the estimated useful lives of the related assets, ranging from 5 to 10 years, using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful life of the asset or the term of the lease. Depreciation and amortization expense on property and equipment amounted to $27,809 and $26,732 for the three months ended August 31, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">&#160; </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INTANGIBLE ASSETS, NET</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets include trademarks, product rights, technology rights and patents, and are accounted for based on Accounting Standards Codification, ASC 350 Intangibles &#8211; Goodwill and Other. In that regard, intangible assets that have indefinite useful lives are not amortized but are tested at least annually for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Intangible assets are being amortized using the straight-line method over the useful life, not to exceed 18 years for marketing and distribution rights, 10 years for purchased technology use rights, and 20 years for patents. Amortization expense amounted to $6,913 and $5,838 for the three months ended August 31, 2021 and 2020, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company assesses the recoverability of these intangible assets by determining whether the amortization of the asset&#8217;s balance over its remaining life can be recovered through projected undiscounted future cash flows. The Company uses a qualitative assessment to determine whether there was any impairment. No impairment adjustment was required as of August 31, 2021 or 2020.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt; COLOR:black">INVESTMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">From time-to-time, the Company makes investments in privately-held companies. &#160;The Company determines whether the fair values of any investments in privately-held entities have declined below their carrying value whenever adverse events or changes in circumstances indicate that recorded values may not be recoverable. &#160;If the Company considers any such decline to be other than temporary (based on various factors, including historical financial results, and the overall health of the investee&#8217;s industry), a write-down to estimated fair value is recorded. Investments represent the Company&#8217;s investment in a Polish based distributor which is primarily engaged in distributing medical products and devices, including those manufactured by the Company, and in certain cases, manufacturing the certain of the products sold. &#160;The Company currently has not written down the investment and has no information that would indicate the carrying value is greater than the fair value.&#160; The Company owns approximately 6% of the investee, and accordingly, applies the cost method to account for the investment. &#160;Under the cost method, investments are recorded at cost, with gains and losses recognized as of the sale date, and income recorded when received.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Payment Arrangement [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">SHARE-BASED COMPENSATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company follows the guidance of the accounting provisions of ASC 718, Share-based Compensation, which requires the use of the fair-value based method to determine compensation expense for all arrangements under which employees and others receive shares of stock or equity instruments (options). The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company&#8217;s common stock estimated over the expected term of the options. The expected forfeiture rate is based on historical forfeitures experienced. The expected term of options granted is derived using the &#8220;simplified method&#8221; which computes expected term as the average of the sum of the vesting term plus the contract term as historically the Company had limited activity surrounding its options. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of<b> </b>the expected term.</span></p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">&#160; </span></p><p style="font-size: 10pt; font-family: 'Courier New'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-family: 'Times New Roman','serif';">The following summary presents the options and warrants granted, exercised, expired, canceled and outstanding for the three months ended August 31, 2021:</span></p><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 48pt;">
<td style="height: 48pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Option Shares</span></p>
</td>
<td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercise Price Weighted Average</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Outstanding May 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,081,366 </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3.59 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Granted </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">24,000 </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">4.25 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercised </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,500)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2.68 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cancelled or expired </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(22,750)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3.02 </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Outstanding August 31, 2021</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">2,081,116 </span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$</span></strong></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">3.60 </span></strong></p>
</td>
</tr>

</table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">During the three months ended August 31, 2021, options to purchase 1,500 shares of common stock were exercised at price of $2.68. Total net proceeds to the Company were $3,895.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">During the three months ended August 31, 2021, the Company granted 24,000 options to purchase common stock at an average purchase price of $4.25. Total net proceeds to the Company were $14,900.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">REVENUE RECOGNITION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The Company has various contracts with customers.&#160; All of the contracts specify that revenues from product sales are recognized at the time the product is shipped, customarily FOB shipping point, which is when the transfer of control of goods has occurred and at which point title passes. The Company does not allow for returns except in the event of defective merchandise and therefore does not establish an allowance for returns. In addition, the Company has contracts with customers wherein they receive purchase discounts for achieving specified sales volumes. The Company evaluated the status of these contracts as of August 31, 2021 and 2020, and does not believe that any additional discounts will be given through the end of the contract periods. </span><span style="FONT-SIZE:10pt">Services for some contract works are invoiced and recognized for work that has been performed as the project progresses. <span style="COLOR:black">The Company sells clinical lab products to domestic and international distributors, including hospitals and clinical laboratories, medical research institutions, medical schools and pharmaceutical companies. OTC products are sold directly to drug stores and e-commerce customers as well as to distributors.&#160; Physicians&#8217; office products are sold to physicians and distributors, all of whom are categorized below according to the type of products sold to them. We also manufacture certain components on a contract basis for domestic and international manufacturers. </span></span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Disaggregation of revenue:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">The following is a breakdown of revenues according to markets to which the products are sold:</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="5" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Three Months Ended</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2020</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Clinical lab</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">886,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">582,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Physician's office</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">257,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">197,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Over-the-counter</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">79,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">185,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Contract Manufacturing</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">40,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">180,000</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,262,000</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,144,000</span></p>
</td>
</tr>

</table><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">See Note 4 for additional information regarding revenue concentrations.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Goods and Service [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">SHIPPING AND HANDLING FEES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The Company includes shipping and handling fees billed to customers in net sales.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">RESEARCH AND DEVELOPMENT</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Research and development costs are expensed as incurred. The Company expensed approximately $440,000 and $712,000 of research and development costs during the three months ended August 31, 2021 and 2020, respectively.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">INCOME TAXES</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: justify; margin: 0in 2.7pt 0pt 0in;"><span style="font-size: 10pt; color: black;">The Company has provided a valuation allowance on deferred income tax assets of approximately $6,226,000 and $5,904,000 as of August 31, 2021 and May 31, 2021, respectively. &#160; </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translations Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">FOREIGN CURRENCY TRANSLATION</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">The subsidiary located in Mexico operates primarily using the Mexican peso. The subsidiary located in Germany operates primarily using the U.S. dollar, with an immaterial amount of transactions occurring using the Euro. Accordingly, assets and liabilities of these subsidiaries are translated using exchange rates in effect at the end of the period, and revenues and costs are translated using average exchange rates for the period. The resulting adjustments to assets and liabilities are presented as a separate component of accumulated other comprehensive loss. There are no adjustments to foreign currency loss that are included in the consolidated statements of operations for the three months ended August 31, 2021 and 2020. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt; COLOR:black">RIGHT-OF-USE ASSETS AND LEASE LIABILITY</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">The Company follows the guidance of ASC 842, Leases, which requires lessees to recognize most leases on the balance sheet with a corresponding right-of-use asset. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The Company leases office space and copy machines, all of which are operating leases. The Company has elected to exclude short-term leases. Most leases include the option to renew and the exercise of the renewal options is at the Company&#8217;s sole discretion. Options to extend or terminate a lease are considered in the lease term to the extent that the option is reasonably certain of exercise.&#160; The leases do not include the options to purchase the leased property.&#160; The depreciable life of assets and leasehold improvements are limited by the expected lease term.</span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">NET LOSS PER SHARE</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 16.2pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt">Basic loss per share is computed as net loss divided by the weighted average number of common shares outstanding for the period. Diluted loss per share reflects the potential dilution that could occur from common shares issuable through stock options, warrants and other convertible securities using the treasury stock method. The total amount of anti-dilutive stock options not included in the loss per share calculation for the three months ended August 31, 2021 and 2020 was 2,081,116 and 1,925,750, respectively. </span></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 2.7pt 0pt 0in"><b><span style="FONT-SIZE:10pt">RECENT ACCOUNTING PRONOUNCEMENTS</span></b></p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in">&#160;</p><p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:justify; MARGIN:0in 2.7pt 0pt 0in"><span style="FONT-SIZE:10pt; COLOR:black">Recent ASUs issued by the FASB and guidance issued by the Securities and Exchange Commission (&#8220;SEC&#8221;) did not, or are not believed by management to, have a material effect on the Company&#8217;s present or future consolidated financial statements. </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_LiquidityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for liquidity position during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_LiquidityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_MarketsAndMethodsOfDistributionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for Markets And Methods Of Distribution during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_MarketsAndMethodsOfDistributionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_PrepaidsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for prepaids.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_PrepaidsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066647775816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">May 31, 2021</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Raw materials</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,493,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,583,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Work in progress</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">926,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,006,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 110.15pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Finished products</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">443,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">617,000</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 110.15pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,862,000</span></p>
</td>
<td style="height: 15.75pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3,206,000</span></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 48pt;">
<td style="height: 48pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Option Shares</span></p>
</td>
<td style="height: 48pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 48pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercise Price Weighted Average</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Outstanding May 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,081,366 </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3.59 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Granted </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">24,000 </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">4.25 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Exercised </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,500)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2.68 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 148.3pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cancelled or expired </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(22,750)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3.02 </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 148.3pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Outstanding August 31, 2021</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">2,081,116 </span></strong></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">$</span></strong></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">3.60 </span></strong></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="5" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Three Months Ended</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2021</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">August 31, 2020</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Clinical lab</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">886,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">582,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Physician's office</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">257,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">197,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Over-the-counter</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">79,000</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">185,000</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 115.9pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Contract Manufacturing</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">40,000</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">180,000</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 115.9pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,262,000</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: windowtext 1pt solid; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,144,000</span></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066637121496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_GeographicInformationDisclosureAbstract', window );"><strong>Geographic Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="WIDTH:550pt; BORDER-COLLAPSE:collapse; ; margin-left: auto; margin-right: auto;" width="733"> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td colspan="5" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">Three Months Ended</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">August 31, 2021</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td colspan="2" style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:center; MARGIN:0in 0in 0pt; text-align: center;"><span style="FONT-SIZE:10pt; COLOR:black">August 31, 2020</span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Revenues from sales to unaffiliated customers:</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 12%; white-space: nowrap;" valign="bottom"/></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Asia</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">675,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">347,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Europe</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">471,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">591,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">North America</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">105,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="HEIGHT:15pt; WIDTH:12%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">134,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">Middle East</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">8,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15pt; WIDTH:12%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">29,000 </span></p></td></tr> <tr style="HEIGHT:15pt"> <td style="HEIGHT:15pt; WIDTH:229.7pt; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0.4in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">South America</span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">3,000 </span></p></td> <td style="HEIGHT:15pt; WIDTH:2%; BACKGROUND:#b8cce4; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:2%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt">&#160;</p></td> <td style="BORDER-TOP:0px; HEIGHT:15pt; BORDER-RIGHT:0px; WIDTH:12%; BACKGROUND:#b8cce4; BORDER-BOTTOM:windowtext 1pt solid; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">43,000 </span></p></td></tr> <tr style="HEIGHT:15.75pt"> <td style="HEIGHT:15.75pt; WIDTH:229.7pt; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; white-space: nowrap;" valign="bottom"/> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,262,000 </span></p></td> <td style="HEIGHT:15.75pt; WIDTH:2%; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"/> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:2%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:0in; width: 2%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; MARGIN:0in 0in 0pt"><span style="FONT-SIZE:10pt; COLOR:black">$</span></p></td> <td style="BORDER-TOP:0px; HEIGHT:15.75pt; BORDER-RIGHT:0px; WIDTH:12%; BORDER-BOTTOM:windowtext 2.25pt double; PADDING-BOTTOM:0in; PADDING-TOP:0in; PADDING-LEFT:0in; BORDER-LEFT:0px; PADDING-RIGHT:2.9pt; width: 12%; white-space: nowrap;" valign="bottom"> <p style="FONT-SIZE:12pt; FONT-FAMILY:&quot;Times New Roman&quot;,&quot;serif&quot;; TEXT-ALIGN:right; MARGIN:0in 0in 0pt; text-align: right;"><span style="FONT-SIZE:10pt; COLOR:black">1,144,000 </span></p></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_GeographicInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_GeographicInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066637121496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Disclosure Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock', window );">Schedule Of Cash Flow Supplemental Disclosures Related To Lease [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Operating cash flows from operating leases&#160;&#160;&#160;&#160;&#160; </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">80,697</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Right-of-use assets obtained in exchange for</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">new operating lease liabilities</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-7">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Weighted average remaining lease term (in years)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">5.02</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 244.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Weighted average discount rate</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">6.50%</span></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 550pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Less than 1 year</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">342,640 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1 to 2 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">352,869 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2 to 3 years</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">363,404 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3 to 4 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 12%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">374,253 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">4 to 5 years</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">385,426 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">5 to 10 years</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">7,517 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total undiscounted lease payments</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 12%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,826,109 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 2.4in; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Less imputed interest</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 2%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15pt; border-right: 0px; width: 12%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">262,244 </span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15.75pt; width: 2.4in; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total operating lease liabilities</span></p>
</td>
<td style="height: 15.75pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 2%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-top: 0px; height: 15.75pt; border-right: 0px; width: 12%; background: #b8cce4; border-bottom: windowtext 2.25pt double; border-left: 0px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,563,865 </span></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information related to lease for the periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066638599416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodAdjustmentAbstract', window );"><strong>Prior Period Adjustment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="width: 732.2px; border-collapse: collapse; margin-left: auto; margin-right: auto; height: 293px;" width="733">

<tr style="height: 0.5in;">
<td style="height: 0px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 77.6667px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 0px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 76.9167px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 0px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 0px; width: 74.9px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cost of sales </span></p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">960,930 </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">64,787 </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,025,717</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Gross Profit </span></p>
</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">182,876 </span></p>
</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(64,787)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">118,089 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Operating Expenses: </span></p>
</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Selling, general and administrative </span></p>
</td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,164,564 </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">141,380 </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,305,944 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 465.583px; white-space: nowrap; padding: 0in 0in 0in 0.15in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Research and development </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">674,693 </span></p>
</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">36,812 </span></p>
</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">711,505 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 451.183px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 0in 0in 0.3in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total operating expense </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">1,839,257 </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 61.9667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">178,192 </span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none solid; border-width: 0px 0px 1pt; height: 15px; width: 62.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,017,449 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 18px;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">Loss from operations</span></td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(1,656,381)</span></td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(242,979)</span></td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(1,899,360)</span></td>
</tr>
<tr style="height: 18px;">
<td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;">&#160;</td>
<td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
</tr>
<tr style="height: 18px;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;"><span style="font-family: times new roman, times, serif; font-size: 10pt;">Loss before income taxes</span></td>
<td style="height: 15px; width: 10.4833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(1,648,290)</span></td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="height: 15px; width: 9.96667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(242,979)</span></td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="height: 15px; width: 7.83333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in; text-align: right;"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">(1,891,269)</span></td>
</tr>
<tr style="height: 18px;">
<td style="width: 479.983px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 10.4833px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 62.2px; white-space: nowrap; padding: 0in 2.9pt 0in 0in; height: 18px;">&#160;</td>
<td style="width: 7.9px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 9.96667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.8333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.01667px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 7.83333px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
<td style="width: 65.95px; white-space: nowrap; padding: 0in; height: 18px;">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,649,415)</span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(242,979)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,892,394)</span></p>
</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 11.6px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 0pt; height: 16px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 16px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 16px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 16.5pt;">
<td style="height: 16px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Basic net loss per common share </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.14)</span></p>
</td>
<td style="height: 16px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.02)</span></p>
</td>
<td style="height: 16px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 16px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.16)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Diluted net loss per common share </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 66.0667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.14)</span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.02)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(0.16)</span></p>
</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 10.4833px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 66.0667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.9px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 9.96667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.8333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.01667px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 7.83333px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15px; width: 65.95px; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15.75pt;">
<td style="height: 15px; width: 479.983px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Comprehensive loss </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.6px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 62.2px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,651,136) </span></p>
</td>
<td style="height: 15px; width: 7.9px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 11.0833px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.8333px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(242,979)</span></p>
</td>
<td style="height: 15px; width: 7.01667px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 8.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$ </span></p>
</td>
<td style="border-color: currentcolor currentcolor windowtext; border-style: none none double; border-width: 0px 0px 2.25pt; height: 15px; width: 65.95px; background: #b8cce4 none repeat scroll 0% 0%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,894,115)</span></p>
</td>
</tr>

</table><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 33pt;">
<td style="height: 33pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 9.66%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 33pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 33pt; border-right: 0px; width: 10.6%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Shareholders' Equity:</span></strong></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 8.58%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 9.54%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 8.58%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 9.54%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Additional paid-in-capital</span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">36,685,176 </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">2,151,567 </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">38,836,743 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Accumulated deficit</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(28,394,768)</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(2,151,567)</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(30,546,335)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Other Equity accounts</span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">936,615 </span></p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"><div style="-sec-ix-hidden: hidden-fact-8">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 1.06%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">936,615 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 67.02%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Total Shareholders' Equity</span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">9,227,023 </span></p>
</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;"><div style="-sec-ix-hidden: hidden-fact-9">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 1.06%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">9,227,023 </span></p>
</td>
</tr>

</table><table cellpadding="0" cellspacing="0" style="width: 550.1pt; border-collapse: collapse; ; margin-left: auto; margin-right: auto;" width="733">

<tr style="height: 37.5pt;">
<td style="height: 37.5pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Previously Reported</span></p>
</td>
<td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Adjustments</span></p>
</td>
<td style="height: 37.5pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td colspan="2" style="border-top: 0px; height: 37.5pt; border-right: 0px; width: 10%; border-bottom: windowtext 1pt solid; border-left: 0px; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: center; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">As Restated</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Cash flows from operating activities:</span></strong></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net loss</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,649,415)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(242,979)</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,892,394)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><strong><span style="font-size: 10pt; color: black;">Adjustments to reconcile net loss to net cash used in operating activities: </span></strong></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Stock option expense</span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">3,808 </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">242,979 </span></p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">246,787 </span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Net cash used in operating activities </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,597,146)</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-10">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">(1,597,146)</span></p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 2%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;">&#160;</p>
</td>
<td style="height: 15pt; width: 10%; background: #b8cce4; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;">&#160;</p>
</td>
</tr>
<tr style="height: 15pt;">
<td style="height: 15pt; width: 370.1pt; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">Cash and cash equivalents at end of period</span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">6,964,314 </span></p>
</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom"><span style="font-size: 10pt; color: black; font-family: times new roman, times, serif;">$</span></td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in; text-align: right;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-11">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">&#160;- </span></p>
</div></td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">&#160;</td>
<td style="height: 15pt; width: 2%; white-space: nowrap; padding: 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">$</span></p>
</td>
<td style="height: 15pt; width: 10%; white-space: nowrap; padding: 0in 2.9pt 0in 0in;" valign="bottom">
<p style="font-size: 12pt; font-family: 'Times New Roman','serif'; text-align: right; margin: 0in 0in 0pt;"><span style="font-size: 10pt; color: black;">6,964,314 </span></p>
</td>
</tr>

</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066634559000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Jan. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="num">$ (32,088,916)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,546,335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue', window );">Shelf Registration Statement, Maximum Authorized Common Stock Issuance, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash, Uninsured Amount</a></td>
<td class="nump">$ 4,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable', window );">Threshold Period Past Due for Write-off of Trade Accounts Receivable</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent', window );">Allowance for Credit Loss, Receivable, Other, Current</a></td>
<td class="nump">$ 743,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid Expense and Other Assets</a></td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInventory', window );">Other Inventory, Gross</a></td>
<td class="nump">211,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory Valuation Reserves</a></td>
<td class="nump">1,797,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,617,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">Inventory, LIFO Reserve</a></td>
<td class="nump">1,683,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation, Depletion and Amortization</a></td>
<td class="nump">27,809<span></span>
</td>
<td class="nump">$ 26,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 6,913<span></span>
</td>
<td class="nump">5,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="nump">$ 3,895<span></span>
</td>
<td class="nump">14,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Other Research and Development Expense</a></td>
<td class="nump">440,000<span></span>
</td>
<td class="nump">$ 712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred Tax Assets, Valuation Allowance</a></td>
<td class="nump">$ 6,226,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
<td class="nump">2,081,116<span></span>
</td>
<td class="nump">1,925,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 2.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="nump">$ 3,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)</a></td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_ProceedsFromStockOptionsGranted', window );">Proceeds from Stock Options Granted</a></td>
<td class="nump">$ 14,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember', window );">Distribution Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmra_PurchasedTechnologyRightsMember', window );">Purchased Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Two Distributors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Distributors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Cost of Goods and Service, Product and Service Benchmark [Member] | One Vendor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Cost of Goods and Service, Product and Service Benchmark [Member] | Two Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Accounts Payable [Member] | One Vendor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_ProceedsFromStockOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from granted of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_ProceedsFromStockOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount related with Maximum Authorized Common Stock Issuance of Shelf Registration Statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on receivable, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period past due for trade accounts receivable to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmra_PurchasedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bmra_PurchasedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_TwoDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_TwoDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_OneVendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_OneVendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_TwoVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_TwoVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066641929432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_InventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 1,493,000<span></span>
</td>
<td class="nump">$ 1,583,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">926,000<span></span>
</td>
<td class="nump">1,006,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished products</a></td>
<td class="nump">443,000<span></span>
</td>
<td class="nump">617,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 2,861,779<span></span>
</td>
<td class="nump">$ 3,206,255<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_InventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_InventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066648984040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity - Share-based Payment Arrangement, Option [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares | shares | shares</a></td>
<td class="nump">2,081,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Option Outstanding, Exercise Price Weighted Average | $ / shares | $ / shares</a></td>
<td class="nump">$ 3.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option Granted, Shares | shares | shares</a></td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Option Granted, Exercise Price Weighted Average | $ / shares | $ / shares</a></td>
<td class="nump">$ 4.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Option Exercised, Shares | shares | shares</a></td>
<td class="num">(1,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option Exercised, Exercise Price Weighted Average | $ / shares | $ / shares</a></td>
<td class="nump">$ 2.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Option Cancelled or expired, Shares | shares | shares</a></td>
<td class="num">(22,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Option Cancelled or expired, Exercise Price Weighted Average | $ / shares | $ / shares</a></td>
<td class="nump">$ 3.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Shares | shares | shares</a></td>
<td class="nump">2,081,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Option Outstanding, Exercise Price Weighted Average | $ / shares | $ / shares</a></td>
<td class="nump">$ 3.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066647978744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">$ 1,262,000<span></span>
</td>
<td class="nump">$ 1,144,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bmra_ClinicalLabMember', window );">Clinical Lab [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">886,000<span></span>
</td>
<td class="nump">582,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bmra_PhysiciansOfficeMember', window );">Physicians Office [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">257,000<span></span>
</td>
<td class="nump">197,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bmra_OverthecounterMember', window );">Over-the-counter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">79,000<span></span>
</td>
<td class="nump">185,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=bmra_ContractManufacturingMember', window );">Contract Manufacturing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue From Customers</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bmra_ClinicalLabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bmra_ClinicalLabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bmra_PhysiciansOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bmra_PhysiciansOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bmra_OverthecounterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bmra_OverthecounterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=bmra_ContractManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=bmra_ContractManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066634430680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="nump">$ 800,710<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 319,622<span></span>
</td>
<td class="nump">$ 246,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of Stock, Number of Shares Issued in Transaction (in Shares)</a></td>
<td class="nump">201,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of Stock, Consideration Received on Transaction</a></td>
<td class="nump">$ 838,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="nump">$ 800,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share (in Dollars per share)</a></td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems', window );"><strong>SHAREHOLDERS' EQUITY (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share (in Dollars per share)</a></td>
<td class="nump">$ 4.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SHAREHOLDERSEQUITYDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SHAREHOLDERSEQUITYDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066647582664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION (Details) - MEXICO<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_GEOGRAPHICINFORMATIONDetailsLineItems', window );"><strong>GEOGRAPHIC INFORMATION (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory, Gross</a></td>
<td class="nump">$ 665,000<span></span>
</td>
<td class="nump">$ 803,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_GEOGRAPHICINFORMATIONDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_GEOGRAPHICINFORMATIONDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066662206008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">$ 1,261,787<span></span>
</td>
<td class="nump">$ 1,143,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">675,000<span></span>
</td>
<td class="nump">347,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">471,000<span></span>
</td>
<td class="nump">591,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">105,000<span></span>
</td>
<td class="nump">134,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember', window );">Middle East [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_SouthAmericaMember', window );">South America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract', window );"><strong>Revenues from sales to unaffiliated customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Sales</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 43,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_MiddleEastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_MiddleEastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_SouthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_SouthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066635591784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 01, 2021</div></th>
<th class="th"><div>Nov. 01, 2016</div></th>
<th class="th"><div>Jun. 18, 2009</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,166<span></span>
</td>
<td class="nump">$ 75,764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=bmra_BuildingInIrvineCaliforniaMember', window );">Building In Irvine California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_OperatingLeaseInitiationDate', window );">Operating Lease Initiation Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 31,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=bmra_BuildingInIrvineCaliforniaMember', window );">Building In Irvine California [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="nump">$ 25,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RentPercentage', window );">Rent Percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertyAvailableForOperatingLeaseMember', window );">Property Available for Operating Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LeaseAmendmentAxis=bmra_FirstAmendmentToLeaseMember', window );">First Amendment To Lease [Member] | Building In Irvine California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MX', window );">MEXICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,421<span></span>
</td>
<td class="nump">$ 10,870<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MX', window );">MEXICO | Property Available for Operating Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_LEASESDetailsLineItems', window );"><strong>LEASES (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Operating Leases, Rent Expense, Minimum Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_LEASESDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_LEASESDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_OperatingLeaseInitiationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the operating lease was initiated, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_OperatingLeaseInitiationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_RentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rent percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_RentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123403832&amp;loc=d3e34039-112682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseMinimumRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=bmra_BuildingInIrvineCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=bmra_BuildingInIrvineCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertyAvailableForOperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis=us-gaap_PropertyAvailableForOperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_LeaseAmendmentAxis=bmra_FirstAmendmentToLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_LeaseAmendmentAxis=bmra_FirstAmendmentToLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066641312776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - Supplemental cash flow information related to leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract', window );"><strong>Supplemental cash flow information related to leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 80,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_RightOfUseAssetsObtainedInExchangeForAbstract', window );"><strong>Right-of-use assets obtained in exchange for</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">5 years 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">6.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_RightOfUseAssetsObtainedInExchangeForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_RightOfUseAssetsObtainedInExchangeForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066641605608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details) - The maturity of lease liabilities<br></strong></div></th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmra_TheMaturityOfLeaseLiabilitiesAbstract', window );"><strong>The maturity of lease liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Less than 1 year</a></td>
<td class="nump">$ 342,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">1 to 2 years</a></td>
<td class="nump">352,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2 to 3 years</a></td>
<td class="nump">363,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">3 to 4 years</a></td>
<td class="nump">374,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">4 to 5 years</a></td>
<td class="nump">385,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">5 to 10 years</a></td>
<td class="nump">7,517<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">1,826,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="nump">262,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 1,563,865<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmra_TheMaturityOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmra_TheMaturityOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmra_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140066639132760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>May 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">$ 960,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">182,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">1,164,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">674,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="nump">1,839,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,656,381)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(1,648,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,649,415)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (1,651,136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid-in-capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,685,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,394,768)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other Equity accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,227,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(1,649,415)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">3,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(1,597,146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">6,964,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Revision of Prior Period, Error Correction, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">64,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="num">(64,787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">141,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">36,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="nump">178,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(242,979)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(242,979)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (242,979)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (242,979)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid-in-capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,151,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,151,567)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other Equity accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(242,979)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">242,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=bmra_RestatementOfCompanysFinancialStatementsMember', window );">Restatement Of Companys Financial Statements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,025,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">118,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">1,305,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">711,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expense</a></td>
<td class="nump">2,017,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(1,899,360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(1,891,269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,892,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share (in Dollars per share)</a></td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (1,894,115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid-in-capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,836,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,546,335)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other Equity accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,227,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(1,892,394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option expense</a></td>
<td class="nump">246,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(1,597,146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 6,964,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=bmra_RestatementOfCompanysFinancialStatementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=bmra_RestatementOfCompanysFinancialStatementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>42
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M516 UIP5;XA9::S8VLS[2O0]QPU.L)HDHSAV Z<'+&G!$GM%R"WEJ.JKMEK
M;8O&KM7]67;(4JHJ 'Y9*2FGT+HR/8(Q#.Z)<T'D=(O (!4Y,>YQO^WXV-[R
M]5P]4UC.T1HBDLFKN</6ICKSY;K^21T8):,8"*,ON5H:P'8>@,9ZR/0:$##_
M'K*AV<<.[E*"20QCTE>W+2-@.R4H0LTAPD9HP0E1JNPG?H2[Z$R244S<N*<#
MXI8.<&@%>)6(;(7*&B:"<D40T *B*[8)I,195J(9R_.$5Q_U6_.ZK!HH/ ;I
MG&/2]<4LUK,XP"T#83L%S;)\+VGZ_[@2_9DK9K$^5UI:PK&U(WW3.P?P)3E
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M++W<J\,RYDF ^G[+F'P;),>QXO@]^Q]02P,$%     @ 88=.4]?PL@Y:!0
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MN\'/YS .TSE40"C13?CC E'\.R(6L4REM'?E%J[R)OLR((Z'[7[OY7C;=51
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M";4+H/-"43OZ!T<P?/!6/P!02P,$%     @ 88=.4\MN<X]& P  '@<  !D
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M]HY<VLNE7B[]_W+WN+>P%"I[_/9:O=_GO[ZY7T%Z":_?']Q7"%>J;I@\ 'W
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M Q=?]" 2J(DMMC"J)Q1B< GQW=86&YOXN5C]$C&1M*KV!3T0GRBU:H?-+L3
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M*$L7\/O:&-]^(0/=VZGK_P!02P,$%     @ 88=.4X"J=)HN!@  B0T  !D
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MU.-8D"!?5'PZ*SBN=Z!&FP[V\<HKE4N5"-4J&K44^SB:H%=\  N+@U4:'/J
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M!BZLXI#.DADL/.KZ$9UY,^<7)36JEVMA'"_Q:3*+G3<=X]CQO(2Z2>K<=F%
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M._M;8^_(0/F78N=92I^G]B+;5TKW=W3&XOH!BA6]^XWO1\,[^MSK2V\7KD-
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M]QQ>FHJ::\9SLA0E2QDH\GVR5EIBJ?RXH"!N%<1607PNMMA!65T"$1LRYV_
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M@I?-HFHN6FSM<E@+C:O&D@7N=I"& =\W0NCWBU'0_EL8_P]02P,$%     @
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MW[L)1CMW<<W5RKTX-';A[Z_E[>SV43/M[_)?ZOV+Z(JIE8!64O$EF'I'233
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M@F:]JJY7YE'LI*(TU:+!\QYHX[+S:7B(B*CK X4P(-)<]+)M&==HH-=8MTH
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M7 /4^9HQ^1[H.=+];23_ 5!+ P04    " !AATY3\F&VNR(#  #?"@  &0
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M'XWY[O"\:TB6FL/>C$EU=#2W:X(7A.L.ZOV2,;EOZ/-C\1=&_W]02P,$%
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MMD*G?C28/'O[DJ=^&+_W/4N7R9RF_NWIVY^MU!=O/'L_>7=R,KH]NSBVGW;
MF1\X22=/(#T?X;P&PZCC)U$_PMP1!WURYK-"BL,<@<%$)A7U[@A/_8QPME ,
MO I2,;ZQYC$8EI)+Y6E3'",E!$MS;^'0SJ!N/4_%A%1=;!O!?B_ZY4? =@8"
M&>>#P+%O#?-93;2F2ER:2;>X,SZ O'Y\LZF-PE*133B>^#N'[F:"+*3*J1K"
MA/[6-)]Q6H <Q<H5W+6L P"UEI49Y(R44I!.P]:C'QC:)>7\&IKZ1W' O2[V
M:CJ"BHIA: 3U0TMC)\"_SV:Y]VB39]%Z-;N3^G-K=B.Z.;0*O5*T8.MNOBZ&
M^!A[B+.3NN:;3YR5HJ)V[T\..)^1K9^WDHK=FVC0*4MCH,KW[JC2;+EO^:5(
M?4/7>MM-ZP+7/'Z%FO]NGDLJJ")\7[1I_9><Y6<KCC[\*\G=C\JQ8*?&_J!Z
MZ2(GKT%D_")%!OT/^MZI<7!F#%8/SN;4_PYO 7P7U%NTC&LF^MF*Y3D5#XX.
M0Z_)PKQE'?";]3DM2,OUS0"F_F[\C>:LK9)AU14DHE^U&W^%[87Q\&)@8C&1
MTS7-LWZJRD4W],S 1.TO<#A&+KO+C6 ^%G,C@&%Q, 68C_7"XOQ/^YFB^[$8
MIFWJ1*:HSQ3UL5XN).L^6!RW3V(N]TZ3)(KB&,MHECD59%C>XAC^W&R8-O#
MXD"D/\LU7FV\0Q[O ZRFCW4(ME.\$[&=XKD&Q)TW\$@2=[6Q.."!50'K'8CO
MC@,]Y?:)(J@JI@U[@G$D23 $>M'=HW&,9">&C[L^V%,214GB1@!S*X@B#(&G
M$4<P!: !0Z*H.P>/SJ-@>TX%NW\]S'\#4$L#!!0    ( &&'3E.7BKL<P
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M2P$"% ,4    " !AATY3.=D!].\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !AATY3F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( &&'3E-6)D=&-04  ' 5   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !AATY3'G[_G2X%  !/$@
M&               @(%Y#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ 88=.4^T^0%D&!P  V!T  !@              ("!W1(  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( &&'3E/X\W)%! 0
M (H/   8              " @1D:  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " !AATY3U_"R#EH%  "$%0  &               @(%3
M'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 88=.4]DU
MR#ML!@  2!@  !@              ("!XR,  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( &&'3E-L>@)*8 H  ,\8   8
M  " @84J  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !A
MATY39,NDIS<>  #P40  &               @($;-0  >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ 88=.4RC>C'Y6 P  _ 8  !@
M         ("!B%,  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( &&'3E/+;G./1@,  !X'   9              " @117  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ 88=.4\DZ*A$3"   J1(
M !D              ("!D5H  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " !AATY3@*ITFBX&  ")#0  &0              @(';8@
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( &&'3E-Q'8L6
M^ $  &H$   9              " @4!I  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ 88=.4U\U:2^X!@  "!   !D
M ("!;VL  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !A
MATY329O$]5 @  !L8   &0              @(%><@  >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( &&'3E/>+J8)K ,  #D(   9
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M970R,"YX;6Q02P$"% ,4    " !AATY3AVCO6'0"  !"!@  &0
M    @(&*J@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M &&'3E/R8;:[(@,  -\*   9              " @36M  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ 88=.4T,<%L\G P  ! L  !D
M             ("!CK   'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " !AATY3;,5YL(D#  !\#   &0              @('LLP  >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( &&'3E/C06SS@P(
M #,&   9              " @:RW  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ 88=.4TA,,#$\ P  +@P  !D              ("!
M9KH  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " !AATY3
M!L9"U_D#  #.$   &0              @('9O0  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( &&'3E.=W:BVO@(  #T'   9
M      " @0G"  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ 88=.4]J&!4^R @  S <  !D              ("!_L0  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !AATY32U!5;0X(  !=*P
M&0              @('GQP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( &&'3E-#0V,K"P,  (<0   -              "  2S0  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ 88=.4Y>*NQS     $P(   L
M         ( !8M,  %]R96QS+RYR96QS4$L! A0#%     @ 88=.4VH9-C$Z
M P  L!0   \              ( !2]0  'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( &&'3E-DA-5Z5P$  )$2   :              "  ;+7  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( &&'3E,Y:2-U@@$
M $P3   3              "  4'9  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     F "8 00H  /3:      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>97</ContextCount>
  <ElementCount>275</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>40</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ConsolidatedCashFlow</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SHAREHOLDERSEQUITY</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - GEOGRAPHIC INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/GEOGRAPHICINFORMATION</Role>
      <ShortName>GEOGRAPHIC INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - GEOGRAPHIC INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables</Role>
      <ShortName>GEOGRAPHIC INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/GEOGRAPHICINFORMATION</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/LEASES</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/InventoriesTable</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/OptionsActivityTable</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/SHAREHOLDERSEQUITY</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - GEOGRAPHIC INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails</Role>
      <ShortName>GEOGRAPHIC INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable</Role>
      <ShortName>GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/LEASESDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/LEASESTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - LEASES (Details) - Supplemental cash flow information related to leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable</Role>
      <ShortName>LEASES (Details) - Supplemental cash flow information related to leases</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/LEASESTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - LEASES (Details) - The maturity of lease liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable</Role>
      <ShortName>LEASES (Details) - The maturity of lease liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/LEASESTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bmra-20210831.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bmra-20210831.htm">bmra-20210831.htm</File>
    <File>bmra-20210831.xsd</File>
    <File>bmra-20210831_cal.xml</File>
    <File>bmra-20210831_def.xml</File>
    <File>bmra-20210831_lab.xml</File>
    <File>bmra-20210831_pre.xml</File>
    <File>exhibit31_1.htm</File>
    <File>exhibit31_2.htm</File>
    <File>exhibit32_1.htm</File>
    <File>exhibit32_2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>47
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bmra-20210831.htm": {
   "axisCustom": 1,
   "axisStandard": 14,
   "contextCount": 97,
   "dts": {
    "calculationLink": {
     "local": [
      "bmra-20210831_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bmra-20210831_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bmra-20210831.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmra-20210831_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmra-20210831_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bmra-20210831.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 329,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 12,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 17
   },
   "keyCustom": 13,
   "keyStandard": 262,
   "memberCustom": 12,
   "memberStandard": 26,
   "nsprefix": "bmra",
   "nsuri": "http://www.biomerica.com/20210831",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.biomerica.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmra:GeographicInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - GEOGRAPHIC INFORMATION",
     "role": "http://www.biomerica.com/role/GEOGRAPHICINFORMATION",
     "shortName": "GEOGRAPHIC INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmra:GeographicInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - LEASES",
     "role": "http://www.biomerica.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.biomerica.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS",
     "role": "http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Accounting Policies, by Policy (Policies)",
     "role": "http://www.biomerica.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - GEOGRAPHIC INFORMATION (Tables)",
     "role": "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables",
     "shortName": "GEOGRAPHIC INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - LEASES (Tables)",
     "role": "http://www.biomerica.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)",
     "role": "http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)",
     "role": "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "role": "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c35",
      "decimals": "0",
      "lang": null,
      "name": "bmra:ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories",
     "role": "http://www.biomerica.com/role/InventoriesTable",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c51",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity",
     "role": "http://www.biomerica.com/role/OptionsActivityTable",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c51",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers",
     "role": "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - SHAREHOLDERS' EQUITY (Details)",
     "role": "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
     "shortName": "SHAREHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c49",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c64",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - GEOGRAPHIC INFORMATION (Details)",
     "role": "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails",
     "shortName": "GEOGRAPHIC INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c64",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales",
     "role": "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable",
     "shortName": "GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c67",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - LEASES (Details)",
     "role": "http://www.biomerica.com/role/LEASESDetails",
     "shortName": "LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - LEASES (Details) - Supplemental cash flow information related to leases",
     "role": "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable",
     "shortName": "LEASES (Details) - Supplemental cash flow information related to leases",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "bmra:ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - LEASES (Details) - The maturity of lease liabilities",
     "role": "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable",
     "shortName": "LEASES (Details) - The maturity of lease liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c85",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows",
     "role": "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c85",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "role": "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c8",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)",
     "role": "http://www.biomerica.com/role/ShareholdersEquityType2or3",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c8",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://www.biomerica.com/role/ConsolidatedCashFlow",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "006 - Disclosure - BASIS OF PRESENTATION",
     "role": "http://www.biomerica.com/role/BASISOFPRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - SHAREHOLDERS' EQUITY",
     "role": "http://www.biomerica.com/role/SHAREHOLDERSEQUITY",
     "shortName": "SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmra-20210831.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 40,
   "tag": {
    "bmra_A5ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "A5ConvertiblePreferredStockMember",
        "terseLabel": "5% Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "A5ConvertiblePreferredStockMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_BuildingInIrvineCaliforniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BuildingInIrvineCaliforniaMember",
        "terseLabel": "Building In Irvine California [Member]"
       }
      }
     },
     "localname": "BuildingInIrvineCaliforniaMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_CashPaidDuringThePeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CashPaidDuringThePeriodForAbstract",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringThePeriodForAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_ClinicalLabMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ClinicalLabMember",
        "terseLabel": "Clinical Lab [Member]"
       }
      }
     },
     "localname": "ClinicalLabMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_ContractManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ContractManufacturingMember",
        "terseLabel": "Contract Manufacturing [Member]"
       }
      }
     },
     "localname": "ContractManufacturingMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_FirstAmendmentToLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FirstAmendmentToLeaseMember",
        "terseLabel": "First Amendment To Lease [Member]"
       }
      }
     },
     "localname": "FirstAmendmentToLeaseMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales [Line Items]"
       }
      }
     },
     "localname": "GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesLineItems",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION (Details) - Geographic information regarding net sales [Table]"
       }
      }
     },
     "localname": "GEOGRAPHICINFORMATIONDetailsGeographicinformationregardingnetsalesTable",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_GEOGRAPHICINFORMATIONDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION (Details) [Line Items]"
       }
      }
     },
     "localname": "GEOGRAPHICINFORMATIONDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_GEOGRAPHICINFORMATIONDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION (Details) [Table]"
       }
      }
     },
     "localname": "GEOGRAPHICINFORMATIONDetailsTable",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_GeographicInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "GeographicInformationDisclosureAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_GeographicInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments according to the geographic areas.",
        "label": "GeographicInformationDisclosureTextBlock",
        "terseLabel": "Geographic Information Disclosure [Text Block]"
       }
      }
     },
     "localname": "GeographicInformationDisclosureTextBlock",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_GeographicInformationRegardingNetSalesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic information regarding net sales [Abstract]"
       }
      }
     },
     "localname": "GeographicInformationRegardingNetSalesAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_IncreaseDecreaseInLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in LeaseLiability",
        "label": "Reduction in lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseLiability",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmra_InventoriesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories [Abstract]"
       }
      }
     },
     "localname": "InventoriesAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_LEASESDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES (Details) [Line Items]"
       }
      }
     },
     "localname": "LEASESDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_LEASESDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES (Details) [Table]"
       }
      }
     },
     "localname": "LEASESDetailsTable",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_LeaseAmendmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseAmendmentAxis",
        "terseLabel": "Lease Amendment [Axis]"
       }
      }
     },
     "localname": "LeaseAmendmentAxis",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_LeaseAmendmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseAmendment [Domain]"
       }
      }
     },
     "localname": "LeaseAmendmentDomain",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_LiquidityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for liquidity position during the period.",
        "label": "LiquidityPolicyTextBlock",
        "terseLabel": "Liquidity [Policy Text Block]"
       }
      }
     },
     "localname": "LiquidityPolicyTextBlock",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_MarketsAndMethodsOfDistributionPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for Markets And Methods Of Distribution during the period.",
        "label": "MarketsAndMethodsOfDistributionPolicyTextBlock",
        "terseLabel": "Markets And Methods Of Distribution [Policy Text Block]"
       }
      }
     },
     "localname": "MarketsAndMethodsOfDistributionPolicyTextBlock",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_OneVendorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OneVendorMember",
        "terseLabel": "One Vendor [Member]"
       }
      }
     },
     "localname": "OneVendorMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_OperatingLeaseInitiationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the operating lease was initiated, in CCYY-MM-DD format.",
        "label": "OperatingLeaseInitiationDate",
        "terseLabel": "Operating Lease Initiation Date"
       }
      }
     },
     "localname": "OperatingLeaseInitiationDate",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from operating lease",
        "label": "Accumulated amortization, Right of Use Assets (in Dollars)"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmra_OperatingLeaseRightofUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Right of Use Asset for Operating Lease.",
        "label": "Amortization of right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightofUseAssetAmortization",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmra_OptionsActivityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Activity [Abstract]"
       }
      }
     },
     "localname": "OptionsActivityAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_OverthecounterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OverthecounterMember",
        "terseLabel": "Over-the-counter [Member]"
       }
      }
     },
     "localname": "OverthecounterMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_PhysiciansOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PhysiciansOfficeMember",
        "terseLabel": "Physicians Office [Member]"
       }
      }
     },
     "localname": "PhysiciansOfficeMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_PreferredStockUndesignatedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of preferred shares undesignated during the period.",
        "label": "Preferred Stock, undesignated shares"
       }
      }
     },
     "localname": "PreferredStockUndesignatedShares",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "bmra_PrepaidsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for prepaids.",
        "label": "PrepaidsPolicyPolicyTextBlock",
        "terseLabel": "Prepaids Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PrepaidsPolicyPolicyTextBlock",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_ProceedsFromStockOptionsGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from granted of option under share-based payment arrangement.",
        "label": "ProceedsFromStockOptionsGranted",
        "terseLabel": "Proceeds from Stock Options Granted"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsGranted",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmra_PropertySubjectToOrAvailableForOperatingLease_Domain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PropertySubjectToOrAvailableForOperatingLease_ [Domain]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLease_Domain",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_PurchasedTechnologyRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PurchasedTechnologyRightsMember",
        "terseLabel": "Purchased Technology Rights [Member]"
       }
      }
     },
     "localname": "PurchasedTechnologyRightsMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_RentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rent percentage.",
        "label": "RentPercentage",
        "terseLabel": "Rent Percentage"
       }
      }
     },
     "localname": "RentPercentage",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmra_RestatementOfCompanysFinancialStatementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RestatementOfCompanysFinancialStatementsMember",
        "terseLabel": "Restatement Of Companys Financial Statements [Member]"
       }
      }
     },
     "localname": "RestatementOfCompanysFinancialStatementsMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows [Abstract]"
       }
      }
     },
     "localname": "RestatementOnTheConsolidatedStatementOfOperationsTheConsolidatedBalanceAndTheConsolidatedStatementOfCashFlowsAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_RevenueFromContractsWithCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractsWithCustomersAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RevenuesFromSalesToUnaffiliatedCustomersAbstract",
        "terseLabel": "Revenues from sales to unaffiliated customers:"
       }
      }
     },
     "localname": "RevenuesFromSalesToUnaffiliatedCustomersAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_RightOfUseAssetsObtainedInExchangeForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RightOfUseAssetsObtainedInExchangeForAbstract",
        "terseLabel": "Right-of-use assets obtained in exchange for"
       }
      }
     },
     "localname": "RightOfUseAssetsObtainedInExchangeForAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SHAREHOLDERSEQUITYDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY (Details) [Line Items]"
       }
      }
     },
     "localname": "SHAREHOLDERSEQUITYDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SHAREHOLDERSEQUITYDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY (Details) [Table]"
       }
      }
     },
     "localname": "SHAREHOLDERSEQUITYDetailsTable",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Line Items]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity [Table]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES (Details) [Table]"
       }
      }
     },
     "localname": "SIGNIFICANTACCOUNTINGPOLICIESDetailsTable",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information related to lease for the periods.",
        "label": "ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
        "terseLabel": "Schedule Of Cash Flow Supplemental Disclosures Related To Lease [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmra_ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount related with Maximum Authorized Common Stock Issuance of Shelf Registration Statement.",
        "label": "ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue",
        "terseLabel": "Shelf Registration Statement, Maximum Authorized Common Stock Issuance, Value"
       }
      }
     },
     "localname": "ShelfRegistrationStatementMaximumAuthorizedCommonStockIssuanceValue",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information related to leases [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationRelatedToLeasesAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_TheMaturityOfLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The maturity of lease liabilities [Abstract]"
       }
      }
     },
     "localname": "TheMaturityOfLeaseLiabilitiesAbstract",
     "nsuri": "http://www.biomerica.com/20210831",
     "xbrltype": "stringItemType"
    },
    "bmra_TwoDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TwoDistributorsMember",
        "terseLabel": "Two Distributors [Member]"
       }
      }
     },
     "localname": "TwoDistributorsMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmra_TwoVendorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TwoVendorsMember",
        "terseLabel": "Two Vendors [Member]"
       }
      }
     },
     "localname": "TwoVendorsMember",
     "nsuri": "http://www.biomerica.com/20210831",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_MX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MEXICO",
        "terseLabel": "MEXICO"
       }
      }
     },
     "localname": "MX",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails",
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security",
        "terseLabel": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.biomerica.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia [Member]",
        "terseLabel": "Asia [Member]"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r229",
      "r232",
      "r259",
      "r260",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r396",
      "r398",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r229",
      "r232",
      "r259",
      "r260",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r396",
      "r398",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "terseLabel": "North America [Member]"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r229",
      "r232",
      "r257",
      "r259",
      "r260",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r396",
      "r398",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r229",
      "r232",
      "r257",
      "r259",
      "r260",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r396",
      "r398",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Error Correction, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Error Correction, Adjustment [Member]"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r1",
      "r98",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r108",
      "r109",
      "r111",
      "r112",
      "r124",
      "r185",
      "r186",
      "r281",
      "r293",
      "r304",
      "r305",
      "r306",
      "r307",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported [Member]"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r167",
      "r168",
      "r248",
      "r250",
      "r397",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable",
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SouthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "South America [Member]",
        "terseLabel": "South America [Member]"
       }
      }
     },
     "localname": "SouthAmericaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r167",
      "r168",
      "r248",
      "r250",
      "r397",
      "r410",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails",
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable",
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]",
        "terseLabel": "Accounts Payable [Member]"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r17",
      "r171",
      "r172"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable, less allowance for doubtful accounts of $742,524 and $837,415 as of August 31, 2021 and May 31, 2021, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r35",
      "r208"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated depreciation and amortization (in Dollars)"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r20",
      "r53",
      "r54",
      "r55",
      "r383",
      "r404",
      "r408"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r52",
      "r55",
      "r62",
      "r63",
      "r64",
      "r98",
      "r99",
      "r100",
      "r301",
      "r399",
      "r400",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r18",
      "r281",
      "r343"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid-in-capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r98",
      "r99",
      "r100",
      "r278",
      "r279",
      "r280",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "Compensation expense in connection with options granted"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:",
        "verboseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r262",
      "r275",
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based Payment Arrangement, Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r24",
      "r177",
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance for doubtful accounts (in Dollars)"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on receivable, classified as other and current.",
        "label": "Allowance for Credit Loss, Receivable, Other, Current",
        "terseLabel": "Allowance for Credit Loss, Receivable, Other, Current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulOtherReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r83",
      "r198",
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r95",
      "r153",
      "r158",
      "r164",
      "r183",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r298",
      "r302",
      "r310",
      "r341",
      "r343",
      "r372",
      "r382"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r50",
      "r95",
      "r183",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r298",
      "r302",
      "r310",
      "r341",
      "r343"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r263",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Accounting [Text Block]"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/BASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r33",
      "r85"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents at end of period",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r78",
      "r313"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, Uninsured Amount",
        "terseLabel": "Cash, Uninsured Amount"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r93",
      "r95",
      "r115",
      "r116",
      "r117",
      "r119",
      "r121",
      "r128",
      "r129",
      "r130",
      "r183",
      "r218",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r230",
      "r231",
      "r234",
      "r238",
      "r310",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r41",
      "r216",
      "r374",
      "r387"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingencies (Notes 1 and 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r217",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies Disclosure [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r98",
      "r99",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock par value (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16",
      "r343"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.08 par value, 25,000,000 shares authorized, 12,510,210 and 12,307,157 issued and outstanding at August 31, 2021 and May 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r57",
      "r59",
      "r60",
      "r68",
      "r377",
      "r390"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive loss",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r308",
      "r309",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r308",
      "r309",
      "r409",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r308",
      "r309",
      "r409",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r133",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration Risk, Credit Risk, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r137",
      "r138",
      "r170",
      "r308",
      "r309",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r72",
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsProductLineMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.",
        "label": "Cost of Goods and Service, Product and Service Benchmark [Member]",
        "terseLabel": "Cost of Goods and Service, Product and Service Benchmark [Member]"
       }
      }
     },
     "localname": "CostOfGoodsProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r73",
      "r95",
      "r183",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r310"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "negatedTerseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Goods and Service [Policy Text Block]"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r136",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Deferred Tax Assets, Valuation Allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r83",
      "r207"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r83",
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation, Depletion and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Text Block [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DistributionRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
        "label": "Distribution Rights [Member]",
        "terseLabel": "Distribution Rights [Member]"
       }
      }
     },
     "localname": "DistributionRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r69",
      "r103",
      "r104",
      "r106",
      "r107",
      "r108",
      "r113",
      "r115",
      "r119",
      "r120",
      "r121",
      "r124",
      "r125",
      "r306",
      "r307",
      "r378",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic net loss per common share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r69",
      "r103",
      "r104",
      "r106",
      "r107",
      "r108",
      "r115",
      "r119",
      "r120",
      "r121",
      "r124",
      "r125",
      "r306",
      "r307",
      "r378",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted net loss per common share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r313"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of exchange rate changes in cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r62",
      "r63",
      "r64",
      "r98",
      "r99",
      "r100",
      "r102",
      "r109",
      "r112",
      "r127",
      "r184",
      "r244",
      "r245",
      "r278",
      "r279",
      "r280",
      "r292",
      "r293",
      "r305",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r399",
      "r400",
      "r401",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination.",
        "label": "Equity Interest Type [Axis]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.",
        "label": "Equity Interest Issued or Issuable, Type [Domain]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting error correction.",
        "label": "Error Correction [Text Block]",
        "terseLabel": "Error Correction [Text Block]"
       }
      }
     },
     "localname": "ErrorCorrectionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization, Intangible Assets (in Dollars)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r199",
      "r200",
      "r204",
      "r206",
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r199",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions and Translations Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r196",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r71",
      "r95",
      "r153",
      "r157",
      "r160",
      "r163",
      "r165",
      "r183",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r310"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross (Loss) Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r66",
      "r153",
      "r157",
      "r160",
      "r163",
      "r165",
      "r371",
      "r375",
      "r379",
      "r393"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Loss before income taxes",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r111",
      "r112",
      "r151",
      "r286",
      "r294",
      "r295",
      "r394"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r61",
      "r284",
      "r285",
      "r287",
      "r288",
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Tax, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r79",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r197",
      "r202"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net of accumulated amortization of $83,683 and $126,769 as of August 31, 2021 and May 31, 2021, respectively"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r25",
      "r194"
     ],
     "calculation": {
      "http://www.biomerica.com/role/InventoriesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Finished products"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/InventoriesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory, Gross",
        "terseLabel": "Inventory, Gross"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReserve": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.",
        "label": "Inventory, LIFO Reserve",
        "terseLabel": "Inventory, LIFO Reserve"
       }
      }
     },
     "localname": "InventoryLIFOReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r46",
      "r47",
      "r48",
      "r192"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory reserve"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r43",
      "r343"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.biomerica.com/role/InventoriesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventories, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/InventoriesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r44",
      "r90",
      "r126",
      "r189",
      "r191",
      "r195",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r194"
     ],
     "calculation": {
      "http://www.biomerica.com/role/InventoriesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/InventoriesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r43",
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory Valuation Reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r26",
      "r194"
     ],
     "calculation": {
      "http://www.biomerica.com/role/InventoriesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/InventoriesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory Write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Dividend and interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r182",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating Leases, Rent Expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date",
        "terseLabel": "Lease Expiration Date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases [Policy Text Block]"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "1 to 2 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "5 to 10 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "4 to 5 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "3 to 4 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2 to 3 years"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r335"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Less than 1 year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases [Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38",
      "r95",
      "r159",
      "r183",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r299",
      "r302",
      "r303",
      "r310",
      "r341",
      "r342"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r23",
      "r95",
      "r183",
      "r310",
      "r343",
      "r373",
      "r385"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Shareholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r40",
      "r95",
      "r183",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r299",
      "r302",
      "r303",
      "r310",
      "r341",
      "r342",
      "r343"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MiddleEastMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Middle East.",
        "label": "Middle East [Member]",
        "terseLabel": "Middle East [Member]"
       }
      }
     },
     "localname": "MiddleEastMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r78",
      "r81",
      "r84"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net cash used in operating activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r56",
      "r58",
      "r64",
      "r67",
      "r84",
      "r95",
      "r101",
      "r103",
      "r104",
      "r106",
      "r107",
      "r111",
      "r112",
      "r118",
      "r153",
      "r157",
      "r160",
      "r163",
      "r165",
      "r183",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r307",
      "r310",
      "r376",
      "r389"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Total operating expense",
        "totalLabel": "Total operating expense"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r153",
      "r157",
      "r160",
      "r163",
      "r165"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Lease liability, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r328"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Lease liability, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r329",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r327"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right of use assets, net of accumulated amortization of $531,974 and $469,077 as of August 31, 2021 and May 31, 2021, respectively"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r334",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r333",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseMinimumRentals": {
     "auth_ref": [
      "r323",
      "r324",
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.",
        "label": "Operating Leases, Rent Expense, Minimum Rentals",
        "terseLabel": "Operating Leases, Rent Expense, Minimum Rentals"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseMinimumRentals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r51",
      "r53",
      "r311",
      "r312",
      "r314"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income:"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherInventory": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of other inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Other Inventory, Gross",
        "terseLabel": "Other Inventory, Gross"
       }
      }
     },
     "localname": "OtherInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other research and development expense.",
        "label": "Other Research and Development Expense",
        "terseLabel": "Other Research and Development Expense"
       }
      }
     },
     "localname": "OtherResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent",
        "terseLabel": "Payments for Rent"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Increase in intangibles"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockNoParValue": {
     "auth_ref": [
      "r15",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, No Par Value (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par Value (in Dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r15",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r15",
      "r343"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, Series A 5% convertible, $0.08 par value, 571,429 shares authorized, none issued and outstanding as of August 31, 2021 and May 31, 2021",
        "terseLabel": "Preferred stock, undesignated, no par value, 4,428,571 shares authorized, none issued and outstanding as of August 31, 2021 and May 31, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.",
        "label": "Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r31",
      "r32"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Period Adjustment [Abstract]"
       }
      }
     },
     "localname": "PriorPeriodAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from sale of common stock, net",
        "terseLabel": "Proceeds from Issuance of Common Stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r77",
      "r277"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of stock options",
        "terseLabel": "Proceeds from Stock Options Exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyAvailableForOperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property available for operating lease.",
        "label": "Property Available for Operating Lease [Member]",
        "terseLabel": "Property Available for Operating Lease [Member]"
       }
      }
     },
     "localname": "PropertyAvailableForOperatingLeaseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r209",
      "r343",
      "r380",
      "r386"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net of accumulated depreciation and amortization of $2,000,167 and $1,972,357 as of August 31, 2021 and May 31, 2021, respectively",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r209",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, Plant and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by property that could be leased or is available for lease.",
        "label": "Property Subject to or Available for Operating Lease [Axis]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r70",
      "r188"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Change in allowance on accounts receivable"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r258",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r258",
      "r338",
      "r340",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r283",
      "r355",
      "r426"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expense, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r19",
      "r245",
      "r281",
      "r343",
      "r384",
      "r403",
      "r408"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r98",
      "r99",
      "r100",
      "r102",
      "r109",
      "r112",
      "r184",
      "r278",
      "r279",
      "r280",
      "r292",
      "r293",
      "r305",
      "r399",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r144",
      "r145",
      "r156",
      "r161",
      "r162",
      "r166",
      "r167",
      "r170",
      "r247",
      "r248",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue From Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r91",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue [Policy Text Block]"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r65",
      "r95",
      "r144",
      "r145",
      "r156",
      "r161",
      "r162",
      "r166",
      "r167",
      "r170",
      "r183",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r310",
      "r379"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Net sales",
        "terseLabel": "Net Sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/GeographicinformationregardingnetsalesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r332",
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Sale of Stock, Consideration Received on Transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of Stock, Number of Shares Issued in Transaction (in Shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of Stock, Price Per Share (in Dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r137",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r111",
      "r112",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RESTATEMENTOFPREVIOUSLYISSUEDFINANCIALSTATEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r9",
      "r28",
      "r29",
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r266",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Option, Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit",
        "terseLabel": "Security Deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r142",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r170",
      "r211",
      "r212",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Option Cancelled or expired, Shares | shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Option Cancelled or expired, Exercise Price Weighted Average | $ / shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Option Granted, Shares | shares",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r268",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options Outstanding, Shares | shares",
        "periodStartLabel": "Options Outstanding, Shares | shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Option Outstanding, Exercise Price Weighted Average | $ / shares",
        "periodStartLabel": "Option Outstanding, Exercise Price Weighted Average | $ / shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r261",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Option Exercised, Exercise Price Weighted Average | $ / shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Option Granted, Exercise Price Weighted Average | $ / shares",
        "terseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r263",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based Payment Arrangement [Policy Text Block]"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price (in Dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balances (in Shares)",
        "periodStartLabel": "Balances (in Shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r88",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies [Text Block]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r142",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r170",
      "r196",
      "r210",
      "r211",
      "r212",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r93",
      "r95",
      "r115",
      "r116",
      "r117",
      "r119",
      "r121",
      "r128",
      "r129",
      "r130",
      "r183",
      "r218",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r230",
      "r231",
      "r234",
      "r238",
      "r244",
      "r310",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r42",
      "r62",
      "r63",
      "r64",
      "r98",
      "r99",
      "r100",
      "r102",
      "r109",
      "r112",
      "r127",
      "r184",
      "r244",
      "r245",
      "r278",
      "r279",
      "r280",
      "r292",
      "r293",
      "r305",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r399",
      "r400",
      "r401",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r98",
      "r99",
      "r100",
      "r127",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Net proceeds from ATM (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r244",
      "r245",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Option Exercised, Shares | shares",
        "terseLabel": "Exercise of stock options (in Shares)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/OptionsActivityTable",
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r244",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Net proceeds from ATM"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r42",
      "r244",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Stock option expense"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedCashFlow",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r21",
      "r22",
      "r95",
      "r179",
      "r183",
      "r310",
      "r343"
     ],
     "calculation": {
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Total Shareholders' Equity",
        "periodEndLabel": "Balances",
        "periodStartLabel": "Balances",
        "totalLabel": "Total Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable",
      "http://www.biomerica.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedBalanceSheet",
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r94",
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SHAREHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Other Equity accounts"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/RestatementontheconsolidatedstatementofoperationstheconsolidatedbalanceandtheconsolidatedstatementofcashflowsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r321",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r321",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r321",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r344",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events [Text Block]"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk [Member]"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period past due for trade accounts receivable to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Threshold Period Past Due for Write-off of Trade Accounts Receivable",
        "terseLabel": "Threshold Period Past Due for Write-off of Trade Accounts Receivable"
       }
      }
     },
     "localname": "ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable [Policy Text Block]"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r131",
      "r132",
      "r134",
      "r135",
      "r139",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r114",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Diluted (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of common and common equivalent shares:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r113",
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Basic (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.biomerica.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403832&loc=d3e34039-112682"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r427": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r428": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r429": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r431": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r432": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r433": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>48
<FILENAME>0001513162-21-000128-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001513162-21-000128-xbrl.zip
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M6^Z-JG:.FG%R] #WL[26J=W UZZ^-+Y_^]X?D*(LL03S@+94L#Y@?;<GR'H
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MS H;D'$;<-?ZUK@3$-\Y<MS19]7@@0KKRR<BE4BD(H(48:".IY&]=O_O_<!
M-82%\NG!:CV837TWA]1V5=UD+8>%F9J:*4RH:L)6"5MU--WL#GYN]=J=VZYO
MK\K"7$5(LI!8,>(L-/^Y9)LES)4P5\?3S=:O/[>_M@>^L:KD+]U6A?1H_1CI
MC[HKPBEAFB[#-%TF8K+?_M9I#+[W6E=?^C!2U15K4K,Z7U^F\V'#4]X6S/_)
M?D0?L+X[U\:-$&?NN]BM;(O^9^%0R?3OX,;86>WZGY:M^3TVE64'8.W4>J\0
M=X;2J5JQQ8TKJ:Z54Q5CS<\&K.\9;FD @4.\<?R*2M PS6^TPCX]_\/2_>XY
M.7+;[C0ZS7;CCF ZU+MO#-K=3DK.0T_L9/CO]_!,&/C-!M/EW/:;:F2$VS@;
M7$>9SKX_:,![K<Z@?YA^GK%&Y?P).==_CS0Z-Z3__6N_?=,& 6OUXR2IGQDQ
M:G8[-ZU.']0(_NIW[]HW($0W$5G"T["[#ZT>TZHEDK55#]=]0HA-^KDB_YK=
M^X=>ZV>86/N7%KGK]OODW?=.X_L-:,W,T=UI:?"9CE&L:S.Z2UO1:ID].\F>
MHG*!':VS3_ZBY.O+3B;=-H,).T66PZG[DW6M"=QD\N,CF1V#_[$_-W9!>.3/
M7\*/^?.NX2-3LUZ1'T2>N(3MKPHOXB3CM\A62K"X]_0 98%#B(&RIF&H<H3,
M.:EG''Q2*1; V9W.A71+W[Z&YPSMSO9'U5R"628KZ;-!++F=6L1U[CJ=;;H$
M!A_:[+TC#0?W+_)>#H>S>M%3=7YZK V'M)0V6[(5W3H49$0U6%EW%Y7(&CW^
MO ,=Y-T)0=A9F<& CZ!RS(HDLTRPZHR0PBYGA'A.[EE5)]<]^D)-CSJQIX%X
MCG;U19:4BBQ5:]6%DT"R*\:;GV9W7O,2ZGE\]50.K9YRJ2C5"I6-U/.$^4A*
MI+J)Y\_C*4[K';%(E2X]53JPW7AW.+^.8MY]\LW'*NM1+!>D:GG1N<?%]4=*
MVX3Z"?4[O?KMY;<W5K^"4I:J\F;J=]*T>OHO+Y?3[."_V:P//W;C?X^[YIYT
M5^0I"<3G&5+MO3PKDR\N5U'%=AAE<O,:7JM)]>KB(9H[>M=4<>ZR4N=CJII(
MA3?7NSF'*M>D0JV>]ESX% NUF5EQ/O4SDB&66".)M1]^+TSSF;1^3+!C,#O-
M3/C*M(9O(@BXR'F=KR >R^N?3;[<IX8!@Y;(,S7!]AJLD8.JC753=UR;=_D\
M>2UP#T><U6!ZKR369_HWSO*&J35F&.[[WI6%*UF6RL5R4HO"EQ,89E4>]TKN
M]I?'8J$LU4NE8V9^&2^D]JA#57LX8@Y!HR_4L";8[_Z0BZ9Q%#VSM8JC+^4<
MDV99-5Y[8JBXHH#9NIFJR5J;52K6I5IE,XN5_31#V UA-\[/;NP)[MK);E0Q
M\BYL%GF?(-M54AW4#"P74EPKK#)23FT!!,L:$B6K%F>O2"6LK@?%]5495:D,
M655]L[4T@0P3^GB9^KA7!+"%/BI20:Y*I=)1U[;//*?(:JZ4L269"V585N=U
MOH(H=L<@:I8\V=8X2)'XH:0B-\I4+'96T=<!H;QA^-4VA]:8HO!O .F5I7*I
M(!4KBY&8V#,CM#$UY#F[/3.[:F.M7@=MW QC+_(B$8YF96)B7N<UK_,51)$7
M!<?%H&/:%9">#OC9&>#HSH=8 DBVB?+<Z"^Z1A%5#/]T;$-&'1?^0&428+)T
MY3@"%'+B)=JV^0+:@4 0[FW:OKX@2,37H^6+1!6IMB$P)/LQF+ =PG:<G^W8
MJX*RE^VH286ZG"I0V<6$D2F8R/D0ZW)*>-NOW#U2L!8T"*U=]4>6>\UFH !S
M=BMFT]+\K6V-\0@MW?2 2-UPM?@K$T%^W0 %L/7#M55P\+JIVF]XN*?3L4P<
MD6VQ/5^!D]ILY:U8E,HQ>R9$/YW,STMH;P+QX6FUMU;'9M*;K9N+(%,$F2+(
M3%F0^6!;+[J#1@G,Q!9AIJC%9+D6DR'WFD!P#&[31_-_I29=V:VNCIA^$<L*
M$R%,Q/F8B 0B\"U,A"S)RN**C@B81<"<+F(ME[Y\=94 \D\S'C;CP5\&UF=W
M#9)]*B7J!)6\ C<EFN4]&C1-1OWP1Q?M0^E=?&=J27UV(39HTM9[-12I7%M<
MV-PTRIXS4)D.M(69$68F*V9FKS!]>S-3JRM2L;[9PE2BL=)!PL-%HW>$QQPN
M:C_)=,Z*:B)\7V%HOJJ./B1F$,1/J U7C,=@<9R1:N\.81;N5KC;K+C;O:+Z
MEFJ;0!/G@=I]U"BF<&O=+ES-],^Y^E+(RXJ(\(7)$2;G@DS.7A%^$B9G\<AE
M$>V+:/\,J":B_96[%0W/I9J(]T_.">%\T^M\$XWW?943$;^(^(71.1-2GWW$
MOYO1$3'_R:/7U$SGK*BV5"0K^<H*D?0_W23F/P_[_D\V,XCOU1=JJ\^4@-EX
MA C?>@J"?.Q2\NG1_O#%?TW_\'28#)Y\Q0W!I@V YFEW_G'&LJFE;V]6<G,3
M4SO'J9VO1)X\=DB)H>:KKH>MM9Q?V'W<W'!-W]O]J935-BY[E4>"$*7!(Y0.
M"U"Z3RQK<;J>Z[@0H@ %%]8LPK0E2%AD12HI%:E:V_V4P8.&O$*!A0*G4X'W
M*C4DJ,"R5"W5I&)U<9O@=IV9LKFPLUD3B<R5>U=6"G9L)GH,/19,O.RI944^
M18HVNU0NDC01XYUAC'>(),U7B8503Z1I0H6%"I]%FK:;"HM$303"QPB$4S\W
M,;5SG-KY2J0XG&BS]B*)-IA)R<S7@/62[7>3WA I4PTWC@&P$AIP41IPEKT@
MMO)>9^FYL]_4\DP:F0N&7>2\SE<01<S/#R0%MS2QZ8B:COY"60X@L7V+UA-V
MY18'E6;@&:*?_0&UZ-:R8;80+7JV3<WA&W%MU70,=A:&Z&@OVE5G(/?9*_MG
M7J89=3(\%?+UINFKS0"UAC^\86J#J0Y]4W43TZ:&K3M VQO/AI\/0 U+@[2J
M^S10?VR0496EBEP4;?*%W1%VYWSLSEXUEW38'5FJ*IO5,47O?1'<IS&XSR:8
M8"LKU5Q(D47_GG2L38A6&N>:%L1XYJW<:KE4D^0-%T@N I4AC(XP.A=@=/;*
M"?8U.K5Z29+E+<[2PE\J< T^T?27+V1*]-MN9Y#KM__5NN9$8*]O&_?MN]^N
M__J'9[D?FQ:D'-1&RO,W/I+[1N];NW,=(>X<;1?O,L<]_J;$?S$^\C\#VW+\
MGV3S2R-4)O'B6U@4WP@9EUB'&3E&M8J5V/7Z<#H:GM?/+3A^S)^#$27J$)?#
M5/,-+"=84A<8C=TZ011TL$'/MFJ 7;7YXMB(.A0D1'7IF)JNDX^7SL3T?.K[
MTWWW0>O70:YQU_[6N1Y2/-D[[H&S.N=?EYPMDV=X,;(_P$^PO\&='QK?6KFO
MO5;C[[FOK=MNKW5-5.-5?7.F=$!K'?W*'H-)L]'_I)*1C0[NIT&W.7=;WRW_
M5"A4*L,A7#Q 3X:BCZ>^H\C[5/:U^M,']4N$[H?S>-F2U:_M[GVKUVXV)-+N
M-/.DT;DA_>]?^^V;=J/7;O43<'HQX]\X4-O$[36[G9M6I]^Z(?!7OWO7OFD,
MX,77QEVCTVR1_L^MUJ#/VJ$E:"/WX5U4@B)*'A,'P"AGLBX6S<&-#,./KUG
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M'RBF/34I#FXCPBTZETRX-19BKS,<=[(0Q8)4+E6D8C&F8<I>:X<9X_+6EB+
M[F:,#H=/1*98Y$LFW4H[<;3,HRXI2E4J*)LE'JF%?J];BCW\Z5MQBX/'?6IE
M0T!CH@^-+%8=F\8G>&AD>>+(#_8+^4>F\;10?MP'1PK+%R!5D1+GD2W&M"1X
M=#*?R&I,*T 'W]HUK9B<4?>-#5-CT>U![/43L,*EL7WK![6'ND.)]01?@6B<
M6!,,JG< : L\X=;+-OL?4<;AA#>>#;1Z@)E8&H<9L@^[G)4!C]>@#J5RH2
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MO2P5"@6I)I=W->&QG!?PK70HX(5 JW=0OP40T3D85(&W3@TK+@)S?0E!RN4
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M?ONFW>BU6_T955.)KGV^:M["XU$:SG_VS6[GIM7IMVX(_-7OWK5O&@-XT1_
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MU28W\4-@# HQ!X*(5"KS\Q(J>FB'G)"*RE*A6)/DTF9:>NE95X]J'F<M?-]
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M*VJXU?K2(X55!]LT84,JH.G<%'F7$SVZ+P!F?;"=>FRS6SBO%:&!+,=.)^Q
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M0[_?E/<\_+=UN/44\?(1R<L#VO4 GFP.W=F'MYG #;8'G-K0=0\A*G@4NS?
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MG;9N5YJM/#]C-T4B$4B!\ PNCLR&_EJ.S( ;]N4HS^O+L2D#EM9FP--J"14
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M(O6PSWU=J<L\J],JB=%IU7H:^+[+=:5B.2N6U<2(9;Y63B/9-5+O7I7>K5^
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MOQQA_]D%#6KP_DR-;E.JE0JRQ%?KM8VPV)^NA@CS.I&"=+6/Y0\J%72H3C_
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M JZISVM+$N4\F\&RU&4,B/N*2DI5-7P&]GR W3Z1I>SI.<#;*N&VU-X[D0>
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M*BFEW>T/F>IBF^DF[-HU;%IX*X/20?N!;]^C29/8KEVE*'XMEW/9/.Y8S[1
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MM_9&JW'5Y:)NN4D*QR\;S5^^/'2>[JXNA,:<*8CRRE=$X^:0]A3F,5+'LLA
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M<>[Z_5^@!QIXRWP*L#RRY#@I8JQL-*,R]XP\Y%N(;9Z 30ZVV8G&BZ;KV&A
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MJR&%%<X<>1>E!4J/%W!B%:6B85FL?Y@A#5Q#Q8)9?AB-3S<>;Z4&WA;@IC&
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M5<;<,H#H:L7.^-'N#.6EL0B_-BR0?2> ]^L<YW8,Z9\N,$G!+[)G7L\D#':
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MY*-77S3ZC?Z[UJWF2OA$IH=K@G R.:FSZL;HDR\<;_7/.@J#F_]02P,$%
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M9]!98'5E(HV= L!+;A[#A8K9\18;ND2ULM*;?=H5,)HJ7!4QRD0VYD'$/M@
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MQP9OE(JI-9O**5!=AXG[N@,/!F@V%Q*+]G:-00^:JJPA'827]AJNOWCN(NT
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MH!)+5]EW>LV?+2OI;KBD)C.4*UY%JQ7AD$J@4KE\K]L.&J(0V (J4FB%%/9
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M+"4A"$6*(XZV%>!MA%9HKU+DJTL<%/<-ZZP3;NX\*VGU00^UN(8)2GUQ";9
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M9-J9]MAI$D=*/PY&]Y.;/P>3R7WOJC\8=NBYTKG9?F:B[%;?83? 25QYUU(
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M\L863^:H'P50&Y4G=$C!O\WI$(!#0UJ'=+!BVQ+Q&@5S;*T6=.UZ6J\1JRG
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M&'X"</,/=Y?"B;VM$61ZOK+)L1&S33Y#_.\KQ$^-4_B<P<B'?L$KIB!1,QF
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M._(#K,9V:G"ZP7:M7)9]O9G>J-#:*DOO&:8XG\I8402U,2Q7+VT,+[X80:U
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MXLQ#BP.L"+54+^[)FY\A+N:^3\K/>"'>%R^CW DS(D;D([JX<9'P([PZ*?H
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M<W$0,&-W3O (21J8$4^R)GQ8#^4R8-+LA>ODMO4>,&FE(#(0H/E1YPXBL_<
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M+Y Z\,/;0Y9?*!=AL44"S/D.KY]"UP5#'%3404$>8'4#9@ 24E+$#I>90F>
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MW#$]>T?=0R[-<K\L;PS- .FX#Y8(;DSH>L@P/?Q@>VO3QQ[5A1-'QN9DNB<
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M%"@4X)N82+D9Z4+L39:1*DIH24MH"3<96"*"KC@(>A,2Y!+_E S^!7&RP>A
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MW09GHA'^).3VBP5R/_K1*X4+6!"6# ;4M4&61@H"02#H57+MG &R^<&V!^8
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MX]8.JY(>>GV6SFBUUE_+VEZ?7H%JE(53M)XM5&4GSV_.5MJCKV8*5VL7XO5
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M=0H0_8.Q E?-G*XF!9[KQJ.<UU((-6\=%X0\3"L-A14EI@;V>CX80/0!V1Z
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MA8&-L'=H<0$#"1R/&Y9]7X\?4HY@:7_UY']FMQ=S__XC,(EN$]39D4%'A]P
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M<$?LVKW-PZBX*BXE]::$L'8>&%7(&M1%YBD:N&+/>BJ7G*OQ(U=CN,)9MPB
M%22[_V@C\+V?_5KWNG?9;SNCZT"[Y[W^N=?WVP?O$<()WP74D3 (!.>V*O1U
M6*HDD2'/C=L"B+X.):0J$"M7A?JI7,,""N->&JHW!(-U(K&6J(^NE'>]XK6(
MN07-Z=\J[U62!I(#>BI1N C'J%A&/+/!!D9&DFN)@&0ATU:$$K*4&Q).2W.
M33IKZU,9@8@P $LZ>8JV*<,\YJ0L.)F-8EG<Q!RKZ+:N26%L+X*K0-!*E#X,
MB.B94O\6+ BV6;"H'/:UPMDDP\MWOHP2M HTNI<1X<R-2CC)"S?@"#52 I_K
M:($#J"%Y(&.9S4FTGW)+Q+2063 *1CU:NM:'J;+%@SM0FNL4;#"VDX2ATI$-
MP'9DNL9T48 ,"LJ4Q.E6)&@:,:B"YR)=:KY@GQ))5R-R9=M+MYBVWA@S0F*&
MN.=Q;@N((A?C,9JFO,?1C&%;K0^=X@MJ $MK>E#(P].=T)( 6U'(IFBX@<HS
M<H26\I3[EV@67ZX6%(O[V]7MTY,3"Q;#BF6VRP,B.B+K;PNIR-9PD8?MA-+P
MZQJ:(^ CQ/Z//FE5685AKBE?:PJX;K!<FBJ3X1:]'<*,"6'C<_'*P7:VW(^!
M-VIHL<!%B E+6)PX#>])O@QCMPABPLVR/5"%66*(R J2/;D3"XSIL;P36&*G
M]8T-U2]GXY&"E4M/9.,;\Z!R<OAG1C7[.KBD2K5@.3*=V+I;1V[%>#L!Y_IK
MZKYH>;8Q;'5GA,;1FC.ES5*%[0U8F^*5*Q/"U2C96=L5*$@\/8HD(K/[=^@U
MS9X3)6Q()/!)(X+C(Y3B<RX1OV5@GH1V=-]]9A[[9O,7O950#Y0 B69'&D-#
M*9!0IY/+(6@F^!WI7M&#K/+9[LEHV%Z^H%"B7MZ%BWD%4PGE?%$R;%4Q/,).
M(Y8%\P2FKM]FBDQ07ZP6RFL@NR:?3C%P_2[L29P<K>)8&^O>H*C:P8BT<ZS!
MTRIR)2SEP#W[6NYPJ1:"))-[%=\+4J6$W[KO%QQ+0<=I&JNYP./91!4UR!_!
M#I3^JCK7GTG?^E=BF9VAW*+_]<[]JW:KV:C_>$A9/!T,S[UA[6QP?=V]&7GM
M4,4Q3XU8)*MV[5WX[5JQO(+Q)\HFQY76^V8%DA/')N4A0CFN-(KKE$?1XCH
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MB5".9'S/YC*=X(PF$8%UD0PG<$Z%U4J@9E@7,G]1#L4K /WH2= %&\L8026
MUC%T@#BFX[5>OZ]69#Q&@O!4PI",@R@+811(E0+F &9)294@SD028D\4K5A0
MK13Q-X]W!]="2:8=@BB+@"2P5\#';FBL2P$W$S:.U-Q4*P4SM+B7)M4<>W%:
MDOL.1YT2OF;ISY;#KP#AGPEA;R,4;TR!7B'<Q'XU'DL\VO#T&-?"I@(B*_U(
M4,"J%0$*^)$T$YI/\Z;(?E( >@ZE"2)E,BPD7= JRC%)M I$B&'#]CAP"05
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M7-@  &)M<F$M,C R,3 X,S$N>'-D4$L! A0#%     @ 88=.4W5MPM$F"P
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M   /              "  ;*R 0!E>&AI8FET,S%?,2YH=&U02P$"% ,4
M" !AATY3Y]H10,$'  "5(@  #P              @ &[N@$ 97AH:6)I=#,Q
M7S(N:'1M4$L! A0#%     @ 88=.4RLY'2E?!   9!    \
M ( !J<(! &5X:&EB:70S,E\Q+FAT;5!+ 0(4 Q0    ( &&'3E.D4_WO9P0
M +<0   /              "  37' 0!E>&AI8FET,S)?,BYH=&U02P4&
/  H "@!^ @  R<L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
